{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "cc8f9942",
   "metadata": {},
   "source": [
    "# Objectif:\n",
    "\n",
    "On souhaite évaluer le nombre de publications qui sont le résultat d'études cliniques liées à l'INSERM.\n",
    "\n",
    "En particulier, on souhaite identifier les études cliniques qui ne donnent lieu à aucune publication et essayer de comprendre les raisons de cette absence de publication."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f4027005",
   "metadata": {},
   "source": [
    "# Organisation :\n",
    "Dans ce premier notebook, l'objectif est d'extraire de manière automatique les données des études cliniques:\n",
    "\n",
    "- On récupère via l'API de *ClinicalTrial* les *ID* (**NCTId**) des études cliniques qui ont :\n",
    "  + pour sponsors l'*INSERM*, l'*ANRS* etc.\n",
    "  + un statut 'COMPLETED'\n",
    "  + une date de fin d'étude postérieure à 2013\n",
    "\n",
    "- A partir de ces **NCTIds**:\n",
    "   + on récupère sur *ClinicalTrial* les **PMIDs** des publications liées à ces études.  \n",
    "    Ces publications sont de 2 types:\n",
    "        1. Elles ont été uploadées sur *CT* par les auteurs de l'étude: `BACKGROUND, RESULT`\n",
    "        2. Elles ont été automatiquement récupérés sur PubMed par *CT*: `DERIVED`\n",
    "    + on récupère sur *PubMed* les **PMIDs** des publications liées à ces études.  \n",
    "      On retrouve général un peu plus de publications que le traitement automatique réalisé par *CT*. \n",
    "\n",
    "- Pour chaque **NCTIds**, on fusionne l'ensemble des **PMIDs** retournées par *CT* et *PubMed*.\n",
    "\n",
    "- A partir de cet ensemble de **PMIDs**, on récupère les infos liés via *Pubmed*: `titre, auteurs, doi`...\n",
    "\n",
    "- On récupère le status OA avec le DOI et l'API d'Unpaywall\n",
    "\n",
    "- On sauvegarde le résultat sous la forme d'une fichier CSV."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "65464cb1-f3cd-42cd-9f89-9aa323196250",
   "metadata": {},
   "source": [
    "# Extraction des NCTIds dans ClinicalTrial:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a3ef6948-8a2a-460c-a3ba-7d300527c78b",
   "metadata": {},
   "source": [
    "<span style=\"color:red\">**Obsolète**</span>  \n",
    "<span style=\"color:red\">**L'API v1 n'est plus disponible depuis mi-2024.**  \n",
    "**Aller directement à [la section API v2](#API-v2:)**</span>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "338bf2ef-bbcc-427a-8840-0f2b91b17292",
   "metadata": {},
   "source": [
    "## API v1:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "548c1a1f-38fd-455f-abd2-6111b492a446",
   "metadata": {},
   "source": [
    "Pour faciliter la récupération des données via l'API v1 de ClinicalTrial, on utilise le wrapper Python: [pytrials](https://github.com/jvfe/pytrials)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7de1cbc9-3b95-40cf-8ceb-73efdc8e9661",
   "metadata": {},
   "source": [
    "Installer ***pytrials***:\n",
    "- Dans Conda Navigator, se placer dans le meme environnement que celui qui execute Jupyter\n",
    "- Lancer Powershell Prompt dans cet environnement\n",
    "- Taper: `pip install pytrials`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "2ae35742-d8a3-448b-b616-636604a16a50",
   "metadata": {},
   "outputs": [],
   "source": [
    "# from pytrials.client import ClinicalTrials\n",
    "# import urllib.parse"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "e22ac03f-cafe-4757-9c41-4bf21940f058",
   "metadata": {},
   "outputs": [],
   "source": [
    "# ct = ClinicalTrials()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f5f94dc3-f00c-4a26-b360-63d46912aab4",
   "metadata": {},
   "source": [
    "### Création de la requête:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "479b8333-7891-4eac-a718-775fb3da2616",
   "metadata": {},
   "source": [
    "On crée la requête qui sera envoyé à l'API de ClinicalTrial"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "979cef8b-2f59-4ffc-b8e1-713c2df54f7d",
   "metadata": {},
   "source": [
    "#### Sponsors:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "fa86d5bc-e8ba-498a-a20d-ba223e05ef89",
   "metadata": {},
   "outputs": [],
   "source": [
    "# sponsors = [\n",
    "#     'anrs',\n",
    "#     'inserm',\n",
    "#     'institut national de la santé et de la recherche médicale',\n",
    "#     'french national agency for research on aids and viral hepatitis',\n",
    "# ]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "11a94424-1569-4107-ba6d-6310db1079ea",
   "metadata": {},
   "outputs": [],
   "source": [
    "# sponsors_expr = [f'AREA[LeadSponsorName]{sponsor}' for sponsor in sponsors]\n",
    "\n",
    "# # Add OR keyword\n",
    "# sponsors_expr = ' OR '.join(sponsors_expr)\n",
    "\n",
    "# # Add parenthesis for correct interpretation of OR expression\n",
    "# sponsors_expr = f'({sponsors_expr})'\n",
    "\n",
    "# sponsors_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f673c610-bd07-4441-8954-bb9471b3eb4d",
   "metadata": {},
   "source": [
    "#### Status:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "b7faf8d7-45d7-42c9-8769-05b4b161b0d8",
   "metadata": {},
   "outputs": [],
   "source": [
    "# status = 'completed'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "718888a1-e9b7-48e6-bb19-d40adbeb12a2",
   "metadata": {},
   "outputs": [],
   "source": [
    "# status_expr = f'AREA[OverallStatus]{status}'\n",
    "# status_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a66697a1-5355-4684-b3cb-ec980f4d7dad",
   "metadata": {},
   "source": [
    "#### Date de fin d'étude supérieure ou égale à 2013:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b8969e43-68f3-451b-b161-ee7f1f054179",
   "metadata": {},
   "source": [
    "<span style=\"color:red\">**Mettre à jour la date si nécessaire**</span>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "643616d1-3184-459f-9aa9-3677975acf08",
   "metadata": {},
   "outputs": [],
   "source": [
    "# date_expr = 'AREA[CompletionDate]RANGE[01/01/2013,MAX]'\n",
    "# date_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a0fba5e7-f5ac-4522-87f4-59750f158c9c",
   "metadata": {},
   "source": [
    "#### Search Expression:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "2a93eed1-3da5-483b-9641-93e073d72eb3",
   "metadata": {},
   "outputs": [],
   "source": [
    "# search_expr = ' AND '.join([sponsors_expr, status_expr, date_expr])\n",
    "# search_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5317cc15-f232-43d2-84a0-dffd039866ff",
   "metadata": {},
   "source": [
    "#### URL encode: "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "74564518-2bff-4de8-854e-5690d8b3be95",
   "metadata": {},
   "outputs": [],
   "source": [
    "# search_expr_url_encode = urllib.parse.quote_plus(search_expr)\n",
    "# search_expr_url_encode"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4ba1adce-a84f-494b-8724-ee555d5c7d57",
   "metadata": {},
   "source": [
    "#### Fields:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c5114e6f-8606-4109-ac13-62d2cf22975a",
   "metadata": {},
   "source": [
    "Les champs que l'on veut récupérer:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "af5a1984-b35d-4af6-85ca-d276ffe37af5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# fields = [\n",
    "#     'NCTId',\n",
    "#     'BriefTitle',\n",
    "#     'OverallStatus',\n",
    "#     'StudyType',\n",
    "#     'LeadSponsorName',\n",
    "#     'CollaboratorName',\n",
    "#     'OrgStudyId',\n",
    "#     'SecondaryId',\n",
    "#     'StudyFirstPostDate',\n",
    "#     'ReferencePMID',\n",
    "#     'ReferenceCitation',\n",
    "#     'ReferenceType',\n",
    "# ]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "67d2fde1-5386-4773-b10a-90a8ff153dc5",
   "metadata": {},
   "source": [
    "### Envoi de la requête :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "ee115e0b-e412-4465-994e-b25dd746c5f9",
   "metadata": {},
   "outputs": [],
   "source": [
    "# study_fields = ct.get_study_fields(\n",
    "#     search_expr=search_expr_url_encode,\n",
    "#     fields=fields,\n",
    "#     max_studies=1000,\n",
    "#     fmt='csv',\n",
    "# )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "0a86dcfc-d52b-4d7c-8041-b3ffac03b982",
   "metadata": {},
   "outputs": [],
   "source": [
    "# print(f'NStudiesReturned: {len(study_fields[1:])}')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "17dec420-05d4-4724-b626-931f5f23c115",
   "metadata": {},
   "source": [
    "### Lire le résultat de la requête dans Pandas :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "3de5e52f-2e18-4c00-85f2-75b4c3249706",
   "metadata": {},
   "outputs": [],
   "source": [
    "# import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "34aced60-0e4c-4fec-8379-37026be31837",
   "metadata": {},
   "outputs": [],
   "source": [
    "# pd.DataFrame.from_records(study_fields[1:], index='Rank', columns=study_fields[0])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "21b09539-cd2a-44e6-85bd-fd1a77c2eac7",
   "metadata": {},
   "source": [
    "## API v2:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e47cc848-f6eb-4c27-8f79-c31d2b6f6a27",
   "metadata": {},
   "source": [
    "L'API v1 ne sera plus supporté a [partir de mi-2024](https://clinicaltrials.gov/data-api/api) :"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ccb8b923-cd0d-4704-af4d-537bc9ff9448",
   "metadata": {},
   "source": [
    ">***Notice to API users:  \n",
    ">The new ClinicalTrials.gov API, version 2.0 is available. Classic API users are strongly encouraged to switch to the modernized API. We will continue to support the classic API until mid-2024 and are planning blackouts for the spring to help with the transition to the modernized API.***"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4760cf2e-125c-4961-bde4-5939a55a9159",
   "metadata": {},
   "source": [
    "De plus, l'API v2 supporte un nouveau champs **\"HasResults\"**, qui pour l'instant n'est que très peu utilisé mais qui pourrait être utile à l'avenir.\n",
    "\n",
    "En contre-partie, l'export des données sous forme de CSV est limité à un certain nombre de champs visible sur cette page: https://clinicaltrials.gov/data-api/about-api/csv-download\n",
    "\n",
    "On est donc obligé d'utiliser l'export de données sous forme de JSON."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "dd0f1b6c-08c4-46a4-bba6-7a4a5254aa3d",
   "metadata": {},
   "outputs": [],
   "source": [
    "import urllib.parse"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cc42bfa7-3115-410a-8244-d1ad36551a3f",
   "metadata": {},
   "source": [
    "### Création de la requête:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0f8d8cb3-4485-4899-9080-09fa01fa4e46",
   "metadata": {},
   "source": [
    "`pytrials` n'étant pas compatible avec la v2, on envoie la requête manuellement en utilisant [Requests](https://requests.readthedocs.io/en/latest/) "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a5fed10d-6587-43fd-8e93-9dfd937db9e0",
   "metadata": {},
   "source": [
    "#### Format:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "c9c74f1a-8345-44a7-8a5e-e034ed6bac96",
   "metadata": {},
   "outputs": [],
   "source": [
    "format = 'json'"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "00b5564b-8a48-4fba-b0eb-f396af6c2f93",
   "metadata": {},
   "source": [
    "#### Sponsors:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "28745196-a342-47e7-9b95-d1f214ba4372",
   "metadata": {},
   "outputs": [],
   "source": [
    "sponsors = [\n",
    "    'anrs',\n",
    "    'inserm',\n",
    "    'institut national de la santé et de la recherche médicale',\n",
    "    'french national agency for research on aids and viral hepatitis',\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "97255a51-e80a-4ded-878e-116f62b761d9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'anrs+OR+inserm+OR+institut+national+de+la+sant%C3%A9+et+de+la+recherche+m%C3%A9dicale+OR+french+national+agency+for+research+on+aids+and+viral+hepatitis'"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sponsors_expr_v2 = ' OR '.join(sponsors)\n",
    "sponsors_expr_v2 = urllib.parse.quote_plus(sponsors_expr_v2)\n",
    "sponsors_expr_v2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f2014ccb-b5ba-4bdb-90e0-040900c08c87",
   "metadata": {},
   "source": [
    "#### Overall_status:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "380fae7f-a745-4cfc-93f2-53d64f75717c",
   "metadata": {},
   "outputs": [],
   "source": [
    "overall_status = 'COMPLETED'"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7a1431ad-b7a8-4c7c-8f97-cfa13cc1aa61",
   "metadata": {},
   "source": [
    "#### Fields:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "98e9a105-7e78-47cc-b572-b42a67b3aaa7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['NCTId',\n",
       " 'BriefTitle',\n",
       " 'OverallStatus',\n",
       " 'StudyType',\n",
       " 'LeadSponsorName',\n",
       " 'CollaboratorName',\n",
       " 'StudyFirstPostDate',\n",
       " 'StartDate',\n",
       " 'CompletionDate',\n",
       " 'ReferencePMID',\n",
       " 'ReferenceCitation',\n",
       " 'ReferenceType',\n",
       " 'hasResults']"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "fields_v2 = [\n",
    "    'NCTId',\n",
    "    'BriefTitle',\n",
    "    # 'OfficialTitle',\n",
    "    'OverallStatus',\n",
    "    'StudyType',\n",
    "    'LeadSponsorName',\n",
    "    'CollaboratorName',\n",
    "    # 'OrgStudyId',\n",
    "    # 'SecondaryId',\n",
    "    'StudyFirstPostDate',\n",
    "    'StartDate',\n",
    "    # 'PrimaryCompletionDate',\n",
    "    'CompletionDate',\n",
    "    'ReferencePMID',\n",
    "    'ReferenceCitation',\n",
    "    'ReferenceType',\n",
    "    'hasResults',\n",
    "]\n",
    "fields_v2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "7830602f-81b0-425c-bc69-f4f96db82948",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'NCTId%2CBriefTitle%2COverallStatus%2CStudyType%2CLeadSponsorName%2CCollaboratorName%2CStudyFirstPostDate%2CStartDate%2CCompletionDate%2CReferencePMID%2CReferenceCitation%2CReferenceType%2ChasResults'"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "fields_expr_v2 = ','.join(fields_v2)\n",
    "fields_expr_v2 = urllib.parse.quote_plus(fields_expr_v2)\n",
    "fields_expr_v2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "047b4eee-4ee5-4691-9c12-68d53ee44db7",
   "metadata": {},
   "source": [
    "#### Date de fin d'étude postérieure à 2013:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "683a7986-d630-4412-8a36-d003e096fd50",
   "metadata": {},
   "source": [
    "<span style=\"color:red\">**Mettre à jour la date si nécessaire**</span>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "e12ffc32-06d6-431d-896e-a6b5569a5817",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'AREA%5BCompletionDate%5DRANGE%5B01%2F01%2F2013%2C+MAX%5D'"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "date = '01/01/2013'\n",
    "date_expr = urllib.parse.quote_plus(f'AREA[CompletionDate]RANGE[{date}, MAX]')\n",
    "date_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fcd86e2b-ebad-4806-b5f4-c9e283db79f4",
   "metadata": {},
   "source": [
    "#### Nombre de résultats max :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "fd0b7d3d-0a8b-43bc-a078-00464b940972",
   "metadata": {},
   "outputs": [],
   "source": [
    "count_total = 'true'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "46cc35ff-1519-4433-a6bc-a49bc4c28e1a",
   "metadata": {},
   "outputs": [],
   "source": [
    "page_size = 1000"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c6c28d63-9bcf-4de6-bea0-4d143fcc002d",
   "metadata": {},
   "source": [
    "#### URL api:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "42d61bdd-b160-45b2-a782-d3b1f887d631",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'https://clinicaltrials.gov/api/v2/studies?format=json&query.lead=anrs+OR+inserm+OR+institut+national+de+la+sant%C3%A9+et+de+la+recherche+m%C3%A9dicale+OR+french+national+agency+for+research+on+aids+and+viral+hepatitis&filter.overallStatus=COMPLETED&fields=NCTId%2CBriefTitle%2COverallStatus%2CStudyType%2CLeadSponsorName%2CCollaboratorName%2CStudyFirstPostDate%2CStartDate%2CCompletionDate%2CReferencePMID%2CReferenceCitation%2CReferenceType%2ChasResults&filter.advanced=AREA%5BCompletionDate%5DRANGE%5B01%2F01%2F2013%2C+MAX%5D&countTotal=true&pageSize=1000'"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Make sure we don't have more than 1000 results, otherwise we need to handle several page of results\n",
    "query_url = f'https://clinicaltrials.gov/api/v2/studies?format={format}&query.lead={sponsors_expr_v2}&filter.overallStatus={overall_status}&fields={fields_expr_v2}&filter.advanced={date_expr}&countTotal={count_total}&pageSize={page_size}'\n",
    "query_url"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "da875083-d048-4247-bba1-e71f88d23d6b",
   "metadata": {},
   "source": [
    "### Envoi de la requête :"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fe125310-7a06-4d21-8ec7-19f802355915",
   "metadata": {},
   "source": [
    "Installer [Requests](https://requests.readthedocs.io/en/latest/) et [Requests_cache](https://requests-cache.readthedocs.io/en/stable/index.html), si ils ne sont pas déjà présent:\n",
    "\n",
    "`python -m pip install requests`  \n",
    "`python -m pip install requests-cache`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "5c83ef54-aa5b-417b-9948-0917421dbb92",
   "metadata": {},
   "outputs": [],
   "source": [
    "from datetime import timedelta\n",
    "import requests\n",
    "import requests_cache\n",
    "\n",
    "# Add caching to all requests functions\n",
    "requests_cache.install_cache(\n",
    "    cache_control = True, # Use Cache-Control response headers for expiration, if available\n",
    "    expire_after = timedelta(days=1), # Otherwise expire responses after one day\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "bfa9259e-3c18-458b-9286-9e16a08123da",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "CachedResponse(_content=b'{\"totalCount\":200,\"studies\":[\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02777229\",\"briefTitle\":\"Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-07\"},\"completionDateStruct\":{\"date\":\"2021-07\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-05-19\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Institut de Recherche pour le Developpement\"},{\"name\":\"UNITAID\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"33355914\",\"type\":\"DERIVED\",\"citation\":\"Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lantche Wandji M, Mpoudi-Etame M, Maradan G, Omgba Bassega P, Varloteaux M, Montoyo A, Kouanfack C, Delaporte E, Boyer S; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). Pharmacoeconomics. 2021 Mar;39(3):331-343. doi: 10.1007/s40273-020-00987-3. Epub 2020 Dec 23.\"},{\"pmid\":\"33010241\",\"type\":\"DERIVED\",\"citation\":\"Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-Etame M, Leroy S, Perrineau S, Lantche Wandji M, Tetsa Tata D, Omgba Bassega P, Abong Bwenda T, Varloteaux M, Tongo M, Mpoudi-Ngole E, Montoyo A, Mercier N, LeMoing V, Peeters M, Reynes J, Delaporte E; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. Lancet HIV. 2020 Oct;7(10):e677-e687. doi: 10.1016/S2352-3018(20)30238-1.\"},{\"pmid\":\"31339676\",\"type\":\"DERIVED\",\"citation\":\"NAMSAL ANRS 12313 Study Group; Kouanfack C, Mpoudi-Etame M, Omgba Bassega P, Eymard-Duvernay S, Leroy S, Boyer S, Peeters M, Calmy A, Delaporte E. Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. N Engl J Med. 2019 Aug 29;381(9):816-826. doi: 10.1056/NEJMoa1904340. Epub 2019 Jul 24.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01882062\",\"briefTitle\":\"Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-05\"},\"completionDateStruct\":{\"date\":\"2013-07\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-06-20\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"25568297\",\"type\":\"RESULT\",\"citation\":\"Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, Valabregue R, Durr A, Mochel F. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology. 2015 Feb 3;84(5):490-5. doi: 10.1212/WNL.0000000000001214. Epub 2015 Jan 7.\"}]}},\"hasResults\":true},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03671291\",\"briefTitle\":\"Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2019-04-03\"},\"completionDateStruct\":{\"date\":\"2021-10-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2018-09-14\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"French National Agency for Research on AIDS and Viral Hepatitis\"},\"collaborators\":[{\"name\":\"University Hospital, Marseille\"},{\"name\":\"University Hospital, Grenoble\"},{\"name\":\"Centre Hospitalier Universitaire de Nice\"},{\"name\":\"University Hospital, Montpellier\"},{\"name\":\"Hospital Purpan\"},{\"name\":\"University Hospital, Bordeaux\"},{\"name\":\"H\\xc3\\xb4pital de la Croix-Rousse\"},{\"name\":\"Centre Hospitalier Universitaire Dijon\"},{\"name\":\"University Hospital of Saint-Etienne\"},{\"name\":\"University Hospital, Clermont-Ferrand\"},{\"name\":\"Centre Hospitalier Universitaire de Besancon\"},{\"name\":\"Tourcoing Hospital\"},{\"name\":\"University Hospital, Strasbourg\"},{\"name\":\"Nantes University Hospital\"},{\"name\":\"Centre Hospitalier R\\xc3\\xa9gional d\\'Orl\\xc3\\xa9ans\"},{\"name\":\"Rennes University Hospital\"},{\"name\":\"Saint Antoine University Hospital\"},{\"name\":\"Tenon Hospital, Paris\"},{\"name\":\"Saint-Louis Hospital, Paris, France\"},{\"name\":\"H\\xc3\\xb4pital Necker-Enfants Malades\"},{\"name\":\"Bicetre Hospital\"},{\"name\":\"Piti\\xc3\\xa9-Salp\\xc3\\xaatri\\xc3\\xa8re Hospital\"},{\"name\":\"Bichat Hospital\"},{\"name\":\"University Hospital Center of Martinique\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT05349162\",\"briefTitle\":\"Epicardial vs. Transvenous ICDs in Children\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2003-01-01\"},\"completionDateStruct\":{\"date\":\"2022-04-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2022-04-27\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Paris Cardiovascular Research Center (Inserm U970)\"},\"collaborators\":[{\"name\":\"H\\xc3\\xb4pital Necker-Enfants Malades\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01703962\",\"briefTitle\":\"Non Invasive IDentification of Gliomas With IDH1 Mutation\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-03-14\"},\"completionDateStruct\":{\"date\":\"2014-03-20\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-10-11\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01508494\",\"briefTitle\":\"Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-06-29\"},\"completionDateStruct\":{\"date\":\"2016-06-22\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-01-12\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02542891\",\"briefTitle\":\"European Comparative Effectiveness Research on Internet-based Depression Treatment\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-09\"},\"completionDateStruct\":{\"date\":\"2018-09-15\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-09-07\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"European Commission\"},{\"name\":\"Fondation FondaMental\"},{\"name\":\"Assistance Publique - H\\xc3\\xb4pitaux de Paris\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"34874888\",\"type\":\"DERIVED\",\"citation\":\"van Genugten CR, Schuurmans J, Hoogendoorn AW, Araya R, Andersson G, Banos R, Botella C, Cerga Pashoja A, Cieslak R, Ebert DD, Garcia-Palacios A, Hazo JB, Herrero R, Holtzmann J, Kemmeren L, Kleiboer A, Krieger T, Smoktunowicz E, Titzler I, Topooco N, Urech A, Smit JH, Riper H. Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study. JMIR Ment Health. 2021 Dec 6;8(12):e32007. doi: 10.2196/32007.\"},{\"pmid\":\"27488181\",\"type\":\"DERIVED\",\"citation\":\"Kleiboer A, Smit J, Bosmans J, Ruwaard J, Andersson G, Topooco N, Berger T, Krieger T, Botella C, Banos R, Chevreul K, Araya R, Cerga-Pashoja A, Cieslak R, Rogala A, Vis C, Draisma S, van Schaik A, Kemmeren L, Ebert D, Berking M, Funk B, Cuijpers P, Riper H. European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries. Trials. 2016 Aug 3;17(1):387. doi: 10.1186/s13063-016-1511-1.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03298360\",\"briefTitle\":\"A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2018-06-28\"},\"completionDateStruct\":{\"date\":\"2020-06-25\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-10-02\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01771562\",\"briefTitle\":\"Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-04\"},\"completionDateStruct\":{\"date\":\"2016-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-01-18\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"30081838\",\"type\":\"DERIVED\",\"citation\":\"Cames C, Pascal L, Ba A, Mbodj H, Ouattara B, Diallo NF, Msellati P, Mbaye N, Sy Signate H, Blanche S, Diack A; MAGGSEN Cohort Study Group. Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study. BMC Infect Dis. 2018 Aug 6;18(1):374. doi: 10.1186/s12879-018-3282-7.\"},{\"pmid\":\"27881690\",\"type\":\"DERIVED\",\"citation\":\"Cames C, Varloteaux M, Have NN, Diom AB, Msellati P, Mbaye N, Mbodj H, Sy Signate H, Diack A; ANRS 12279 MAGGSEN Cohort Study Group. Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study. Food Nutr Bull. 2017 Mar;38(1):27-36. doi: 10.1177/0379572116679053. Epub 2016 Nov 23.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01453192\",\"briefTitle\":\"Renal Transplantation and Raltegravir in HIV-Infected Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-12\"},\"completionDateStruct\":{\"date\":\"2015-11\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-10-17\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Merck Sharp & Dohme LLC\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01490489\",\"briefTitle\":\"EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-07-11\"},\"completionDateStruct\":{\"date\":\"2015-03-13\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-12-13\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"17531315\",\"type\":\"RESULT\",\"citation\":\"Hoffmann P, Feige JJ, Alfaidy N. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. Placenta. 2007 Oct;28(10):1049-58. doi: 10.1016/j.placenta.2007.03.008. Epub 2007 May 25.\"},{\"pmid\":\"16384869\",\"type\":\"RESULT\",\"citation\":\"Hoffmann P, Feige JJ, Alfaidy N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology. 2006 Apr;147(4):1675-84. doi: 10.1210/en.2005-0912. Epub 2005 Dec 29.\"},{\"pmid\":\"19602057\",\"type\":\"RESULT\",\"citation\":\"Hoffmann P, Saoudi Y, Benharouga M, Graham CH, Schaal JP, Mazouni C, Feige JJ, Alfaidy N. Role of EG-VEGF in human placentation: Physiological and pathological implications. J Cell Mol Med. 2009 Aug;13(8B):2224-2235. doi: 10.1111/j.1582-4934.2008.00554.x.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01033760\",\"briefTitle\":\"Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-04\"},\"completionDateStruct\":{\"date\":\"2013-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2009-12-16\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Gilead Sciences\"},{\"name\":\"Merck Sharp & Dohme LLC\"},{\"name\":\"Pfizer\"},{\"name\":\"Janssen-Cilag Ltd.\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"28708873\",\"type\":\"DERIVED\",\"citation\":\"Cheret A, Durier C, Melard A, Ploquin M, Heitzmann J, Lecuroux C, Avettand-Fenoel V, David L, Pialoux G, Chennebault JM, Muller-Trutwin M, Goujard C, Rouzioux C, Meyer L; ANRS OPTIPRIM study group. Impact of early cART on HIV blood and semen compartments at the time of primary infection. PLoS One. 2017 Jul 14;12(7):e0180191. doi: 10.1371/journal.pone.0180191. eCollection 2017.\"},{\"pmid\":\"25701561\",\"type\":\"DERIVED\",\"citation\":\"Cheret A, Nembot G, Melard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoen B, Delfraissy JF, Meyer L, Rouzioux C; OPTIPRIM ANRS Study Group. Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial. Lancet Infect Dis. 2015 Apr;15(4):387-96. doi: 10.1016/S1473-3099(15)70021-6. Epub 2015 Feb 18.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01335529\",\"briefTitle\":\"Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-05\"},\"completionDateStruct\":{\"date\":\"2014-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-04-14\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Rennes University Hospital\"},{\"name\":\"Merck Sharp & Dohme LLC\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"27077673\",\"type\":\"DERIVED\",\"citation\":\"Poizot-Martin I, Bellissant E, Garraffo R, Colson P, Piroth L, Solas C, Renault A, Bourliere M, Halfon P, Ghosn J, Alric L, Naqvi A, Carrieri P, Molina JM; ANRS HC27 BOCEPREVIH Study Group. Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. HIV Clin Trials. 2016 Mar;17(2):63-71. doi: 10.1080/15284336.2015.1135553. Epub 2016 Feb 11.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03047967\",\"briefTitle\":\"Effects of Prenatal Tobacco Smoke Exposure on Lung Function and Respiratory Epithelium Functionality in Newborns\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-11-10\"},\"completionDateStruct\":{\"date\":\"2019-02-09\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-02-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00323804\",\"briefTitle\":\"Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2006-05\"},\"completionDateStruct\":{\"date\":\"2013-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2006-05-10\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Merck Sharp & Dohme LLC\"},{\"name\":\"Rennes University Hospital\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02267304\",\"briefTitle\":\"Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-10-30\"},\"completionDateStruct\":{\"date\":\"2016-08-30\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-10-17\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03109067\",\"briefTitle\":\"Genetic and Metabolism of Post-prandial HDL Particles\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-09-21\"},\"completionDateStruct\":{\"date\":\"2015-11-21\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-04-12\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01552044\",\"briefTitle\":\"Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-01\"},\"completionDateStruct\":{\"date\":\"2013-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-03-13\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01127204\",\"briefTitle\":\"Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-06\"},\"completionDateStruct\":{\"date\":\"2015-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2010-05-20\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"European and Developing Countries Clinical Trials Partnership (EDCTP)\"},{\"name\":\"Public Research Centre Health, Luxembourg\"},{\"name\":\"Ministry of Foreign Affairs, Luxembourg\"},{\"name\":\"University of Ouagadougou, Burkina Faso\"},{\"name\":\"Programme PAC-CI, Site ANRS-MIE de C\\xc3\\xb4te d\\'Ivoire\"},{\"name\":\"Ministry of Health, Rwanda\"},{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},{\"name\":\"University of Bordeaux\"},{\"name\":\"Institut de Sante Publique, d\\'Epid\\xc3\\xa9miologie et de D\\xc3\\xa9veloppement\"},{\"name\":\"Universit\\xc3\\xa9 Montpellier\"},{\"name\":\"University of Paris 5 - Rene Descartes\"},{\"name\":\"Queen Fabiola Children\\'s University Hospital\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"34723858\",\"type\":\"DERIVED\",\"citation\":\"Pressiat C, Toni TD, Treluyer JM, Yonaba C, Dahourou DL, Malateste K, Seguin-Devaux C, Leroy V, Hirt D; MONOD ANRS Study Group. High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy. AIDS. 2021 Nov 15;35(14):2409-2410. doi: 10.1097/QAD.0000000000003043. No abstract available.\"},{\"pmid\":\"31334298\",\"type\":\"DERIVED\",\"citation\":\"Desmonde S, Frank SC, Coovadia A, Dahourou DL, Hou T, Abrams EJ, Amorissani-Folquet M, Walensky RP, Strehlau R, Penazzato M, Freedberg KA, Kuhn L, Leroy V, Ciaranello AL. Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. Open Forum Infect Dis. 2019 Jun 11;6(7):ofz276. doi: 10.1093/ofid/ofz276. eCollection 2019 Jul.\"},{\"pmid\":\"28800382\",\"type\":\"DERIVED\",\"citation\":\"Pressiat C, Mea-Assande V, Yonaba C, Treluyer JM, Dahourou DL, Amorissani-Folquet M, Blanche S, Eboua F, Ye D, Lui G, Malateste K, Zheng Y, Leroy V, Hirt D; MONOD Study Group. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines. Br J Clin Pharmacol. 2017 Dec;83(12):2729-2740. doi: 10.1111/bcp.13397. Epub 2017 Sep 20.\"},{\"pmid\":\"28483965\",\"type\":\"DERIVED\",\"citation\":\"Pressiat C, Amorissani-Folquet M, Yonaba C, Treluyer JM, Dahourou DL, Eboua F, Blanche S, Mea-Assande V, Bouazza N, Foissac F, Malateste K, Ouedraogo S, Lui G, Leroy V, Hirt D. Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00297-17. doi: 10.1128/AAC.00297-17. Print 2017 Jul.\"},{\"pmid\":\"28453240\",\"type\":\"DERIVED\",\"citation\":\"Amani-Bosse C, Dahourou DL, Malateste K, Amorissani-Folquet M, Coulibaly M, Dattez S, Emieme A, Barry M, Rouzioux C, N\\'gbeche S, Yonaba C, Timite-Konan M, Mea V, Ouedraogo S, Blanche S, Meda N, Seguin-Devaux C, Leroy V. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d\\'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort. J Int AIDS Soc. 2017 Apr 25;20(1):21362. doi: 10.7448/IAS.20.01.21362.\"},{\"pmid\":\"28434406\",\"type\":\"DERIVED\",\"citation\":\"Dahourou DL, Amorissani-Folquet M, Malateste K, Amani-Bosse C, Coulibaly M, Seguin-Devaux C, Toni T, Ouedraogo R, Blanche S, Yonaba C, Eboua F, Lepage P, Avit D, Ouedraogo S, Van de Perre P, N\\'Gbeche S, Kalmogho A, Salamon R, Meda N, Timite-Konan M, Leroy V; MONOD Study Group. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Cote d\\'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial. BMC Med. 2017 Apr 24;15(1):85. doi: 10.1186/s12916-017-0842-4.\"},{\"pmid\":\"27015798\",\"type\":\"DERIVED\",\"citation\":\"Dahourou DL, Amorissani-Folquet M, Coulibaly M, Avit-Edi D, Meda N, Timite-Konan M, Arendt V, Ye D, Amani-Bosse C, Salamon R, Lepage P, Leroy V; Monod Anrs 12206 Study Group. Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013. J Int AIDS Soc. 2016 Mar 23;19(1):20601. doi: 10.7448/IAS.19.1.20601. eCollection 2016.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03642704\",\"briefTitle\":\"HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-02-22\"},\"completionDateStruct\":{\"date\":\"2019-09-17\"},\"studyFirstPostDateStruct\":{\"date\":\"2018-08-22\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02496312\",\"briefTitle\":\"Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-07-10\"},\"completionDateStruct\":{\"date\":\"2015-10-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-07-14\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"12461757\",\"type\":\"BACKGROUND\",\"citation\":\"Robert PH, Clairet S, Benoit M, Koutaich J, Bertogliati C, Tible O, Caci H, Borg M, Brocker P, Bedoucha P. The apathy inventory: assessment of apathy and awareness in Alzheimer\\'s disease, Parkinson\\'s disease and mild cognitive impairment. Int J Geriatr Psychiatry. 2002 Dec;17(12):1099-105. doi: 10.1002/gps.755.\"},{\"pmid\":\"10436334\",\"type\":\"BACKGROUND\",\"citation\":\"Pasquier F, Lebert F, Lavenu I, Guillaume B. The clinical picture of frontotemporal dementia: diagnosis and follow-up. Dement Geriatr Cogn Disord. 1999;10 Suppl 1:10-4. doi: 10.1159/000051206.\"},{\"pmid\":\"19713543\",\"type\":\"BACKGROUND\",\"citation\":\"Mayo NE, Fellows LK, Scott SC, Cameron J, Wood-Dauphinee S. A longitudinal view of apathy and its impact after stroke. Stroke. 2009 Oct;40(10):3299-307. doi: 10.1161/STROKEAHA.109.554410. Epub 2009 Aug 27.\"},{\"pmid\":\"17027767\",\"type\":\"BACKGROUND\",\"citation\":\"Winograd-Gurvich C, Fitzgerald PB, Georgiou-Karistianis N, Bradshaw JL, White OB. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson\\'s disease. Brain Res Bull. 2006 Oct 16;70(4-6):312-21. doi: 10.1016/j.brainresbull.2006.06.007. Epub 2006 Jul 5.\"},{\"pmid\":\"10678322\",\"type\":\"BACKGROUND\",\"citation\":\"Marin RS, Firinciogullari S, Biedrzycki RC. Group differences in the relationship between apathy and depression. J Nerv Ment Dis. 1994 Apr;182(4):235-9. doi: 10.1097/00005053-199404000-00008.\"},{\"pmid\":\"18307266\",\"type\":\"BACKGROUND\",\"citation\":\"Dujardin K, Sockeel P, Delliaux M, Destee A, Defebvre L. The Lille Apathy Rating Scale: validation of a caregiver-based version. Mov Disord. 2008 Apr 30;23(6):845-9. doi: 10.1002/mds.21968.\"},{\"pmid\":\"19533496\",\"type\":\"BACKGROUND\",\"citation\":\"Lane-Brown AT, Tate RL. Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. Neuropsychol Rehabil. 2009 Aug;19(4):481-516. doi: 10.1080/09602010902949207.\"},{\"pmid\":\"15897497\",\"type\":\"BACKGROUND\",\"citation\":\"Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y, Dubois B. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson\\'s disease? J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):775-9. doi: 10.1136/jnnp.2003.033258.\"},{\"pmid\":\"19933975\",\"type\":\"BACKGROUND\",\"citation\":\"Le Jeune F, Drapier D, Bourguignon A, Peron J, Mesbah H, Drapier S, Sauleau P, Haegelen C, Travers D, Garin E, Malbert CH, Millet B, Verin M. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology. 2009 Nov 24;73(21):1746-51. doi: 10.1212/WNL.0b013e3181c34b34.\"},{\"pmid\":\"1821241\",\"type\":\"BACKGROUND\",\"citation\":\"Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 1991 Summer;3(3):243-54. doi: 10.1176/jnp.3.3.243.\"},{\"pmid\":\"16207933\",\"type\":\"BACKGROUND\",\"citation\":\"Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex. 2006 Jul;16(7):916-28. doi: 10.1093/cercor/bhj043. Epub 2005 Oct 5.\"},{\"pmid\":\"17131230\",\"type\":\"BACKGROUND\",\"citation\":\"Levy R, Czernecki V. Apathy and the basal ganglia. J Neurol. 2006 Dec;253 Suppl 7:VII54-61. doi: 10.1007/s00415-006-7012-5.\"},{\"pmid\":\"10941190\",\"type\":\"BACKGROUND\",\"citation\":\"Brown RG, Pluck G. Negative symptoms: the \\'pathology\\' of motivation and goal-directed behaviour. Trends Neurosci. 2000 Sep;23(9):412-7. doi: 10.1016/s0166-2236(00)01626-x.\"},{\"pmid\":\"16421064\",\"type\":\"BACKGROUND\",\"citation\":\"Muller U, Czymmek J, Thone-Otto A, Von Cramon DY. Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy. Brain Inj. 2006 Feb;20(2):157-60. doi: 10.1080/02699050500443467.\"},{\"pmid\":\"21895376\",\"type\":\"BACKGROUND\",\"citation\":\"Funkiewiez A, Bertoux M, de Souza LC, Levy R, Dubois B. The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. Neuropsychology. 2012 Jan;26(1):81-90. doi: 10.1037/a0025318. Epub 2011 Sep 5.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01473472\",\"briefTitle\":\"On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-01\"},\"completionDateStruct\":{\"date\":\"2016-12-15\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-11-17\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"31784343\",\"type\":\"DERIVED\",\"citation\":\"Antoni G, Tremblay C, Delaugerre C, Charreau I, Cua E, Rojas Castro D, Raffi F, Chas J, Huleux T, Spire B, Capitant C, Cotte L, Meyer L, Molina JM; ANRS IPERGAY study group. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Lancet HIV. 2020 Feb;7(2):e113-e120. doi: 10.1016/S2352-3018(19)30341-8. Epub 2019 Nov 26.\"},{\"pmid\":\"29229440\",\"type\":\"DERIVED\",\"citation\":\"Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, Capitant C, Rojas-Castro D, Fonsart J, Bercot B, Bebear C, Cotte L, Robineau O, Raffi F, Charbonneau P, Aslan A, Chas J, Niedbalski L, Spire B, Sagaon-Teyssier L, Carette D, Mestre SL, Dore V, Meyer L; ANRS IPERGAY Study Group. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018 Mar;18(3):308-317. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8.\"},{\"pmid\":\"28747274\",\"type\":\"DERIVED\",\"citation\":\"Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Dore V, Meyer L; ANRS IPERGAY Study Group. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017 Sep;4(9):e402-e410. doi: 10.1016/S2352-3018(17)30089-9. Epub 2017 Jul 23.\"},{\"pmid\":\"26624850\",\"type\":\"DERIVED\",\"citation\":\"Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Preau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Dore V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF; ANRS IPERGAY Study Group. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02073604\",\"briefTitle\":\"Role of the SMA During Unimanual and Bimanual Movements Preparation: the Mirror Movements Paradigm\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-03\"},\"completionDateStruct\":{\"date\":\"2016-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-02-27\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04849767\",\"briefTitle\":\"National Survey About Trajectory and Life Conditions of HIV Trans People in France\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2020-10-01\"},\"completionDateStruct\":{\"date\":\"2023-12-31\"},\"studyFirstPostDateStruct\":{\"date\":\"2021-04-19\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"34916316\",\"type\":\"DERIVED\",\"citation\":\"Mora M, Rincon G, Bourrelly M, Maradan G, Freire Maresca A, Michard F, Rouveix E, Pannetier J, Leriche D, Alain T, Yazdanpanah Y, Michels D, Spire B. Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV). BMJ Open. 2021 Dec 16;11(12):e052691. doi: 10.1136/bmjopen-2021-052691.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01525472\",\"briefTitle\":\"Accelerated Aging of the Cells of Visceral Adipose Tissue in Morbid Obese Subjects\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-02-13\"},\"completionDateStruct\":{\"date\":\"2015-10-20\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-02-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04484740\",\"briefTitle\":\"Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2021-01-29\"},\"completionDateStruct\":{\"date\":\"2023-05-27\"},\"studyFirstPostDateStruct\":{\"date\":\"2020-07-24\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Medical University of Vienna\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02384967\",\"briefTitle\":\"Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-03\"},\"completionDateStruct\":{\"date\":\"2016-10\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-03-10\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"29905808\",\"type\":\"DERIVED\",\"citation\":\"Le MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS 165 DARULIGHT Study Group. Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study. J Antimicrob Chemother. 2018 Aug 1;73(8):2120-2128. doi: 10.1093/jac/dky193.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03335995\",\"briefTitle\":\"Stroke Prognosis in Intensive CarE\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-10-18\"},\"completionDateStruct\":{\"date\":\"2020-11-18\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-11-08\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"32026446\",\"type\":\"DERIVED\",\"citation\":\"Sonneville R, Mazighi M, Bresson D, Crassard I, Crozier S, de Montmollin E, Degos V, Faugeras F, Gayat E, Josse L, Lamy C, Magalhaes E, Maldjian A, Ruckly S, Servan J, Vassel P, Vigue B, Timsit JF, Woimant F; SPICE investigators. Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study. Neurocrit Care. 2020 Apr;32(2):624-629. doi: 10.1007/s12028-019-00907-0.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01647295\",\"briefTitle\":\"Social Interactions: Ocular Explorations and Pupillometry in Autism\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-02-25\"},\"completionDateStruct\":{\"date\":\"2019-06-18\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-07-23\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01226446\",\"briefTitle\":\"Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-11\"},\"completionDateStruct\":{\"date\":\"2013-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2010-10-22\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"French National Agency for Research on AIDS and Viral Hepatitis\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"25987791\",\"type\":\"DERIVED\",\"citation\":\"Terrier B, Lapidus N, Pol S, Serfaty L, Ratziu V, Asselah T, Thibault V, Souberbielle JC, Carrat F, Cacoub P. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. World J Gastroenterol. 2015 May 14;21(18):5647-53. doi: 10.3748/wjg.v21.i18.5647.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04780191\",\"briefTitle\":\"Investigation of Treatment Using the MyoRegulator\\xc2\\xae Device in Patients With Spasticity in the Lower Limb Due to Stroke\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2018-07-19\"},\"completionDateStruct\":{\"date\":\"2021-01-19\"},\"studyFirstPostDateStruct\":{\"date\":\"2021-03-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"PathMaker Neurosystems Inc.\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"32232101\",\"type\":\"BACKGROUND\",\"citation\":\"Paget-Blanc A, Chang JL, Saul M, Lin R, Ahmed Z, Volpe BT. Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation. Bioelectron Med. 2019 Jul 23;5:11. doi: 10.1186/s42234-019-0028-9. eCollection 2019.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01066962\",\"briefTitle\":\"Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral na\\xc3\\xafve Subjects\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-08\"},\"completionDateStruct\":{\"date\":\"2013-10\"},\"studyFirstPostDateStruct\":{\"date\":\"2010-02-10\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"NEAT - European AIDS Treatment Network\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"33794182\",\"type\":\"DERIVED\",\"citation\":\"Esteban-Cantos A, Rodriguez-Centeno J, Barruz P, Alejos B, Saiz-Medrano G, Nevado J, Martin A, Gaya F, De Miguel R, Bernardino JI, Montejano R, Mena-Garay B, Cadinanos J, Florence E, Mulcahy F, Banhegyi D, Antinori A, Pozniak A, Wallet C, Raffi F, Rodes B, Arribas JR; NEAT001/ANRS143 Study Group. Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. Lancet HIV. 2021 Apr;8(4):e197-e205. doi: 10.1016/S2352-3018(21)00006-0. Erratum In: Lancet HIV. 2021 Dec;8(12):e734.\"},{\"pmid\":\"30365452\",\"type\":\"DERIVED\",\"citation\":\"Ammassari A, Stohr W, Antinori A, Molina JM, Schwimmer C, Domingo P, Thalme A, Di Pietro M, Wallet C, Pozniak A, Richert L, Raffi F; NEAT001/ANRS143 Trial Study Group. Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial. J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):481-490. doi: 10.1097/QAI.0000000000001834.\"},{\"pmid\":\"26520926\",\"type\":\"DERIVED\",\"citation\":\"Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buno A, Castagna A, Girard PM, Chene G, Raffi F, Arribas JR; NEAT001/ANRS143 Study Group. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. Lancet HIV. 2015 Nov;2(11):e464-73. doi: 10.1016/S2352-3018(15)00181-2. Epub 2015 Sep 30.\"},{\"pmid\":\"25103176\",\"type\":\"DERIVED\",\"citation\":\"Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chene G, Pozniak A; NEAT001/ANRS143 Study Group. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. Lancet. 2014 Nov 29;384(9958):1942-51. doi: 10.1016/S0140-6736(14)61170-3. Epub 2014 Aug 4.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02486731\",\"briefTitle\":\"Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-12-16\"},\"completionDateStruct\":{\"date\":\"2018-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-07-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT05199831\",\"briefTitle\":\"Situational Analysis of HIV-related Disability in the Context of Ivory Coast\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2021-02-05\"},\"completionDateStruct\":{\"date\":\"2022-08-10\"},\"studyFirstPostDateStruct\":{\"date\":\"2022-01-20\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Programme PAC-CI, Site ANRS-MIE de C\\xc3\\xb4te d\\'Ivoire\"},\"collaborators\":[{\"name\":\"Institute of Research for Development, France\"},{\"name\":\"Institut de Sante Publique, d\\'Epidemiologie et de Developpement\"},{\"name\":\"University of Toronto\"},{\"name\":\"Universit\\xc3\\xa9 de Lille\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02107365\",\"briefTitle\":\"Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-11\"},\"completionDateStruct\":{\"date\":\"2015-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-04-08\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Bristol-Myers Squibb\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03150290\",\"briefTitle\":\"Brown Adipose Tissue in ALS\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-10-26\"},\"completionDateStruct\":{\"date\":\"2019-04-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-05-12\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01605890\",\"briefTitle\":\"Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-07\"},\"completionDateStruct\":{\"date\":\"2015-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-05-25\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Gilead Sciences\"},{\"name\":\"Merck Sharp & Dohme LLC\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"29590335\",\"type\":\"DERIVED\",\"citation\":\"Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G; France REcherche Nord&Sud Sida-Hiv Hepatites (ANRS) 159 HIV-2 Trial Study Group. First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2). Clin Infect Dis. 2018 Sep 28;67(8):1161-1167. doi: 10.1093/cid/ciy245.\"}]}},\"hasResults\":true},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01432821\",\"briefTitle\":\"Blinking and Yawning in Epilepsy: The Role of Dopamine\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-09\"},\"completionDateStruct\":{\"date\":\"2014-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-09-13\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"15037514\",\"type\":\"RESULT\",\"citation\":\"Ahmad S, Fowler LJ, Whitton PS. Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. Br J Pharmacol. 2004 May;142(1):136-42. doi: 10.1038/sj.bjp.0705737. Epub 2004 Mar 22.\"},{\"pmid\":\"15777732\",\"type\":\"RESULT\",\"citation\":\"Ahmad S, Fowler LJ, Whitton PS. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res. 2005 Feb;63(2-3):141-9. doi: 10.1016/j.eplepsyres.2005.02.002.\"},{\"pmid\":\"12914551\",\"type\":\"RESULT\",\"citation\":\"Aymard G, Berlin I, de Brettes B, Diquet B. Pharmacokinetic-pharmacodynamic study of apomorphine\\'s effect on growth hormone secretion in healthy subjects. Fundam Clin Pharmacol. 2003 Aug;17(4):473-81. doi: 10.1046/j.1472-8206.2003.00152.x.\"},{\"pmid\":\"15249613\",\"type\":\"RESULT\",\"citation\":\"Biraben A, Semah F, Ribeiro MJ, Douaud G, Remy P, Depaulis A. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. Neurology. 2004 Jul 13;63(1):73-7. doi: 10.1212/01.wnl.0000132840.40838.13.\"},{\"pmid\":\"2271377\",\"type\":\"RESULT\",\"citation\":\"Blin O, Masson G, Azulay JP, Fondarai J, Serratrice G. Apomorphine-induced blinking and yawning in healthy volunteers. Br J Clin Pharmacol. 1990 Nov;30(5):769-73. doi: 10.1111/j.1365-2125.1990.tb03848.x.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02071784\",\"briefTitle\":\"Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-07-08\"},\"completionDateStruct\":{\"date\":\"2016-10-24\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-02-26\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02738502\",\"briefTitle\":\"Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-07-06\"},\"completionDateStruct\":{\"date\":\"2020-07-16\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-04-14\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"26709605\",\"type\":\"BACKGROUND\",\"citation\":\"Arribas JR, Girard PM, Paton N, Winston A, Marcelin AG, Elbirt D, Hill A, Hadacek MB. Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials. HIV Med. 2016 May;17(5):358-67. doi: 10.1111/hiv.12348. Epub 2015 Dec 28.\"},{\"pmid\":\"23766338\",\"type\":\"BACKGROUND\",\"citation\":\"Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. Clin Infect Dis. 2013 Sep;57(6):891-902. doi: 10.1093/cid/cit390. Epub 2013 Jun 12.\"},{\"pmid\":\"23559464\",\"type\":\"BACKGROUND\",\"citation\":\"Andre-Schmutz I, Dal-Cortivo L, Six E, Kaltenbach S, Cocchiarella F, Le Chenadec J, Cagnard N, Cordier AG, Benachi A, Mandelbrot L, Azria E, Bouallag N, Luce S, Ternaux B, Reimann C, Revy P, Radford-Weiss I, Leschi C, Recchia A, Mavilio F, Cavazzana M, Blanche S. Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination. J Infect Dis. 2013 Jul 15;208(2):235-43. doi: 10.1093/infdis/jit149. Epub 2013 Apr 4.\"},{\"pmid\":\"26854809\",\"type\":\"BACKGROUND\",\"citation\":\"Hleyhel M, Goujon S, Delteil C, Vasiljevic A, Luzi S, Stephan JL, Reliquet V, Jannier S, Tubiana R, Dollfus C, Faye A, Mandelbrot L, Clavel J, Warszawski J, Blanche S; ANRS French Perinatal Cohort Study Group. Risk of cancer in children exposed to didanosine in utero. AIDS. 2016 May 15;30(8):1245-56. doi: 10.1097/QAD.0000000000001051.\"},{\"pmid\":\"26197844\",\"type\":\"BACKGROUND\",\"citation\":\"Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S; ANRS-EPF Study Group. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis. 2015 Dec 1;61(11):1715-25. doi: 10.1093/cid/civ578. Epub 2015 Jul 21.\"},{\"pmid\":\"22160145\",\"type\":\"BACKGROUND\",\"citation\":\"Valantin MA, Lambert-Niclot S, Flandre P, Morand-Joubert L, Cabie A, Meynard JL, Ponscarme D, Ajana F, Slama L, Curjol A, Cuzin L, Schneider L, Taburet AM, Marcelin AG, Katlama C; MONOI ANRS 136 Study Group. Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study. J Antimicrob Chemother. 2012 Mar;67(3):691-5. doi: 10.1093/jac/dkr504. Epub 2011 Dec 7.\"},{\"pmid\":\"22848481\",\"type\":\"BACKGROUND\",\"citation\":\"Lambert-Niclot S, Flandre P, Valantin MA, Soulie C, Fourati S, Wirden M, Sayon S, Pakianather S, Bocket L, Masquelier B, Dos Santos G, Katlama C, Calvez V, Marcelin AG. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. PLoS One. 2012;7(7):e41390. doi: 10.1371/journal.pone.0041390. Epub 2012 Jul 25.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03652090\",\"briefTitle\":\"Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic Fibrosis\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-09-01\"},\"completionDateStruct\":{\"date\":\"2016-03-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2018-08-29\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"ABCF2\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02126384\",\"briefTitle\":\"Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-11-18\"},\"completionDateStruct\":{\"date\":\"2016-04-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-04-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02992184\",\"briefTitle\":\"PoC-HCV Genedrive Viral Detection Assay Validation Study\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-09\"},\"completionDateStruct\":{\"date\":\"2016-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-12-14\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"EPISTEM\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"29615488\",\"type\":\"DERIVED\",\"citation\":\"Llibre A, Shimakawa Y, Mottez E, Ainsworth S, Buivan TP, Firth R, Harrison E, Rosenberg AR, Meritet JF, Fontanet A, Castan P, Madejon A, Laverick M, Glass A, Viana R, Pol S, McClure CP, Irving WL, Miele G, Albert ML, Duffy D. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. Gut. 2018 Nov;67(11):2017-2024. doi: 10.1136/gutjnl-2017-315783. Epub 2018 Apr 3.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04824638\",\"briefTitle\":\"BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2021-03-08\"},\"completionDateStruct\":{\"date\":\"2023-12-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2021-04-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02212379\",\"briefTitle\":\"Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-01\"},\"completionDateStruct\":{\"date\":\"2018-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-08-08\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Merck Sharp & Dohme LLC\"},{\"name\":\"Janssen-Cilag Ltd.\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":true},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02113943\",\"briefTitle\":\"Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Citalopram on Motivation\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-04\"},\"completionDateStruct\":{\"date\":\"2014-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-04-15\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01426243\",\"briefTitle\":\"The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-07\"},\"completionDateStruct\":{\"date\":\"2017-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-08-31\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"French National Agency for Research on AIDS and Viral Hepatitis\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"30096071\",\"type\":\"DERIVED\",\"citation\":\"Colin de Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F; ANRS EP46 NOVAA Group. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients. AIDS. 2018 Oct 23;32(16):2291-2299. doi: 10.1097/QAD.0000000000001963.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03519503\",\"briefTitle\":\"Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-02-27\"},\"completionDateStruct\":{\"date\":\"2018-02-15\"},\"studyFirstPostDateStruct\":{\"date\":\"2018-05-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"21602695\",\"type\":\"BACKGROUND\",\"citation\":\"Heidari S, Mofenson L, Cotton MF, Marlink R, Cahn P, Katabira E. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):290-6. doi: 10.1097/QAI.0b013e318221c56a.\"},{\"pmid\":\"22814853\",\"type\":\"BACKGROUND\",\"citation\":\"Van de Perre P, Rubbo PA, Viljoen J, Nagot N, Tylleskar T, Lepage P, Vendrell JP, Tuaillon E. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. Sci Transl Med. 2012 Jul 18;4(143):143sr3. doi: 10.1126/scitranslmed.3003327.\"},{\"pmid\":\"26603917\",\"type\":\"BACKGROUND\",\"citation\":\"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Marechal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskar T, Van de Perre P; ANRS 12174 Trial Group. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Erratum In: Lancet. 2019 Jun 22;393(10190):2492.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02314208\",\"briefTitle\":\"Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-01\"},\"completionDateStruct\":{\"date\":\"2018-01-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-12-11\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01348308\",\"briefTitle\":\"Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-09\"},\"completionDateStruct\":{\"date\":\"2016-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-05-05\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Pfizer\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"32040959\",\"type\":\"DERIVED\",\"citation\":\"Levy Y, Lelievre JD, Assoumou L, Aznar E, Pulido F, Tambussi G, Crespo M, Meybeck A, Molina JM, Delaugerre C, Izopet J, Peytavin G, Cardon F, Diallo A, Lancar R, Beniguel L, Costagliola D. Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial. Ann Intern Med. 2020 Mar 3;172(5):297-305. doi: 10.7326/M19-2133. Epub 2020 Feb 11.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01942655\",\"briefTitle\":\"IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-06-01\"},\"completionDateStruct\":{\"date\":\"2018-03-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-09-16\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01332955\",\"briefTitle\":\"Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-04\"},\"completionDateStruct\":{\"date\":\"2013-09\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-04-11\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Janssen-Cilag Ltd.\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"25139963\",\"type\":\"DERIVED\",\"citation\":\"Cotte L, Braun J, Lascoux-Combe C, Vincent C, Valantin MA, Sogni P, Lacombe K, Neau D, Aumaitre H, Batisse D, de Truchis P, Gervais A, Michelet C, Morlat P, Vittecoq D, Rosa I, Bertucci I, Chevaliez S, Aboulker JP, Molina JM; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) HC26 Study Group. Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial. Clin Infect Dis. 2014 Dec 15;59(12):1768-76. doi: 10.1093/cid/ciu659. Epub 2014 Aug 18.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04945655\",\"briefTitle\":\"Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2021-11-15\"},\"completionDateStruct\":{\"date\":\"2023-04-30\"},\"studyFirstPostDateStruct\":{\"date\":\"2021-06-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"35332045\",\"type\":\"DERIVED\",\"citation\":\"Bocquier A, Michel M, Giraudeau B, Bonnay S, Gagneux-Brunon A, Gauchet A, Gilberg S, Le Duc-Banaszuk AS, Mueller JE, Chevreul K, Thilly N; PrevHPV Study group. Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study). BMJ Open. 2022 Mar 24;12(3):e057943. doi: 10.1136/bmjopen-2021-057943.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01696708\",\"briefTitle\":\"Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-12-06\"},\"completionDateStruct\":{\"date\":\"2015-11\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-10-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"25568297\",\"type\":\"DERIVED\",\"citation\":\"Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, Valabregue R, Durr A, Mochel F. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology. 2015 Feb 3;84(5):490-5. doi: 10.1212/WNL.0000000000001214. Epub 2015 Jan 7.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02323308\",\"briefTitle\":\"Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-12\"},\"completionDateStruct\":{\"date\":\"2014-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-12-23\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01509508\",\"briefTitle\":\"Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-03\"},\"completionDateStruct\":{\"date\":\"2016-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-01-13\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Africa Centre For Health and Population Studies\"},{\"name\":\"University of KwaZulu\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"32970730\",\"type\":\"DERIVED\",\"citation\":\"Iwuji C, Chimukuche RS, Zuma T, Plazy M, Larmarange J, Orne-Gliemann J, Siedner M, Shahmanesh M, Seeley J. Test but not treat: Community members\\' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa. PLoS One. 2020 Sep 24;15(9):e0239513. doi: 10.1371/journal.pone.0239513. eCollection 2020.\"},{\"pmid\":\"31637821\",\"type\":\"DERIVED\",\"citation\":\"Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiebaut R, Tanser F, Barnighausen T, Orne-Gliemann J, Pillay D, Dabis F; ANRS 12249 TasP Study Group. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa. J Int AIDS Soc. 2019 Oct;22(10):e25402. doi: 10.1002/jia2.25402.\"},{\"pmid\":\"30412926\",\"type\":\"DERIVED\",\"citation\":\"Perriat D, Plazy M, Gumede D, Boyer S, Pillay D, Dabis F, Seeley J, Orne-Gliemann J; ANRS 12249 TasP Study Group. \\\\\"If you are here at the clinic, you do not know how many people need help in the community\\\\\": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat. PLoS One. 2018 Nov 9;13(11):e0202473. doi: 10.1371/journal.pone.0202473. eCollection 2018.\"},{\"pmid\":\"30321314\",\"type\":\"DERIVED\",\"citation\":\"Derache A, Iwuji CC, Baisley K, Danaviah S, Marcelin AG, Calvez V, de Oliveira T, Dabis F, Porter K, Pillay D. Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial. Clin Infect Dis. 2019 Jul 2;69(2):207-214. doi: 10.1093/cid/ciy881.\"},{\"pmid\":\"30027600\",\"type\":\"DERIVED\",\"citation\":\"Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiebaut R, Tanser F, Barnighausen T, Pillay D, Dabis F, Orne-Gliemann J; ANRS 12249 TasP Study Group. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa). J Int AIDS Soc. 2018 Jul;21 Suppl 4(Suppl Suppl 4):e25128. doi: 10.1002/jia2.25128.\"},{\"pmid\":\"29890048\",\"type\":\"DERIVED\",\"citation\":\"Iwuji C, McGrath N, Calmy A, Dabis F, Pillay D, Newell ML, Baisley K, Porter K. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial. J Int AIDS Soc. 2018 Jun;21(6):e25112. doi: 10.1002/jia2.25112.\"},{\"pmid\":\"29199100\",\"type\":\"DERIVED\",\"citation\":\"Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F, Okesola N, Makowa T, Dreyer J, Herbst K, McGrath N, Barnighausen T, Boyer S, De Oliveira T, Rekacewicz C, Bazin B, Newell ML, Pillay D, Dabis F; ANRS 12249 TasP Study Group. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV. 2018 Mar;5(3):e116-e125. doi: 10.1016/S2352-3018(17)30205-9. Epub 2017 Nov 30.\"},{\"pmid\":\"28329393\",\"type\":\"DERIVED\",\"citation\":\"Collier D, Iwuji C, Derache A, de Oliveira T, Okesola N, Calmy A, Dabis F, Pillay D, Gupta RK; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 12249 Treatment as Prevention (TasP) Study Group. Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis. Clin Infect Dis. 2017 Apr 15;64(8):1006-1016. doi: 10.1093/cid/cix015.\"},{\"pmid\":\"27504637\",\"type\":\"DERIVED\",\"citation\":\"Iwuji CC, Orne-Gliemann J, Larmarange J, Okesola N, Tanser F, Thiebaut R, Rekacewicz C, Newell ML, Dabis F; ANRS 12249 TasP trial group. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. PLoS Med. 2016 Aug 9;13(8):e1002107. doi: 10.1371/journal.pmed.1002107. eCollection 2016 Aug.\"},{\"pmid\":\"25880823\",\"type\":\"DERIVED\",\"citation\":\"Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Barnighausen T, Zuma T, Dray-Spira R, Spire B, Rochat T, Lert F, Imrie J; ANRS 12249 TasP Group. Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. BMC Public Health. 2015 Mar 1;15:209. doi: 10.1186/s12889-015-1344-y.\"},{\"pmid\":\"23880306\",\"type\":\"DERIVED\",\"citation\":\"Iwuji CC, Orne-Gliemann J, Tanser F, Boyer S, Lessells RJ, Lert F, Imrie J, Barnighausen T, Rekacewicz C, Bazin B, Newell ML, Dabis F; ANRS 12249 TasP Study Group. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials. 2013 Jul 23;14:230. doi: 10.1186/1745-6215-14-230.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02469350\",\"briefTitle\":\"Serious Game for Parkinson\\'s Disease Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-06\"},\"completionDateStruct\":{\"date\":\"2017-10-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-06-11\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"29636105\",\"type\":\"DERIVED\",\"citation\":\"Nuic D, Vinti M, Karachi C, Foulon P, Van Hamme A, Welter ML. The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson\\'s disease patients: a pilot study. J Neuroeng Rehabil. 2018 Apr 10;15(1):31. doi: 10.1186/s12984-018-0375-x.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02488395\",\"briefTitle\":\"Superior Colliculus Activity in Parkinson Disease: a Potential Marker?\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-10-07\"},\"completionDateStruct\":{\"date\":\"2018-01-19\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-07-02\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"22639796\",\"type\":\"RESULT\",\"citation\":\"Marino RA, Levy R, Boehnke S, White BJ, Itti L, Munoz DP. Linking visual response properties in the superior colliculus to saccade behavior. Eur J Neurosci. 2012 Jun;35(11):1738-52. doi: 10.1111/j.1460-9568.2012.08079.x. Epub 2012 May 28.\"},{\"pmid\":\"6774653\",\"type\":\"RESULT\",\"citation\":\"Wurtz RH, Albano JE. Visual-motor function of the primate superior colliculus. Annu Rev Neurosci. 1980;3:189-226. doi: 10.1146/annurev.ne.03.030180.001201. No abstract available.\"},{\"pmid\":\"23916713\",\"type\":\"RESULT\",\"citation\":\"Rolland M, Carcenac C, Overton PG, Savasta M, Coizet V. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson\\'s disease. Neuroscience. 2013 Nov 12;252:277-88. doi: 10.1016/j.neuroscience.2013.07.047. Epub 2013 Jul 31.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00946595\",\"briefTitle\":\"Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2009-11\"},\"completionDateStruct\":{\"date\":\"2014-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2009-07-27\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"French National Agency for Research on AIDS and Viral Hepatitis\"},\"collaborators\":[{\"name\":\"Abbott\"},{\"name\":\"Gilead Sciences\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"30968368\",\"type\":\"DERIVED\",\"citation\":\"Garay OU, Nishimwe ML, Bousmah MA, Janah A, Girard PM, Chene G, Moinot L, Sagaon-Teyssier L, Meynard JL, Spire B, Boyer S. Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM). Pharmacoecon Open. 2019 Dec;3(4):505-515. doi: 10.1007/s41669-019-0130-7.\"},{\"pmid\":\"29767684\",\"type\":\"DERIVED\",\"citation\":\"Lambert-Niclot S, Grude M, Meynard JL, Marcelin AG, Valantin MA, Flandre P, Izopet J, Moinot L, Bouteloup V, Calvez V, Katlama C, Girard PM, Morand-Joubert L. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clin Infect Dis. 2018 Nov 28;67(12):1883-1889. doi: 10.1093/cid/ciy382.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01546181\",\"briefTitle\":\"Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-10\"},\"completionDateStruct\":{\"date\":\"2017-06-15\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-03-07\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"25077537\",\"type\":\"RESULT\",\"citation\":\"Paques M, Miloudi C, Kulcsar C, Leseigneur A, Chaumette C, Koch E. High-resolution imaging of gunn\\'s dots. Retina. 2015 Jan;35(1):120-4. doi: 10.1097/IAE.0000000000000269.\"},{\"pmid\":\"26344727\",\"type\":\"RESULT\",\"citation\":\"Audo I, Gocho K, Rossant F, Mohand-Said S, Loquin K, Bloch I, Sahel JA, Paques M. Functional and high-resolution retinal imaging monitoring photoreceptor damage in acute macular neuroretinopathy. Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):855-64. doi: 10.1007/s00417-015-3136-6. Epub 2015 Sep 7.\"},{\"pmid\":\"25997175\",\"type\":\"RESULT\",\"citation\":\"Paques M, Brolly A, Benesty J, Lerme N, Koch E, Rossant F, Bloch I, Girmens JF. Venous Nicking Without Arteriovenous Contact: The Role of the Arteriolar Microenvironment in Arteriovenous Nickings. JAMA Ophthalmol. 2015 Aug;133(8):947-50. doi: 10.1001/jamaophthalmol.2015.1132.\"},{\"pmid\":\"26523388\",\"type\":\"RESULT\",\"citation\":\"Miloudi C, Rossant F, Bloch I, Chaumette C, Leseigneur A, Sahel JA, Meimon S, Mrejen S, Paques M. The Negative Cone Mosaic: A New Manifestation of the Optical Stiles-Crawford Effect in Normal Eyes. Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7043-50. doi: 10.1167/iovs.15-17022.\"},{\"pmid\":\"23620431\",\"type\":\"RESULT\",\"citation\":\"Gocho K, Sarda V, Falah S, Sahel JA, Sennlaub F, Benchaboune M, Ullern M, Paques M. Adaptive optics imaging of geographic atrophy. Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3673-80. doi: 10.1167/iovs.12-10672.\"},{\"pmid\":\"24406779\",\"type\":\"RESULT\",\"citation\":\"Koch E, Rosenbaum D, Brolly A, Sahel JA, Chaumet-Riffaud P, Girerd X, Rossant F, Paques M. Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes. J Hypertens. 2014 Apr;32(4):890-8. doi: 10.1097/HJH.0000000000000095.\"},{\"pmid\":\"24576889\",\"type\":\"RESULT\",\"citation\":\"Errera MH, Coisy S, Fardeau C, Sahel JA, Kallel S, Westcott M, Bodaghi B, Paques M. Retinal vasculitis imaging by adaptive optics. Ophthalmology. 2014 Jun;121(6):1311-2.e2. doi: 10.1016/j.ophtha.2013.12.036. Epub 2014 Feb 25. No abstract available.\"},{\"pmid\":\"24337723\",\"type\":\"RESULT\",\"citation\":\"Faure C, Gocho K, Le Mer Y, Sahel JA, Paques M, Audo I. Functional and high resolution retinal imaging assessment in a case of ocular siderosis. Doc Ophthalmol. 2014 Feb;128(1):69-75. doi: 10.1007/s10633-013-9421-y. Epub 2013 Dec 13.\"},{\"pmid\":\"29369084\",\"type\":\"RESULT\",\"citation\":\"Bottin C, Grieve K, Rossant F, Pedinielli A, Mrejen S, Paques M. DIRECTIONAL VARIABILITY OF FUNDUS REFLECTANCE IN ACUTE MACULAR NEURORETINOPATHY: EVIDENCE FOR A CONTRIBUTION OF THE STILES-CRAWFORD EFFECT. Retin Cases Brief Rep. 2018 Fall;12 Suppl 1:S19-S24. doi: 10.1097/ICB.0000000000000701.\"},{\"pmid\":\"25284764\",\"type\":\"RESULT\",\"citation\":\"Jacob J, Paques M, Krivosic V, Dupas B, Couturier A, Kulcsar C, Tadayoni R, Massin P, Gaudric A. Meaning of visualizing retinal cone mosaic on adaptive optics images. Am J Ophthalmol. 2015 Jan;159(1):118-23.e1. doi: 10.1016/j.ajo.2014.09.043. Epub 2014 Oct 2.\"},{\"pmid\":\"27065002\",\"type\":\"RESULT\",\"citation\":\"Rosenbaum D, Mattina A, Koch E, Rossant F, Gallo A, Kachenoura N, Paques M, Redheuil A, Girerd X. Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics. J Hypertens. 2016 Jun;34(6):1115-22. doi: 10.1097/HJH.0000000000000894.\"},{\"pmid\":\"27009576\",\"type\":\"RESULT\",\"citation\":\"Rosenbaum D, Kachenoura N, Koch E, Paques M, Cluzel P, Redheuil A, Girerd X. Relationships between retinal arteriole anatomy and aortic geometry and function and peripheral resistance in hypertensives. Hypertens Res. 2016 Jul;39(7):536-42. doi: 10.1038/hr.2016.26. Epub 2016 Mar 24.\"},{\"pmid\":\"28900746\",\"type\":\"RESULT\",\"citation\":\"Faure C, Paques M, Audo I. Electrophysiological features and multimodal imaging in ritonavir-related maculopathy. Doc Ophthalmol. 2017 Dec;135(3):241-248. doi: 10.1007/s10633-017-9612-z. Epub 2017 Sep 12.\"},{\"pmid\":\"30947025\",\"type\":\"RESULT\",\"citation\":\"Boileve A, Jozwiak M, Malka D, Boige V, Le Roy F, Paques M, Ducreux M. Vision loss after chemotherapy: an irinotecan-induced retinopathy. Eur J Cancer. 2019 May;112:80-82. doi: 10.1016/j.ejca.2019.02.015. Epub 2019 Apr 1. No abstract available.\"},{\"pmid\":\"30010022\",\"type\":\"RESULT\",\"citation\":\"Paques M, Meimon S, Rossant F, Rosenbaum D, Mrejen S, Sennlaub F, Grieve K. Adaptive optics ophthalmoscopy: Application to age-related macular degeneration and vascular diseases. Prog Retin Eye Res. 2018 Sep;66:1-16. doi: 10.1016/j.preteyeres.2018.07.001. Epub 2018 Jul 17.\"},{\"pmid\":\"31568064\",\"type\":\"RESULT\",\"citation\":\"Sodi A, Germain DP, Bacherini D, Finocchio L, Pacini B, Marziali E, Lenzetti C, Tanini I, Koraichi F, Coriat C, Nencini P, Olivotto I, Virgili G, Rizzo S, Paques M. IN VIVO OBSERVATION OF RETINAL VASCULAR DEPOSITS USING ADAPTIVE OPTICS IMAGING IN FABRY DISEASE. Retina. 2020 Aug;40(8):1623-1629. doi: 10.1097/IAE.0000000000002648.\"},{\"pmid\":\"31573376\",\"type\":\"RESULT\",\"citation\":\"Errera MH, Laguarrigue M, Rossant F, Koch E, Chaumette C, Fardeau C, Westcott M, Sahel JA, Bodaghi B, Benesty J, Paques M. High-Resolution Imaging of Retinal Vasculitis by Flood Illumination Adaptive Optics Ophthalmoscopy: A Follow-up Study. Ocul Immunol Inflamm. 2020 Nov 16;28(8):1171-1180. doi: 10.1080/09273948.2019.1646773. Epub 2019 Oct 1.\"},{\"pmid\":\"31922497\",\"type\":\"RESULT\",\"citation\":\"Paques M, Rossant F, Finocchio L, Grieve K, Sahel JA, Pedinielli A, Mrejen S. ATTENUATION OUTER RETINAL BANDS ON OPTICAL COHERENCE TOMOGRAPHY FOLLOWING MACULAR EDEMA: A Possible Manifestation of Photoreceptor Misalignment. Retina. 2020 Nov;40(11):2232-2239. doi: 10.1097/IAE.0000000000002738.\"},{\"pmid\":\"31972545\",\"type\":\"RESULT\",\"citation\":\"Gallo A, Chaigneau E, Jublanc C, Rosenbaum D, Mattina A, Paques M, Rossant F, Girerd X, Leban M, Bruckert E. IGF-1 is an independent predictor of retinal arterioles remodeling in subjects with uncontrolled acromegaly. Eur J Endocrinol. 2020 Mar;182(3):375-383. doi: 10.1530/EJE-19-0390.\"},{\"pmid\":\"26418443\",\"type\":\"DERIVED\",\"citation\":\"Jacob J, Krivosic V, Paques M, Tadayoni R, Gaudric A. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2. Retina. 2016 Mar;36(3):545-51. doi: 10.1097/IAE.0000000000000737.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03870438\",\"briefTitle\":\"Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2019-12-14\"},\"completionDateStruct\":{\"date\":\"2022-10-31\"},\"studyFirstPostDateStruct\":{\"date\":\"2019-03-12\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"University Teaching Hospital, Lusaka, Zambia\"},{\"name\":\"Centre Muraz\"},{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},{\"name\":\"University of Bergen\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"26603917\",\"type\":\"BACKGROUND\",\"citation\":\"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Marechal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskar T, Van de Perre P; ANRS 12174 Trial Group. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Erratum In: Lancet. 2019 Jun 22;393(10190):2492.\"},{\"pmid\":\"33872801\",\"type\":\"BACKGROUND\",\"citation\":\"Mennecier A, Kankasa C, Fao P, Moles JP, Eymard-Duvernay S, Mwiya M, Kania D, Chunda-Liyoka C, Sakana L, Rutagwera D, Tassembedo S, Wilfred-Tonga MM, Mosqueira B, Tylleskar T, Nagot N, Van de Perre P; ANRS 12397 Study group. Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso. Contemp Clin Trials. 2021 Jun;105:106402. doi: 10.1016/j.cct.2021.106402. Epub 2021 Apr 17.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01555450\",\"briefTitle\":\"Study of Patient Navigation to Reduce Social Inequalities\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-03\"},\"completionDateStruct\":{\"date\":\"2013-11\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-03-15\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"National Cancer Institute, France\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"21256688\",\"type\":\"BACKGROUND\",\"citation\":\"Dejardin O, Berchi C, Mignon A, Pornet C, Guillaume E, Guittet L, Bouvier V, Sailly M, Salinas A, Christophe V, Launoy G. [Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?]. Rev Epidemiol Sante Publique. 2011 Feb;59(1):45-51. doi: 10.1016/j.respe.2010.10.008. Epub 2011 Jan 21. French.\"},{\"pmid\":\"29909873\",\"type\":\"DERIVED\",\"citation\":\"De Mil R, Guillaume E, Guittet L, Dejardin O, Bouvier V, Pornet C, Christophe V, Notari A, Delattre-Massy H, De Seze C, Peng J, Launoy G, Berchi C. Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial. Value Health. 2018 Jun;21(6):685-691. doi: 10.1016/j.jval.2017.09.020. Epub 2017 Nov 10.\"},{\"pmid\":\"28823681\",\"type\":\"DERIVED\",\"citation\":\"Guillaume E, Dejardin O, Bouvier V, De Mil R, Berchi C, Pornet C, Christophe V, Notari A, Delattre Massy H, De Seze C, Peng J, Guittet L, Launoy G. Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial. Prev Med. 2017 Oct;103:76-83. doi: 10.1016/j.ypmed.2017.08.012. Epub 2017 Aug 16.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01514890\",\"briefTitle\":\"French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-02\"},\"completionDateStruct\":{\"date\":\"2014-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-01-23\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"25556540\",\"type\":\"DERIVED\",\"citation\":\"Sultanik P, Mallet V, Lagaye S, Casrouge A, Dorival C, Barthe Y, Fontaine H, Hezode C, Mottez E, Bronowicki JP, Carrat F, Theodorou I, Abel L, Gayat E, Fontanet A, Pol S, Albert ML; ANRS CO20-CUPIC. Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy. Liver Int. 2015 Jul;35(7):1833-44. doi: 10.1111/liv.12759. Epub 2015 Jan 23.\"},{\"pmid\":\"24704719\",\"type\":\"DERIVED\",\"citation\":\"Hezode C, Fontaine H, Dorival C, Zoulim F, Larrey D, Canva V, De Ledinghen V, Poynard T, Samuel D, Bourliere M, Alric L, Raabe JJ, Zarski JP, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Chazouilleres O, Abergel A, Guyader D, Metivier S, Tran A, Di Martino V, Causse X, Dao T, Lucidarme D, Portal I, Cacoub P, Gournay J, Grando-Lemaire V, Hillon P, Attali P, Fontanges T, Rosa I, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. Gastroenterology. 2014 Jul;147(1):132-142.e4. doi: 10.1053/j.gastro.2014.03.051. Epub 2014 Apr 3.\"},{\"pmid\":\"23669289\",\"type\":\"DERIVED\",\"citation\":\"Hezode C, Fontaine H, Dorival C, Larrey D, Zoulim F, Canva V, de Ledinghen V, Poynard T, Samuel D, Bourliere M, Zarski JP, Raabe JJ, Alric L, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Metivier S, Tran A, Serfaty L, Abergel A, Causse X, Di Martino V, Guyader D, Lucidarme D, Grando-Lemaire V, Hillon P, Feray C, Dao T, Cacoub P, Rosa I, Attali P, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. J Hepatol. 2013 Sep;59(3):434-41. doi: 10.1016/j.jhep.2013.04.035. Epub 2013 May 10.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04133012\",\"briefTitle\":\"Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2020-02-10\"},\"completionDateStruct\":{\"date\":\"2023-06-09\"},\"studyFirstPostDateStruct\":{\"date\":\"2019-10-21\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"ViiV Healthcare\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00658346\",\"briefTitle\":\"Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-06\"},\"completionDateStruct\":{\"date\":\"2016-09\"},\"studyFirstPostDateStruct\":{\"date\":\"2008-04-15\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"31063537\",\"type\":\"DERIVED\",\"citation\":\"Kouanfack C, Unal G, Schaeffer L, Kfutwah A, Aghokeng A, Mougnutou R, Tchemgui-Noumsi N, Alessandri-Gradt E, Delaporte E, Simon F, Vray M, Plantier JC; ANRS 12168 DynaMO Study. Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. Clin Infect Dis. 2020 Mar 17;70(7):1471-1477. doi: 10.1093/cid/ciz371.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02073630\",\"briefTitle\":\"Contribution of the Cerebellum In Sensory-motor Adaptation Via Gamma Oscillations: the Case of Dystonia\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-02\"},\"completionDateStruct\":{\"date\":\"2016-08\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-02-27\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03446430\",\"briefTitle\":\"Validation of Laser Doppler Vibrometer (LDV) for Measurement of Arterial Stiffness in Hypertensive Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2018-06-21\"},\"completionDateStruct\":{\"date\":\"2018-12-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2018-02-26\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01693848\",\"briefTitle\":\"\\\\\"Cancersensor\\\\\" Metastasis Resection\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-09\"},\"completionDateStruct\":{\"date\":\"2014-11\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-09-26\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT05040048\",\"briefTitle\":\"Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer\\'s Disease and Parkinson\\'s Disease\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-09-04\"},\"completionDateStruct\":{\"date\":\"2018-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2021-09-10\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Innovative Medicines Initiative\"},{\"name\":\"Institut d\\'Investigacions Biom\\xc3\\xa8diques August Pi i Sunyer\"},{\"name\":\"ICM Co. Ltd.\"},{\"name\":\"University Hospital, Bonn\"},{\"name\":\"Karolinska Institutet\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02453048\",\"briefTitle\":\"Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-09\"},\"completionDateStruct\":{\"date\":\"2017-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-05-25\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"24421886\",\"type\":\"BACKGROUND\",\"citation\":\"Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergstrom J, Ljungman M, Torner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One. 2014 Jan 8;9(1):e83449. doi: 10.1371/journal.pone.0083449. eCollection 2014.\"},{\"pmid\":\"24793938\",\"type\":\"BACKGROUND\",\"citation\":\"Jahnmatz M, Amu S, Ljungman M, Wehlin L, Chiodi F, Mielcarek N, Locht C, Thorstensson R. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. Vaccine. 2014 Jun 5;32(27):3350-6. doi: 10.1016/j.vaccine.2014.04.048. Epub 2014 Apr 29.\"},{\"pmid\":\"24950361\",\"type\":\"BACKGROUND\",\"citation\":\"Feunou PF, Kammoun H, Debrie AS, Locht C. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice. Vaccine. 2014 Jul 23;32(34):4281-8. doi: 10.1016/j.vaccine.2014.06.019. Epub 2014 Jun 17.\"},{\"pmid\":\"22814407\",\"type\":\"BACKGROUND\",\"citation\":\"Kammoun H, Feunou PF, Foligne B, Debrie AS, Raze D, Mielcarek N, Locht C. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Vaccine. 2012 Aug 31;30(40):5864-70. doi: 10.1016/j.vaccine.2012.07.005. Epub 2012 Jul 17.\"},{\"pmid\":\"21430219\",\"type\":\"BACKGROUND\",\"citation\":\"Fedele G, Bianco M, Debrie AS, Locht C, Ausiello CM. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. J Immunol. 2011 May 1;186(9):5388-96. doi: 10.4049/jimmunol.1003765. Epub 2011 Mar 23.\"},{\"pmid\":\"21147936\",\"type\":\"BACKGROUND\",\"citation\":\"Skerry CM, Mahon BP. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. Clin Vaccine Immunol. 2011 Feb;18(2):187-93. doi: 10.1128/CVI.00371-10. Epub 2010 Dec 8.\"},{\"pmid\":\"20708998\",\"type\":\"BACKGROUND\",\"citation\":\"Feunou PF, Kammoun H, Debrie AS, Mielcarek N, Locht C. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Vaccine. 2010 Oct 8;28(43):7047-53. doi: 10.1016/j.vaccine.2010.08.017. Epub 2010 Aug 13.\"},{\"pmid\":\"20419113\",\"type\":\"BACKGROUND\",\"citation\":\"Feunou PF, Bertout J, Locht C. T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS One. 2010 Apr 15;5(4):e10178. doi: 10.1371/journal.pone.0010178.\"},{\"pmid\":\"20107007\",\"type\":\"BACKGROUND\",\"citation\":\"Mielcarek N, Debrie AS, Mahieux S, Locht C. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Clin Vaccine Immunol. 2010 Mar;17(3):317-24. doi: 10.1128/CVI.00322-09. Epub 2010 Jan 27.\"},{\"pmid\":\"19625486\",\"type\":\"BACKGROUND\",\"citation\":\"Skerry CM, Cassidy JP, English K, Feunou-Feunou P, Locht C, Mahon BP. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol. 2009 Sep;16(9):1344-51. doi: 10.1128/CVI.00082-09. Epub 2009 Jul 22.\"},{\"pmid\":\"18762220\",\"type\":\"BACKGROUND\",\"citation\":\"Feunou PF, Ismaili J, Debrie AS, Huot L, Hot D, Raze D, Lemoine Y, Locht C. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Vaccine. 2008 Oct 23;26(45):5722-7. doi: 10.1016/j.vaccine.2008.08.018. Epub 2008 Aug 30.\"},{\"pmid\":\"32687804\",\"type\":\"DERIVED\",\"citation\":\"Jahnmatz M, Richert L, Al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C; BPZE1 study team. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. Lancet Infect Dis. 2020 Nov;20(11):1290-1301. doi: 10.1016/S1473-3099(20)30274-7. Epub 2020 Jul 17. Erratum In: Lancet Infect Dis. 2020 Sep;20(9):e215.\"},{\"pmid\":\"31945015\",\"type\":\"DERIVED\",\"citation\":\"Lin A, Apostolovic D, Jahnmatz M, Liang F, Ols S, Tecleab T, Wu C, van Hage M, Solovay K, Rubin K, Locht C, Thorstensson R, Thalen M, Lore K. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. J Clin Invest. 2020 May 1;130(5):2332-2346. doi: 10.1172/JCI135020.\"}]}},\"hasResults\":true},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01207986\",\"briefTitle\":\"Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-02\"},\"completionDateStruct\":{\"date\":\"2014-08\"},\"studyFirstPostDateStruct\":{\"date\":\"2010-09-23\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01620957\",\"briefTitle\":\"Longitudinal Study of the Default-mode Network Connectivity in Brain Injured Patients Recovering From Coma\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-07-10\"},\"completionDateStruct\":{\"date\":\"2017-07\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-06-15\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"University Hospital, Toulouse\"},{\"name\":\"Association des Traumatis\\xc3\\xa9s du Crane et de la Face, Paris, France\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00640263\",\"briefTitle\":\"Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2009-12\"},\"completionDateStruct\":{\"date\":\"2014-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2008-03-21\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"French National Agency for Research on AIDS and Viral Hepatitis\"},\"collaborators\":[{\"name\":\"European and Developing Countries Clinical Trials Partnership (EDCTP)\"},{\"name\":\"The Research Council of Norway\"},{\"name\":\"Swedish International Development Cooperation Agency (SIDA)\"},{\"name\":\"Universit\\xc3\\xa9 Montpellier\"},{\"name\":\"University of Bergen\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"17825642\",\"type\":\"BACKGROUND\",\"citation\":\"Kourtis AP, Jamieson DJ, de Vincenzi I, Taylor A, Thigpen MC, Dao H, Farley T, Fowler MG. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S113-22. doi: 10.1016/j.ajog.2007.03.003.\"},{\"pmid\":\"32991450\",\"type\":\"DERIVED\",\"citation\":\"Birungi N, Fadnes LT, Engebretsen IMS, Tumwine JK, Astrom AN; for ANRS 12174 AND 12341 study groups. Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial. Medicine (Baltimore). 2020 Sep 25;99(39):e22352. doi: 10.1097/MD.0000000000022352.\"},{\"pmid\":\"32228542\",\"type\":\"DERIVED\",\"citation\":\"Birungi N, Fadnes LT, Engebretsen IMS, Lie SA, Tumwine JK, Astrom AN; ANRS 12174 and 12341 study groups. Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children. BMC Public Health. 2020 Mar 30;20(1):423. doi: 10.1186/s12889-020-08564-1.\"},{\"pmid\":\"32067040\",\"type\":\"DERIVED\",\"citation\":\"Montoya-Ferrer A, Sanosyan A, Fayd\\'herbe de Maudave A, Pisoni A, Bollore K, Moles JP, Peries M, Tylleskar T, Tumwine JK, Ndeezi G, Gorgolas M, Nagot N, van de Perre P, Tuaillon E. Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda. Clin Infect Dis. 2021 Mar 15;72(6):1026-1032. doi: 10.1093/cid/ciaa161.\"},{\"pmid\":\"31994250\",\"type\":\"DERIVED\",\"citation\":\"Birungi N, Fadnes LT, Engebretsen IMS, Lie SA, Tumwine JK, Astrom AN; ANRS 12174 and 12341 study groups. Association of maternal HIV-1 severity with dental caries: an observational study of uninfected 5- to 7-yr-old children of HIV-1-infected mothers without severe immune suppression. Eur J Oral Sci. 2020 Feb;128(1):46-54. doi: 10.1111/eos.12669. Epub 2020 Jan 29.\"},{\"pmid\":\"31633158\",\"type\":\"DERIVED\",\"citation\":\"Kariyawasam D, Peries M, Foissac F, Eymard-Duvernay S, Tylleskar T, Singata-Madliki M, Kankasa C, Meda N, Tumwine J, Mwiya M, Engebretsen I, Fluck CE, Hartmann MF, Wudy SA, Hirt D, Treluyer JM, Moles JP, Blanche S, Van De Perre P, Polak M, Nagot N; ANRS 12174 Trial Group. Lopinavir-Ritonavir Impairs Adrenal Function in Infants. Clin Infect Dis. 2020 Aug 14;71(4):1030-1039. doi: 10.1093/cid/ciz888.\"},{\"pmid\":\"30814028\",\"type\":\"DERIVED\",\"citation\":\"Blanche S, Tylleskar T, Peries M, Kankasa C, Engebretsen I, Meda N, Tumwine JK, Singata-Madliki M, Mwiya M, Van de Perre P, Nagot N; ANRS 12174 Trial Group. Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial. Lancet HIV. 2019 May;6(5):e307-e314. doi: 10.1016/S2352-3018(18)30361-8. Epub 2019 Feb 24.\"},{\"pmid\":\"28469697\",\"type\":\"DERIVED\",\"citation\":\"Some EN, Engebretsen IMS, Nagot N, Meda N, Lombard C, Vallo R, Peries M, Kankasa C, Tumwine JK, Hofmeyr GJ, Singata M, Harper K, Van De Perre P, Tylleskar T; ANRS 12174 Trial Group. Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial. Int Breastfeed J. 2017 May 2;12:22. doi: 10.1186/s13006-017-0112-2. eCollection 2016.\"},{\"pmid\":\"27895016\",\"type\":\"DERIVED\",\"citation\":\"Foissac F, Blume J, Treluyer JM, Tylleskar T, Kankasa C, Meda N, Tumwine JK, Singata-Madliki M, Harper K, Illamola SM, Bouazza N, Nagot N, Van de Perre P, Blanche S, Hirt D. Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01869-16. doi: 10.1128/AAC.01869-16. Print 2017 Feb.\"},{\"pmid\":\"26603917\",\"type\":\"DERIVED\",\"citation\":\"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Marechal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskar T, Van de Perre P; ANRS 12174 Trial Group. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Erratum In: Lancet. 2019 Jun 22;393(10190):2492.\"},{\"pmid\":\"23039034\",\"type\":\"DERIVED\",\"citation\":\"Nagot N, Kankasa C, Meda N, Hofmeyr J, Nikodem C, Tumwine JK, Karamagi C, Sommerfelt H, Neveu D, Tylleskar T, Van de Perre P; PROMISE-PEP group. Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174. BMC Infect Dis. 2012 Oct 6;12:246. doi: 10.1186/1471-2334-12-246.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02987530\",\"briefTitle\":\"National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-04-11\"},\"completionDateStruct\":{\"date\":\"2020-01-31\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-12-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04808986\",\"briefTitle\":\"Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2021-05-10\"},\"completionDateStruct\":{\"date\":\"2021-10-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2021-03-22\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02626286\",\"briefTitle\":\"Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-06\"},\"completionDateStruct\":{\"date\":\"2021-01-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-12-10\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Expertise France\"},{\"name\":\"Universit\\xc3\\xa9 Montpellier\"},{\"name\":\"IRD Unit\\xc3\\xa9 SESSTIM (IRD, Inserm, Universit\\xc3\\xa9 Aix-Marseille)\"},{\"name\":\"Coalition Internationale Sida\"},{\"name\":\"ARCAD-SIDA MALI\"},{\"name\":\"Espace Confiance, C\\xc3\\xb4te d\\'Ivoire\"},{\"name\":\"Programme PAC-CI, Abidjan, C\\xc3\\xb4te d\\'Ivoire\"},{\"name\":\"Association African Solidarit\\xc3\\xa9\"},{\"name\":\"Centre de Recherche Internationale pour la Sant\\xc3\\xa9, Ouagadougou, Burkina Faso\"},{\"name\":\"Espoir Vie-Togo - ONG\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"34352834\",\"type\":\"DERIVED\",\"citation\":\"Dah TTE, Yaya I, Mensah E, Coulibaly A, Kouame JM, Traore I, Mora M, Palvadeau P, Anoma C, Keita BD, Spire B, Laurent C; CohMSM Study Group. Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa. AIDS. 2021 Nov 1;35(13):2201-2210. doi: 10.1097/QAD.0000000000003046.\"},{\"pmid\":\"34022820\",\"type\":\"DERIVED\",\"citation\":\"Dah TTE, Yaya I, Sagaon-Teyssier L, Coulibaly A, Kouame MJ, Agboyibor MK, Maiga K, Traore I, Mora M, Palvadeau P, Rojas-Castro D, Diallo F, Mensah E, Anoma C, Keita BD, Spire B, Laurent C; CohMSM Study Group. Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). BMC Public Health. 2021 May 22;21(1):972. doi: 10.1186/s12889-021-10994-4.\"},{\"pmid\":\"33753460\",\"type\":\"DERIVED\",\"citation\":\"Yaya I, Diallo F, Kouame MJ, Agboyibor MK, Traore I, Coulibaly A, Maiga K, Mora M, Palvadeau P, Dah ETT, Mensah E, Anoma C, Dembele Keita B, Spire B, Laurent C; CohMSM Study Group. Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France). Sex Transm Infect. 2022 Mar;98(2):85-94. doi: 10.1136/sextrans-2020-054755. Epub 2021 Mar 22.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00670839\",\"briefTitle\":\"Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2008-05\"},\"completionDateStruct\":{\"date\":\"2013-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2008-05-02\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"MCM Vaccines B.V.\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"26257021\",\"type\":\"DERIVED\",\"citation\":\"Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F; ANRS HB04 B-BOOST study group. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. Lancet Infect Dis. 2015 Nov;15(11):1283-91. doi: 10.1016/S1473-3099(15)00220-0. Epub 2015 Aug 6.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02573948\",\"briefTitle\":\"Feasibility of Interventions on People Who Inject Drugs in Vietnam\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-09\"},\"completionDateStruct\":{\"date\":\"2016-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-10-12\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"National Institute on Drug Abuse (NIDA)\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"26080690\",\"type\":\"BACKGROUND\",\"citation\":\"Elliott JC, Hasin DS, Stohl M, Des Jarlais DC. HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users. AIDS Behav. 2016 Mar;20(3):548-54. doi: 10.1007/s10461-015-1113-z.\"},{\"pmid\":\"26075647\",\"type\":\"BACKGROUND\",\"citation\":\"Perlman DC, Des Jarlais DC, Feelemyer J. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs? J Addict Dis. 2015;34(2-3):198-205. doi: 10.1080/10550887.2015.1059111.\"},{\"pmid\":\"26050614\",\"type\":\"BACKGROUND\",\"citation\":\"Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. Int J Drug Policy. 2015 Nov;26(11):1056-63. doi: 10.1016/j.drugpo.2015.04.015. Epub 2015 Apr 27.\"},{\"pmid\":\"26032121\",\"type\":\"BACKGROUND\",\"citation\":\"Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, Panopoulos A, Malliori M, Psichogiou M, Pharris A, Wiessing L, van de Laar M, Donoghoe M, Heckathorn DD, Friedman SR, Des Jarlais DC. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Addiction. 2015 Sep;110(9):1453-67. doi: 10.1111/add.12999. Epub 2015 Jul 14.\"},{\"pmid\":\"25540950\",\"type\":\"BACKGROUND\",\"citation\":\"Des Jarlais DC. AIDS, people who use drugs, and altruism: reflection on a personal image. Subst Use Misuse. 2015 Mar;50(4):532-3. doi: 10.3109/10826084.2015.978185. Epub 2014 Dec 26. No abstract available.\"},{\"pmid\":\"28800503\",\"type\":\"RESULT\",\"citation\":\"Michel L, Des Jarlais DC, Duong Thi H, Khuat Thi Hai O, Pham Minh K, Peries M, Vallo R, Nham Thi Tuyet T, Hoang Thi G, Le Sao M, Feelemyer J, Vu Hai V, Moles JP, Laureillard D, Nagot N; DRIVE Study Team. Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. Drug Alcohol Depend. 2017 Oct 1;179:198-204. doi: 10.1016/j.drugalcdep.2017.07.004. Epub 2017 Aug 2.\"},{\"pmid\":\"27178119\",\"type\":\"RESULT\",\"citation\":\"Des Jarlais D, Duong HT, Pham Minh K, Khuat OH, Nham TT, Arasteh K, Feelemyer J, Heckathorn DD, Peries M, Moles JP, Laureillard D, Nagot N; (The Drive Study Team). Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. AIDS Care. 2016 Oct;28(10):1312-5. doi: 10.1080/09540121.2016.1178698. Epub 2016 May 13.\"},{\"pmid\":\"27006257\",\"type\":\"RESULT\",\"citation\":\"Des Jarlais DC, Thi Huong D, Thi Hai Oanh K, Khue Pham M, Thi Giang H, Thi Tuyet Thanh N, Arasteh K, Feelemyer J, Hammett T, Peries M, Michel L, Vu Hai V, Roustide MJ, Moles JP, Laureillard D, Nagot N; DRIVE Study Team. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. Int J Drug Policy. 2016 Jun;32:50-6. doi: 10.1016/j.drugpo.2016.02.021. Epub 2016 Feb 27.\"},{\"pmid\":\"28612212\",\"type\":\"RESULT\",\"citation\":\"Duong HT, Jarlais DD, Khuat OHT, Arasteh K, Feelemyer J, Khue PM, Giang HT, Laureillard D, Hai VV, Vallo R, Michel L, Moles JP, Nagot N; Drive Study Group. Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014. AIDS Behav. 2018 Jul;22(7):2161-2171. doi: 10.1007/s10461-017-1814-6.\"}]}},\"hasResults\":true},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02014727\",\"briefTitle\":\"Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel \\xc2\\xae as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-01\"},\"completionDateStruct\":{\"date\":\"2015-07\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-12-18\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"EVI Industries, Inc.\"},{\"name\":\"BPRC\"},{\"name\":\"Recherche Clinique Paris Descartes Necker Cochin Sainte Anne\"},{\"name\":\"Centre national de recherche et de formation sur le paludisme\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"28947345\",\"type\":\"DERIVED\",\"citation\":\"Sirima SB, Durier C, Kara L, Houard S, Gansane A, Loulergue P, Bahuaud M, Benhamouda N, Nebie I, Faber B, Remarque E, Launay O; AMA1-DiCo Study Group. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel(R) in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial. Vaccine. 2017 Oct 27;35(45):6218-6227. doi: 10.1016/j.vaccine.2017.09.027. Epub 2017 Sep 22.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04008927\",\"briefTitle\":\"A Community-based Intervention Among Active Drug Users in Montpellier\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2020-09-18\"},\"completionDateStruct\":{\"date\":\"2021-09-10\"},\"studyFirstPostDateStruct\":{\"date\":\"2019-07-05\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"27168667\",\"type\":\"BACKGROUND\",\"citation\":\"Blackburn NA, Patel RC, Zibbell JE. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014. Public Health Rep. 2016 May-Jun;131 Suppl 2(Suppl 2):91-7. doi: 10.1177/00333549161310S214.\"},{\"pmid\":\"26806260\",\"type\":\"BACKGROUND\",\"citation\":\"Chevaliez S, Poiteau L, Rosa I, Soulier A, Roudot-Thoraval F, Laperche S, Hezode C, Pawlotsky JM. Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care. Clin Microbiol Infect. 2016 May;22(5):459.e1-6. doi: 10.1016/j.cmi.2016.01.009. Epub 2016 Jan 22.\"},{\"pmid\":\"22310560\",\"type\":\"BACKGROUND\",\"citation\":\"Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.\"},{\"pmid\":\"29432973\",\"type\":\"BACKGROUND\",\"citation\":\"Des Jarlais D, Khue PM, Feelemyer J, Arasteh K, Thi Huong D, Thi Hai Oanh K, Thi Giang H, Thi Tuyet Thanh N, Vinh VH, Heckathorn DD, Moles JP, Vallo R, Quillet C, Rapoud D, Michel L, Laureillard D, Hammett T, Nagot N. Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam. Drug Alcohol Depend. 2018 Apr 1;185:106-111. doi: 10.1016/j.drugalcdep.2017.11.033. Epub 2018 Feb 2.\"},{\"pmid\":\"27178119\",\"type\":\"BACKGROUND\",\"citation\":\"Des Jarlais D, Duong HT, Pham Minh K, Khuat OH, Nham TT, Arasteh K, Feelemyer J, Heckathorn DD, Peries M, Moles JP, Laureillard D, Nagot N; (The Drive Study Team). Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. AIDS Care. 2016 Oct;28(10):1312-5. doi: 10.1080/09540121.2016.1178698. Epub 2016 May 13.\"},{\"pmid\":\"27537841\",\"type\":\"BACKGROUND\",\"citation\":\"Dore GJ, Altice F, Litwin AH, Dalgard O, Gane EJ, Shibolet O, Luetkemeyer A, Nahass R, Peng CY, Conway B, Grebely J, Howe AY, Gendrano IN, Chen E, Huang HC, Dutko FJ, Nickle DC, Nguyen BY, Wahl J, Barr E, Robertson MN, Platt HL; C-EDGE CO-STAR Study Group. Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial. Ann Intern Med. 2016 Nov 1;165(9):625-634. doi: 10.7326/M16-0816. Epub 2016 Aug 9.\"},{\"pmid\":\"28004616\",\"type\":\"BACKGROUND\",\"citation\":\"Leon L, Kasereka S, Barin F, Larsen C, Weill-Barillet L, Pascal X, Chevaliez S, Pillonel J, Jauffret-Roustide M, LE Strat Y. Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys. Epidemiol Infect. 2017 Apr;145(5):895-907. doi: 10.1017/S0950268816002934. Epub 2016 Dec 22.\"},{\"pmid\":\"35774932\",\"type\":\"DERIVED\",\"citation\":\"Nagot N, D\\'Ottavi M, Quillet C, Debellefontaine A, Castellani J, Langendorfer N, Hanslik B, Guichard S, Baglioni R, Faucherre V, Tuaillon E, Pageaux GP, Laureillard D, Donnadieu-Rigole H. Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C. Open Forum Infect Dis. 2022 Apr 14;9(6):ofac181. doi: 10.1093/ofid/ofac181. eCollection 2022 Jun.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03546127\",\"briefTitle\":\"Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-05-23\"},\"completionDateStruct\":{\"date\":\"2017-09-21\"},\"studyFirstPostDateStruct\":{\"date\":\"2018-06-06\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Institut Bergoni\\xc3\\xa9\"},{\"name\":\"Plateforme labellis\\xc3\\xa9e Inca - Institut Bergoni\\xc3\\xa9, Bordeaux\"},{\"name\":\"Plateforme labellis\\xc3\\xa9e Inca - H\\xc3\\xb4pital Europ\\xc3\\xa9en Georges Pompidou, Paris\"},{\"name\":\"CNRGH, Evry\"},{\"name\":\"EUCLID Clinical Trial Platform\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02650427\",\"briefTitle\":\"A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-02\"},\"completionDateStruct\":{\"date\":\"2018-09\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-01-08\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02497274\",\"briefTitle\":\"Obesity and Lipids: a Matter of Taste?\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-01-11\"},\"completionDateStruct\":{\"date\":\"2019-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-07-14\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT05311865\",\"briefTitle\":\"Transmission of Covid-19 During Clubbing Events in Closed Places\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2021-09-04\"},\"completionDateStruct\":{\"date\":\"2022-02-26\"},\"studyFirstPostDateStruct\":{\"date\":\"2022-04-05\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Cerballiance\"},{\"name\":\"Kappa Sant\\xc3\\xa9\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02592174\",\"briefTitle\":\"Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-01-26\"},\"completionDateStruct\":{\"date\":\"2017-10-27\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-10-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Merck Sharp & Dohme LLC\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"31755936\",\"type\":\"DERIVED\",\"citation\":\"Makinson A, Dubois J, Eymard-Duvernay S, Leclercq P, Zaegel-Faucher O, Bernard L, Vassallo M, Barbuat C, Geny C, Thouvenot E, Costagliola D, Ozguler A, Zins M, Simony M, Reynes J, Berr C. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study. Clin Infect Dis. 2020 Jun 10;70(12):2641-2648. doi: 10.1093/cid/ciz670.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02100774\",\"briefTitle\":\"Effect of Genetic Variants on Fat-soluble Vitamin Bioavailability\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2009-01\"},\"completionDateStruct\":{\"date\":\"2013-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-04-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Institut National de Recherche pour l\\'Agriculture, l\\'Alimentation et l\\'Environnement\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"21957063\",\"type\":\"BACKGROUND\",\"citation\":\"Borel P. Genetic variations involved in interindividual variability in carotenoid status. Mol Nutr Food Res. 2012 Feb;56(2):228-40. doi: 10.1002/mnfr.201100322. Epub 2011 Sep 29.\"},{\"pmid\":\"27798339\",\"type\":\"DERIVED\",\"citation\":\"Desmarchelier C, Borel P, Goncalves A, Kopec R, Nowicki M, Morange S, Lesavre N, Portugal H, Reboul E. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Cholecalciferol Bioavailability in Healthy Men. J Nutr. 2016 Dec;146(12):2421-2428. doi: 10.3945/jn.116.237115. Epub 2016 Oct 26.\"},{\"pmid\":\"26063065\",\"type\":\"DERIVED\",\"citation\":\"Borel P, Desmarchelier C, Nowicki M, Bott R. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Dietary beta-Carotene Bioavailability in Healthy Men. J Nutr. 2015 Aug;145(8):1740-7. doi: 10.3945/jn.115.212837. Epub 2015 Jun 10.\"},{\"pmid\":\"24808487\",\"type\":\"DERIVED\",\"citation\":\"Borel P, Desmarchelier C, Nowicki M, Bott R, Morange S, Lesavre N. Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration. Am J Clin Nutr. 2014 Jul;100(1):168-75. doi: 10.3945/ajcn.114.085720. Epub 2014 May 7.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02273765\",\"briefTitle\":\"Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-09-11\"},\"completionDateStruct\":{\"date\":\"2018-11-28\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-10-24\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Merck Sharp & Dohme LLC\"},{\"name\":\"Ministry of Health, Brazil\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"33667406\",\"type\":\"DERIVED\",\"citation\":\"De Castro N, Marcy O, Chazallon C, Messou E, Eholie S, N\\'takpe JB, Bhatt N, Khosa C, Timana Massango I, Laureillard D, Chau GD, Domergue A, Veloso V, Escada R, Wagner Cardoso S, Delaugerre C, Anglaret X, Molina JM, Grinsztejn B; ANRS 12300 Reflate TB2 study group. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial. Lancet Infect Dis. 2021 Jun;21(6):813-822. doi: 10.1016/S1473-3099(20)30869-0. Epub 2021 Mar 2.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01022476\",\"briefTitle\":\"Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-05\"},\"completionDateStruct\":{\"date\":\"2013-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2009-12-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Merck Sharp & Dohme LLC\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02078076\",\"briefTitle\":\"IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie s\\xc3\\xa9v\\xc3\\xa8re\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-06\"},\"completionDateStruct\":{\"date\":\"2015-11\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-03-05\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02099474\",\"briefTitle\":\"Evaluation of Raltegravir During the Third Trimester of Pregnancy\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-06-30\"},\"completionDateStruct\":{\"date\":\"2017-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-03-31\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"32661003\",\"type\":\"DERIVED\",\"citation\":\"Zheng Y, Hirt D, Delmas S, Lui G, Benaboud S, Lechedanec J, Treluyer JM, Chenevier-Gobeaux C, Arezes E, Gelley A, Amri I, Urien S, Bouazza N, Foissac F, Warszawski J, Ghosn J. Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial. Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00759-20. doi: 10.1128/AAC.00759-20. Print 2020 Sep 21.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03078439\",\"briefTitle\":\"EPIPAGE2 Cohort Study Follow up at Five and a Half Years\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-09-02\"},\"completionDateStruct\":{\"date\":\"2018-01-08\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-03-13\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02081066\",\"briefTitle\":\"Identification of CETP as a Marker of Atherosclerosis\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-09-25\"},\"completionDateStruct\":{\"date\":\"2020-09\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-03-07\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04470648\",\"briefTitle\":\"COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2020-07-22\"},\"completionDateStruct\":{\"date\":\"2021-08-22\"},\"studyFirstPostDateStruct\":{\"date\":\"2020-07-14\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Samusocial de Paris\"},{\"name\":\"Assistance Publique - H\\xc3\\xb4pitaux de Paris\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"32070465\",\"type\":\"RESULT\",\"citation\":\"Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C, Yamani E, Behillil S, Ismael S, Nguyen D, Malvy D, Lescure FX, Georges S, Lazarus C, Tabai A, Stempfelet M, Enouf V, Coignard B, Levy-Bruhl D; Investigation team. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020 Feb;25(6):2000094. doi: 10.2807/1560-7917.ES.2020.25.6.2000094.\"},{\"pmid\":\"32224310\",\"type\":\"RESULT\",\"citation\":\"Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 Jun;20(6):697-706. doi: 10.1016/S1473-3099(20)30200-0. Epub 2020 Mar 27. Erratum In: Lancet Infect Dis. 2020 May 19;: Lancet Infect Dis. 2020 Jun;20(6):e116.\"},{\"pmid\":\"32371096\",\"type\":\"RESULT\",\"citation\":\"Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, Brichler S, Cohen Y. SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents. 2020 Jun;55(6):106006. doi: 10.1016/j.ijantimicag.2020.106006. Epub 2020 May 3.\"},{\"pmid\":\"31978945\",\"type\":\"RESULT\",\"citation\":\"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.\"},{\"pmid\":\"32046819\",\"type\":\"RESULT\",\"citation\":\"Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020 Feb;25(5):2000062. doi: 10.2807/1560-7917.ES.2020.25.5.2000062.\"},{\"pmid\":\"31995857\",\"type\":\"RESULT\",\"citation\":\"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.\"},{\"pmid\":\"32109013\",\"type\":\"RESULT\",\"citation\":\"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.\"},{\"pmid\":\"32338732\",\"type\":\"RESULT\",\"citation\":\"Baggett TP, Keyes H, Sporn N, Gaeta JM. Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston. JAMA. 2020 Jun 2;323(21):2191-2192. doi: 10.1001/jama.2020.6887.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02566148\",\"briefTitle\":\"Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-02\"},\"completionDateStruct\":{\"date\":\"2013-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-10-02\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Ministry of Health, France\"},{\"name\":\"Institut de Recherche pour le Developpement\"},{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},{\"name\":\"Institut national de prevention et d\\'education pour la sante\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"29982518\",\"type\":\"DERIVED\",\"citation\":\"Vignier N, Dray Spira R, Pannetier J, Ravalihasy A, Gosselin A, Lert F, Lydie N, Bouchaud O, Desgrees Du Lou A, Chauvin P; PARCOURS Study Group. Refusal to provide healthcare to sub-Saharan migrants in France: a comparison according to their HIV and HBV status. Eur J Public Health. 2018 Oct 1;28(5):904-910. doi: 10.1093/eurpub/cky118.\"},{\"pmid\":\"29437866\",\"type\":\"DERIVED\",\"citation\":\"Gosselin A, Desgrees du Lou A, Lelievre E; PARCOURS Study Group. How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France. J Epidemiol Community Health. 2018 Jun;72(6):507-512. doi: 10.1136/jech-2017-209739. Epub 2018 Feb 2.\"},{\"pmid\":\"29307383\",\"type\":\"DERIVED\",\"citation\":\"Pannetier J, Ravalihasy A, Lydie N, Lert F, Desgrees du Lou A; Parcours study group. Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study. Lancet Public Health. 2018 Jan;3(1):e16-e23. doi: 10.1016/S2468-2667(17)30211-6. Epub 2017 Nov 23.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04315948\",\"briefTitle\":\"Trial of Treatments for COVID-19 in Hospitalized Adults\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2020-03-22\"},\"completionDateStruct\":{\"date\":\"2023-09-25\"},\"studyFirstPostDateStruct\":{\"date\":\"2020-03-20\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"32958495\",\"type\":\"BACKGROUND\",\"citation\":\"Ader F; Discovery French Trial Management Team. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. BMJ Open. 2020 Sep 21;10(9):e041437. doi: 10.1136/bmjopen-2020-041437.\"},{\"pmid\":\"34763056\",\"type\":\"BACKGROUND\",\"citation\":\"EU-Response investigators group; Diallo A, Troseid M, Simensen VC, Boston A, Demotes J, Olsen IC, Chung F, Paiva JA, Hites M, Ader F, Arribas JR, Baratt-Due A, Melien O, Tacconelli E, Staub T, Greil R, Tsiodras S, Briel M, Esperou H, Mentre F, Eustace J, Saillard J, Delmas C, LeMestre S, Dumousseaux M, Costagliola D, Rottingen JA, Yazdanpanah Y. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. Clin Microbiol Infect. 2022 Jan;28(1):1-5. doi: 10.1016/j.cmi.2021.10.011. Epub 2021 Nov 8. No abstract available.\"},{\"pmid\":\"35623577\",\"type\":\"BACKGROUND\",\"citation\":\"Troseid M, Hentzien M, Ader F, Cardoso SW, Arribas JR, Molina JM, Mueller N, Hites M, Bonnet F, Manuel O, Costagliola D, Grinsztejn B, Olsen IC, Yazdapanah Y, Calmy A; EU RESPONSE; COMBINE. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. Clin Microbiol Infect. 2022 Sep;28(9):1182-1183. doi: 10.1016/j.cmi.2022.05.005. Epub 2022 May 25. No abstract available.\"},{\"pmid\":\"36680782\",\"type\":\"BACKGROUND\",\"citation\":\"Terzic V, Levoyer L, Figarella M, Bigagli E, Mercier N, De Gastines L, Gibowski S, Troseid M, Demotes J, Olsen IC, Hites M, Ader F, Lopez JRA, Mentre F, Esperou H, Costagliola D, Rottingen JA, Poissy J, Roze JC, Warris A, O\\'Leary J, Fernandes RM, Assoumou L, Hankard R, Turner MA, Yazdanpanah Y, Diallo A; EU-Response safety group; c4c safety group. Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. Br J Clin Pharmacol. 2023 Apr;89(4):1318-1328. doi: 10.1111/bcp.15669. Epub 2023 Feb 8.\"},{\"pmid\":\"36828006\",\"type\":\"BACKGROUND\",\"citation\":\"Amstutz A, Speich B, Mentre F, Rueegg CS, Belhadi D, Assoumou L, Burdet C, Murthy S, Dodd LE, Wang Y, Tikkinen KAO, Ader F, Hites M, Bouscambert M, Trabaud MA, Fralick M, Lee TC, Pinto R, Barratt-Due A, Lund-Johansen F, Muller F, Nevalainen OPO, Cao B, Bonnett T, Griessbach A, Taji Heravi A, Schonenberger C, Janiaud P, Werlen L, Aghlmandi S, Schandelmaier S, Yazdanpanah Y, Costagliola D, Olsen IC, Briel M. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet Respir Med. 2023 May;11(5):453-464. doi: 10.1016/S2213-2600(22)00528-8. Epub 2023 Feb 21. Erratum In: Lancet Respir Med. 2023 Aug;11(8):e77.\"},{\"pmid\":\"32473020\",\"type\":\"BACKGROUND\",\"citation\":\"Le MP, Peiffer-Smadja N, Guedj J, Neant N, Mentre F, Ader F, Yazdanpanah Y, Peytavin G. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. J Antimicrob Chemother. 2020 Sep 1;75(9):2376-2380. doi: 10.1093/jac/dkaa191.\"},{\"pmid\":\"33089306\",\"type\":\"BACKGROUND\",\"citation\":\"Le MP, Peiffer-Smadja N, Guedj J, Neant N, Mentre F, Ader F, Yazdanpanah Y, Peytavin G; C-20-15 DisCoVeRy French Steering Committee. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors\\' response. J Antimicrob Chemother. 2021 Jan 1;76(1):277-279. doi: 10.1093/jac/dkaa415. No abstract available.\"},{\"pmid\":\"37269068\",\"type\":\"BACKGROUND\",\"citation\":\"Mercier N, Belhadi D, DeChanet A, Delmas C, Saillard J, Dumousseaux M, Le Mestre S, Fougerou-Leurent C, Ferrane A, Burdet C, Esperou H, Ader F, Hites M, Peiffer-Smadja N, Poissy J, Andrejak C, Paiva JA, Tacconelli E, Staub T, Greil R, Costagliola D, Mentre F, Yazdanpanah Y, Diallo A; DisCoVeRy Safety Working group. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial. Pharmacol Res Perspect. 2023 Jun;11(3):e01072. doi: 10.1002/prp2.1072.\"},{\"pmid\":\"37302469\",\"type\":\"BACKGROUND\",\"citation\":\"Fougerou-Leurent C, Delmas C, Saillard J, Dumousseaux M, Ferrane A, Mercier N, Terzic V, Le Mestre S, Dechanet A, Belhadi D, Metois A, Burdet C, Mentre F, Noret M, Diallo A, Petrov-Sanchez V, Couffin-Cadiergues S, Hites M, Ader F, Esperou H. Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study. Contemp Clin Trials. 2023 Aug;131:107267. doi: 10.1016/j.cct.2023.107267. Epub 2023 Jun 9.\"},{\"pmid\":\"33264556\",\"type\":\"RESULT\",\"citation\":\"WHO Solidarity Trial Consortium; Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernandez Garcia C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, Garcia PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portoles A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Rottingen JA, Swaminathan S. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.\"},{\"pmid\":\"34048876\",\"type\":\"RESULT\",\"citation\":\"Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabie A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Le MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentre F; DisCoVeRy study group. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-beta-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec;27(12):1826-1837. doi: 10.1016/j.cmi.2021.05.020. Epub 2021 May 26.\"},{\"pmid\":\"34534511\",\"type\":\"RESULT\",\"citation\":\"Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Le MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentre F; DisCoVeRy Study Group. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet Infect Dis. 2022 Feb;22(2):209-221. doi: 10.1016/S1473-3099(21)00485-0. Epub 2021 Sep 14.\"},{\"pmid\":\"35233617\",\"type\":\"RESULT\",\"citation\":\"Lingas G, Neant N, Gaymard A, Belhadi D, Peytavin G, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Wallet F, Gagneux-Brunon A, Mentre F, Ader F, Burdet C, Guedj J, Bouscambert-Duchamp M. Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. J Antimicrob Chemother. 2022 Apr 27;77(5):1404-1412. doi: 10.1093/jac/dkac048.\"},{\"pmid\":\"35643099\",\"type\":\"RESULT\",\"citation\":\"Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Mentre F, Burdet C; DisCoVeRy Study Group. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. Lancet Infect Dis. 2022 Jun;22(6):764-765. doi: 10.1016/S1473-3099(22)00295-X. No abstract available.\"},{\"pmid\":\"35533972\",\"type\":\"RESULT\",\"citation\":\"Ader F; DisCoVeRy Study Group. An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-beta-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results. Clin Microbiol Infect. 2022 Sep;28(9):1293-1296. doi: 10.1016/j.cmi.2022.04.016. Epub 2022 May 7. No abstract available.\"},{\"pmid\":\"37728045\",\"type\":\"RESULT\",\"citation\":\"Neant N, Lingas G, Gaymard A, Belhadi D, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Bouscambert-Duchamp M, Gagneux-Brunon A, Ader F, Mentre F, Wallet F, Burdet C, Guedj J; DisCoVeRy study group. Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients. CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):2027-2037. doi: 10.1002/psp4.13051. Epub 2023 Oct 11.\"},{\"pmid\":\"35512728\",\"type\":\"DERIVED\",\"citation\":\"WHO Solidarity Trial Consortium. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Lancet. 2022 May 21;399(10339):1941-1953. doi: 10.1016/S0140-6736(22)00519-0. Epub 2022 May 2. Erratum In: Lancet. 2022 Oct 29;400(10362):1512. Lancet. 2024 Jan 13;403(10422):146.\"},{\"pmid\":\"34473343\",\"type\":\"DERIVED\",\"citation\":\"Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.\"},{\"pmid\":\"34350582\",\"type\":\"DERIVED\",\"citation\":\"Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8(8):CD014962. doi: 10.1002/14651858.CD014962.\"},{\"pmid\":\"32304640\",\"type\":\"DERIVED\",\"citation\":\"Taccone FS, Gorham J, Vincent JL. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. Lancet Respir Med. 2020 Jun;8(6):539-541. doi: 10.1016/S2213-2600(20)30172-7. Epub 2020 Apr 15. No abstract available.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01713335\",\"briefTitle\":\"Proteasis Evaluation in COPD\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-10-18\"},\"completionDateStruct\":{\"date\":\"2017-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-10-24\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01874808\",\"briefTitle\":\"From Movement Preparation to Gait Execution in ALS\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-06-21\"},\"completionDateStruct\":{\"date\":\"2015-12-21\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-06-11\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Universit\\xc3\\xa9 Paris Ouest-EA 2931-CEntre de Recherches sur le Sport et le Mouvement\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01895920\",\"briefTitle\":\"Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-01\"},\"completionDateStruct\":{\"date\":\"2018-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-07-11\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02978924\",\"briefTitle\":\"Trans-spinal Direct Current Stimulation in Primary Orthostatic Tremor\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-01-17\"},\"completionDateStruct\":{\"date\":\"2017-11-28\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-12-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02160119\",\"briefTitle\":\"Emotional and Change-related Attention in Autism\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-05-27\"},\"completionDateStruct\":{\"date\":\"2018-05-27\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-06-10\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04631224\",\"briefTitle\":\"Longitudinal Analysis of Oral Communication in Friedreich\\'s Ataxia\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-02\"},\"completionDateStruct\":{\"date\":\"2017-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2020-11-17\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01693835\",\"briefTitle\":\"\\\\\"Cancersensor\\\\\": Circadian Rhythms\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-08\"},\"completionDateStruct\":{\"date\":\"2014-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-09-26\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01917175\",\"briefTitle\":\"Early Identification and Treatment of Early HIV Infection in C\\xc3\\xb4te d\\'Ivoire\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"1997-06\"},\"completionDateStruct\":{\"date\":\"2018-09\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-08-06\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01952587\",\"briefTitle\":\"X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-11\"},\"completionDateStruct\":{\"date\":\"2015-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-09-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02329054\",\"briefTitle\":\"Efficacy of Favipiravir Against Ebola (JIKI)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-12\"},\"completionDateStruct\":{\"date\":\"2015-09\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-12-31\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"25435054\",\"type\":\"BACKGROUND\",\"citation\":\"Mentre F, Taburet AM, Guedj J, Anglaret X, Keita S, de Lamballerie X, Malvy D. Dose regimen of favipiravir for Ebola virus disease. Lancet Infect Dis. 2015 Feb;15(2):150-1. doi: 10.1016/S1473-3099(14)71047-3. Epub 2014 Nov 28. No abstract available.\"},{\"pmid\":\"27046271\",\"type\":\"RESULT\",\"citation\":\"Sissoko D, Laouenan C, Folkesson E, M\\'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Munoz VC, Doumbouya L, Harouna S, Kighoma PM, Koundouno FR, Lolamou R, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wolfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Uwamahoro MG, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D\\'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, de Sainte Fare EB, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Duverger TA, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Gunther S, de Lamballerie X, Keita S, Mentre F, Anglaret X, Malvy D; JIKI Study Group. Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016 Apr 5;13(4):e1002009. doi: 10.1371/journal.pmed.1002009. eCollection 2016 Apr.\"},{\"pmid\":\"28231247\",\"type\":\"DERIVED\",\"citation\":\"Nguyen TH, Guedj J, Anglaret X, Laouenan C, Madelain V, Taburet AM, Baize S, Sissoko D, Pastorino B, Rodallec A, Piorkowski G, Carazo S, Conde MN, Gala JL, Bore JA, Carbonnelle C, Jacquot F, Raoul H, Malvy D, de Lamballerie X, Mentre F; JIKI study group. Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. PLoS Negl Trop Dis. 2017 Feb 23;11(2):e0005389. doi: 10.1371/journal.pntd.0005389. eCollection 2017 Feb.\"},{\"pmid\":\"26930627\",\"type\":\"DERIVED\",\"citation\":\"Sissoko D, Laouenan C, Folkesson E, M\\'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna, Kighoma PM, Koundouno FR, Rene Lolamou, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wolfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D\\'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Gunther S, de Lamballerie X, Keita S, Mentre F, Anglaret X, Malvy D; JIKI Study Group. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar. Erratum In: PLoS Med. 2016 Apr;13(4):e1002009. Dortenzio, Eric [corrected to D\\'Ortenzio, Eric]. PLoS Med. 2016 Jun;13(6):e1002066.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04842851\",\"briefTitle\":\"Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2004-01-01\"},\"completionDateStruct\":{\"date\":\"2020-12-31\"},\"studyFirstPostDateStruct\":{\"date\":\"2021-04-13\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Paris Cardiovascular Research Center (Inserm U970)\"},\"collaborators\":[{\"name\":\"Marie Lannelongue Hospital, Le Plessis Robinson, France\"},{\"name\":\"Clinique Pasteur Toulouse\"},{\"name\":\"Groupe Hospitalier Pitie-Salpetriere\"},{\"name\":\"Hopital Louis Pradel\"},{\"name\":\"University Hospital, Montpellier\"},{\"name\":\"European Georges Pompidou Hospital\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02093754\",\"briefTitle\":\"Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-05\"},\"completionDateStruct\":{\"date\":\"2016-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-03-21\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02916732\",\"briefTitle\":\"Zika Virus Infection\\'s Pregnancy Consequences in French Department of America\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-04\"},\"completionDateStruct\":{\"date\":\"2019-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-09-27\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"33657112\",\"type\":\"RESULT\",\"citation\":\"Funk AL, Hoen B, Vingdassalom I, Ryan C, Kadhel P, Schepers K, Gaete S, Tressieres B, Fontanet A. Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016. PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009048. doi: 10.1371/journal.pntd.0009048. eCollection 2021 Mar.\"},{\"pmid\":\"29539287\",\"type\":\"RESULT\",\"citation\":\"Hoen B, Schaub B, Funk AL, Ardillon V, Boullard M, Cabie A, Callier C, Carles G, Cassadou S, Cesaire R, Douine M, Herrmann-Storck C, Kadhel P, Laouenan C, Madec Y, Monthieux A, Nacher M, Najioullah F, Rousset D, Ryan C, Schepers K, Stegmann-Planchard S, Tressieres B, Volumenie JL, Yassinguezo S, Janky E, Fontanet A. Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas. N Engl J Med. 2018 Mar 15;378(11):985-994. doi: 10.1056/NEJMoa1709481.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03215732\",\"briefTitle\":\"Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-10-19\"},\"completionDateStruct\":{\"date\":\"2019-07-31\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-07-12\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Institute of Research for Development, France\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"31320358\",\"type\":\"DERIVED\",\"citation\":\"Coste M, De Seze M, Diallo A, Carrieri MP, Marcellin F, Boyer S; ANRS 12356 AmBASS Study Group. Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). BMJ Open. 2019 Jul 17;9(7):e030211. doi: 10.1136/bmjopen-2019-030211.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01089387\",\"briefTitle\":\"Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-05\"},\"completionDateStruct\":{\"date\":\"2015-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2010-03-18\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"28753830\",\"type\":\"DERIVED\",\"citation\":\"Yiou R, Hamidou L, Birebent B, Bitari D, Le Corvoisier P, Contremoulins I, Rodriguez AM, Augustin D, Roudot-Thoraval F, de la Taille A, Rouard H. Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial. Eur Urol Focus. 2017 Dec;3(6):643-645. doi: 10.1016/j.euf.2017.06.009. Epub 2017 Jun 24.\"},{\"pmid\":\"25974235\",\"type\":\"DERIVED\",\"citation\":\"Khera M, Albersen M, Mulhall JP. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med. 2015 May;12(5):1105-6. doi: 10.1111/jsm.12871. No abstract available.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01269632\",\"briefTitle\":\"Cohort of Young Adults Infected With HIV Since Birth or During Childhood\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-06\"},\"completionDateStruct\":{\"date\":\"2018-12-27\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-01-04\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"French National Agency for Research on AIDS and Viral Hepatitis\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04120415\",\"briefTitle\":\"A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2022-06-21\"},\"completionDateStruct\":{\"date\":\"2023-07-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2019-10-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"EuroVacc Foundation\"},{\"name\":\"European AIDS Treatment Group (EATG)\"},{\"name\":\"Medical Research Council\"},{\"name\":\"University College London Hospitals\"},{\"name\":\"University of Liverpool\"},{\"name\":\"Erasmus Medical Center\"},{\"name\":\"Henri Mondor University Hospital\"},{\"name\":\"European Georges Pompidou Hospital\"},{\"name\":\"Saint-Louis Hospital, Paris, France\"},{\"name\":\"Centre Hospitalier Universitaire Vaudois\"},{\"name\":\"Chelsea and Westminster Hospital, UK\"},{\"name\":\"Universit\\xc3\\xa4tsklinikum Hamburg-Eppendorf\"},{\"name\":\"Hospital Clinic of Barcelona\"},{\"name\":\"Istituto Nazionale Malattie Infettive Lazaro Spallanzani\"},{\"name\":\"Imperial College London\"},{\"name\":\"Institut d\\'Investigacions Biom\\xc3\\xa8diques August Pi i Sunyer\"},{\"name\":\"European Commission\"},{\"name\":\"Swiss Government\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02236832\",\"briefTitle\":\"Study of the Neural Basis of Analogical Reasoning\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-02\"},\"completionDateStruct\":{\"date\":\"2021-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-09-11\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Fondation pour la Recherche M\\xc3\\xa9dicale\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00604149\",\"briefTitle\":\"Cardiac AResT And GENEtic\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2008-01\"},\"completionDateStruct\":{\"date\":\"2014-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2008-01-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01779752\",\"briefTitle\":\"Vestibular Cortex and TMS\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-01-20\"},\"completionDateStruct\":{\"date\":\"2016-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-01-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02647632\",\"briefTitle\":\"Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-01\"},\"completionDateStruct\":{\"date\":\"2017-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-01-06\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"29077864\",\"type\":\"DERIVED\",\"citation\":\"de Ledinghen V, Laforest C, Hezode C, Pol S, Renault A, Alric L, Larrey D, Metivier S, Tran A, Jezequel C, Samuel D, Zoulim F, Tual C, Pailhe A, Gibowski S, Bourliere M, Bellissant E, Pawlotsky JM. Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study. Clin Infect Dis. 2018 Mar 19;66(7):1013-1018. doi: 10.1093/cid/cix916.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01905059\",\"briefTitle\":\"Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-02\"},\"completionDateStruct\":{\"date\":\"2017-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-07-23\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Janssen Pharmaceuticals\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"16249701\",\"type\":\"BACKGROUND\",\"citation\":\"Arribas JR, Pulido F, Delgado R, Lorenzo A, Miralles P, Arranz A, Gonzalez-Garcia JJ, Cepeda C, Hervas R, Pano JR, Gaya F, Carcas A, Montes ML, Costa JR, Pena JM. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):280-7. doi: 10.1097/01.qai.0000180077.59159.f4.\"},{\"pmid\":\"18097218\",\"type\":\"BACKGROUND\",\"citation\":\"Pulido F, Arribas JR, Delgado R, Cabrero E, Gonzalez-Garcia J, Perez-Elias MJ, Arranz A, Portilla J, Pasquau J, Iribarren JA, Rubio R, Norton M; OK04 Study Group. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. AIDS. 2008 Jan 11;22(2):F1-9. doi: 10.1097/QAD.0b013e3282f4243b.\"},{\"pmid\":\"18540803\",\"type\":\"BACKGROUND\",\"citation\":\"Cameron DW, da Silva BA, Arribas JR, Myers RA, Bellos NC, Gilmore N, King MS, Bernstein BM, Brun SC, Hanna GJ. A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy. J Infect Dis. 2008 Jul 15;198(2):234-40. doi: 10.1086/589622.\"},{\"pmid\":\"21886816\",\"type\":\"BACKGROUND\",\"citation\":\"Cahn P, Montaner J, Junod P, Patterson P, Krolewiecki A, Andrade-Villanueva J, Cassetti I, Sierra-Madero J, Casiro AD, Bortolozzi R, Lupo SH, Longo N, Rampakakis E, Ackad N, Sampalis JS. Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. PLoS One. 2011;6(8):e23726. doi: 10.1371/journal.pone.0023726. Epub 2011 Aug 19.\"},{\"pmid\":\"17545707\",\"type\":\"BACKGROUND\",\"citation\":\"Vernazza P, Daneel S, Schiffer V, Decosterd L, Fierz W, Klimkait T, Hoffmann M, Hirschel B. The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. AIDS. 2007 Jun 19;21(10):1309-15. doi: 10.1097/QAD.0b013e32814e6b1c.\"},{\"pmid\":\"20802298\",\"type\":\"BACKGROUND\",\"citation\":\"Gutmann C, Cusini A, Gunthard HF, Fux C, Hirschel B, Decosterd LA, Cavassini M, Yerly S, Vernazza PL; Swiss HIV Cohort Study (SHCS). Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir. AIDS. 2010 Sep 24;24(15):2347-54. doi: 10.1097/QAD.0b013e32833db9a1.\"},{\"pmid\":\"20802297\",\"type\":\"BACKGROUND\",\"citation\":\"Katlama C, Valantin MA, Algarte-Genin M, Duvivier C, Lambert-Niclot S, Girard PM, Molina JM, Hoen B, Pakianather S, Peytavin G, Marcelin AG, Flandre P. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. AIDS. 2010 Sep 24;24(15):2365-74. doi: 10.1097/QAD.0b013e32833dec20.\"},{\"pmid\":\"20010070\",\"type\":\"BACKGROUND\",\"citation\":\"Arribas JR, Horban A, Gerstoft J, Fatkenheuer G, Nelson M, Clumeck N, Pulido F, Hill A, van Delft Y, Stark T, Moecklinghoff C. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. AIDS. 2010 Jan 16;24(2):223-30. doi: 10.1097/QAD.0b013e3283348944.\"},{\"pmid\":\"21811554\",\"type\":\"BACKGROUND\",\"citation\":\"Mathis S, Khanlari B, Pulido F, Schechter M, Negredo E, Nelson M, Vernazza P, Cahn P, Meynard JL, Arribas J, Bucher HC. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. PLoS One. 2011;6(7):e22003. doi: 10.1371/journal.pone.0022003. Epub 2011 Jul 19.\"},{\"pmid\":\"22814125\",\"type\":\"BACKGROUND\",\"citation\":\"Gilks CF, Walker AS, Dunn DT, Gibb DM, Kikaire B, Reid A, Musana H, Mambule I, Kasirye R, Robertson V, Ssali F, Spyer M, Pillay D, Yirrell D, Kaleebu P; DART Virology Group and Trial Team. Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA). Antivir Ther. 2012;17(7):1363-73. doi: 10.3851/IMP2253. Epub 2012 Jul 19.\"},{\"pmid\":\"22441252\",\"type\":\"BACKGROUND\",\"citation\":\"Bartlett JA, Ribaudo HJ, Wallis CL, Aga E, Katzenstein DA, Stevens WS, Norton MR, Klingman KL, Hosseinipour MC, Crump JA, Supparatpinyo K, Badal-Faesen S, Kallungal BA, Kumarasamy N. Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. AIDS. 2012 Jul 17;26(11):1345-54. doi: 10.1097/QAD.0b013e328353b066.\"},{\"pmid\":\"16549962\",\"type\":\"BACKGROUND\",\"citation\":\"Castagna A, Danise A, Menzo S, Galli L, Gianotti N, Carini E, Boeri E, Galli A, Cernuschi M, Hasson H, Clementi M, Lazzarin A. Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). AIDS. 2006 Apr 4;20(6):795-803. doi: 10.1097/01.aids.0000218542.08845.b2.\"},{\"pmid\":\"23075703\",\"type\":\"BACKGROUND\",\"citation\":\"Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavej S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Kerr SJ, Sophonphan J, Bhakeecheep S, Hirschel B, Ruxrungtham K; HIV STAR Study Group. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. Antivir Ther. 2012;17(7):1351-61. doi: 10.3851/IMP2443. Epub 2012 Jul 2. Erratum In: Antivir Ther. 2012;17(7):1389-90.\"},{\"pmid\":\"28566227\",\"type\":\"DERIVED\",\"citation\":\"Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E; MOBIDIP study group. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03005652\",\"briefTitle\":\"Effects Of An 8-Weeks Mindfulness-based Intervention In Individuals With Subjective Cognitive Decline\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-04-21\"},\"completionDateStruct\":{\"date\":\"2018-09-18\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-12-29\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"36068621\",\"type\":\"DERIVED\",\"citation\":\"Whitfield T, Demnitz-King H, Schlosser M, Barnhofer T, Frison E, Coll-Padros N, Dautricourt S, Requier F, Delarue M, Gonneaud J, Klimecki OM, Lutz A, Paly L, Salmon E, Schild AK, Walker Z, Jessen F, Chetelat G, Collette F, Wirth M, Marchant NL; Medit-Ageing Research Group. Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial. Alzheimers Res Ther. 2022 Sep 6;14(1):125. doi: 10.1186/s13195-022-01057-w.\"},{\"pmid\":\"35853750\",\"type\":\"DERIVED\",\"citation\":\"Demnitz-King H, Gonneaud J, Klimecki OM, Chocat A, Collette F, Dautricourt S, Jessen F, Krolak-Salmon P, Lutz A, Morse RM, Molinuevo JL, Poisnel G, Touron E, Wirth M, Walker Z, Chetelat G, Marchant NL; Medit-Ageing Research Group. Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults. Neurology. 2022 Sep 27;99(13):e1422-e1431. doi: 10.1212/WNL.0000000000200951. Epub 2022 Jul 19.\"},{\"pmid\":\"33873195\",\"type\":\"DERIVED\",\"citation\":\"Marchant NL, Barnhofer T, Coueron R, Wirth M, Lutz A, Arenaza-Urquijo EM, Collette F, Poisnel G, Demnitz-King H, Schild AK, Coll-Padros N, Delphin-Combe F, Whitfield T, Schlosser M, Gonneaud J, Asselineau J, Walker Z, Krolak-Salmon P, Molinuevo JL, Frison E, Chetelat G, Jessen F, Klimecki OM; The Medit-Ageing Research Group. Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial. Psychother Psychosom. 2021;90(5):341-350. doi: 10.1159/000515669. Epub 2021 Apr 19.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02542800\",\"briefTitle\":\"The Influence of Collective Schemas on Individual Memory\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-09\"},\"completionDateStruct\":{\"date\":\"2017-06-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-09-07\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"La R\\xc3\\xa9gion Basse-Normandie\"},{\"name\":\"Universit\\xc3\\xa9 de Caen Normandie\"},{\"name\":\"University Hospital, Caen\"},{\"name\":\"Ecole Pratique des Hautes Etudes\"},{\"name\":\"Equipement d\\'Excellence Matrice\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01779713\",\"briefTitle\":\"Transcriptomic Signature of Vasospasm Consecutive to Sub-arachnoid Aneurismal Hemorrhage\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-02-04\"},\"completionDateStruct\":{\"date\":\"2016-07-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-01-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"30354977\",\"type\":\"DERIVED\",\"citation\":\"Pulcrano-Nicolas AS, Proust C, Clarencon F, Jacquens A, Perret C, Roux M, Shotar E, Thibord F, Puybasset L, Garnier S, Degos V, Tregouet DA. Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage. Stroke. 2018 Sep;49(9):2220-2223. doi: 10.1161/STROKEAHA.118.021101.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01842919\",\"briefTitle\":\"Dance and Huntington Disease\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-04\"},\"completionDateStruct\":{\"date\":\"2016-07-08\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-04-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02405013\",\"briefTitle\":\"Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-10\"},\"completionDateStruct\":{\"date\":\"2017-11\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-04-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01801618\",\"briefTitle\":\"National Evaluation of PI-based 2nd Line Efficacy in Cambodia\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-02\"},\"completionDateStruct\":{\"date\":\"2014-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-03-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT06260319\",\"briefTitle\":\"Decoding Developmental Disorders in Humams\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2019-01-01\"},\"completionDateStruct\":{\"date\":\"2024-01-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2024-02-15\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Imagine Institute\"},{\"name\":\"Commissariat A L\\'energie Atomique\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02125500\",\"briefTitle\":\"Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-08\"},\"completionDateStruct\":{\"date\":\"2015-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-04-29\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00445575\",\"briefTitle\":\"Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2007-07-22\"},\"completionDateStruct\":{\"date\":\"2017-12-07\"},\"studyFirstPostDateStruct\":{\"date\":\"2007-03-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"ZonMw: The Netherlands Organisation for Health Research and Development\"},{\"name\":\"Cliniques universitaires Saint-Luc- Universit\\xc3\\xa9 Catholique de Louvain\"},{\"name\":\"Charite University, Berlin, Germany\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02051413\",\"briefTitle\":\"Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-02-18\"},\"completionDateStruct\":{\"date\":\"2018-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-01-31\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00136630\",\"briefTitle\":\"Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2005-05\"},\"completionDateStruct\":{\"date\":\"2020-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2005-08-29\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Assistance Publique - H\\xc3\\xb4pitaux de Paris\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"16193476\",\"type\":\"RESULT\",\"citation\":\"Klebe S, Durr A, Rentschler A, Hahn-Barma V, Abele M, Bouslam N, Schols L, Jedynak P, Forlani S, Denis E, Dussert C, Agid Y, Bauer P, Globas C, Wullner U, Brice A, Riess O, Stevanin G. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol. 2005 Nov;58(5):720-9. doi: 10.1002/ana.20628.\"},{\"pmid\":\"15313841\",\"type\":\"RESULT\",\"citation\":\"Stevanin G, Hahn V, Lohmann E, Bouslam N, Gouttard M, Soumphonphakdy C, Welter ML, Ollagnon-Roman E, Lemainque A, Ruberg M, Brice A, Durr A. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol. 2004 Aug;61(8):1242-8. doi: 10.1001/archneur.61.8.1242.\"},{\"pmid\":\"15365159\",\"type\":\"RESULT\",\"citation\":\"Stevanin G, Durr A, Dussert C, Penet C, Brice A. Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians. Neurology. 2004 Sep 14;63(5):936. doi: 10.1212/01.wnl.0000137020.30604.1e. No abstract available.\"},{\"pmid\":\"16501573\",\"type\":\"RESULT\",\"citation\":\"Waters MF, Minassian NA, Stevanin G, Figueroa KP, Bannister JP, Nolte D, Mock AF, Evidente VG, Fee DB, Muller U, Durr A, Brice A, Papazian DM, Pulst SM. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat Genet. 2006 Apr;38(4):447-51. doi: 10.1038/ng1758. Epub 2006 Feb 26.\"},{\"pmid\":\"16055926\",\"type\":\"RESULT\",\"citation\":\"Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet. 2006 Mar;43(3):259-65. doi: 10.1136/jmg.2005.035311. Epub 2005 Jul 31.\"},{\"pmid\":\"17098887\",\"type\":\"RESULT\",\"citation\":\"Depienne C, Fedirko E, Forlani S, Cazeneuve C, Ribai P, Feki I, Tallaksen C, Nguyen K, Stankoff B, Ruberg M, Stevanin G, Durr A, Brice A. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet. 2007 Apr;44(4):281-4. doi: 10.1136/jmg.2006.046425. Epub 2006 Nov 10.\"},{\"pmid\":\"17597328\",\"type\":\"RESULT\",\"citation\":\"Depienne C, Fedirko E, Faucheux JM, Forlani S, Bricka B, Goizet C, Lesourd S, Stevanin G, Ruberg M, Durr A, Brice A. A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP. Neurogenetics. 2007 Aug;8(3):231-3. doi: 10.1007/s10048-007-0090-4. Epub 2007 Jun 28.\"},{\"pmid\":\"17605047\",\"type\":\"RESULT\",\"citation\":\"Hanein S, Durr A, Ribai P, Forlani S, Leutenegger AL, Nelson I, Babron MC, Elleuch N, Depienne C, Charon C, Brice A, Stevanin G. A novel locus for autosomal dominant \\\\\"uncomplicated\\\\\" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3. Hum Genet. 2007 Nov;122(3-4):261-73. doi: 10.1007/s00439-007-0396-1. Epub 2007 Jun 28.\"},{\"pmid\":\"17957230\",\"type\":\"RESULT\",\"citation\":\"Ribai P, Depienne C, Fedirko E, Jothy AC, Viveweger C, Hahn-Barma V, Brice A, Durr A. Mental deficiency in three families with SPG4 spastic paraplegia. Eur J Hum Genet. 2008 Jan;16(1):97-104. doi: 10.1038/sj.ejhg.5201922. Epub 2007 Oct 24.\"},{\"pmid\":\"18378516\",\"type\":\"RESULT\",\"citation\":\"du Montcel ST, Charles P, Ribai P, Goizet C, Le Bayon A, Labauge P, Guyant-Marechal L, Forlani S, Jauffret C, Vandenberghe N, N\\'guyen K, Le Ber I, Devos D, Vincitorio CM, Manto MU, Tison F, Hannequin D, Ruberg M, Brice A, Durr A. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Brain. 2008 May;131(Pt 5):1352-61. doi: 10.1093/brain/awn059. Epub 2008 Mar 31.\"},{\"pmid\":\"18853458\",\"type\":\"RESULT\",\"citation\":\"Goizet C, Boukhris A, Mundwiller E, Tallaksen C, Forlani S, Toutain A, Carriere N, Paquis V, Depienne C, Durr A, Stevanin G, Brice A. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat. 2009 Feb;30(2):E376-85. doi: 10.1002/humu.20920.\"},{\"pmid\":\"24780882\",\"type\":\"DERIVED\",\"citation\":\"Tezenas du Montcel S, Durr A, Rakowicz M, Nanetti L, Charles P, Sulek A, Mariotti C, Rola R, Schols L, Bauer P, Dufaure-Gare I, Jacobi H, Forlani S, Schmitz-Hubsch T, Filla A, Timmann D, van de Warrenburg BP, Marelli C, Kang JS, Giunti P, Cook A, Baliko L, Melegh B, Boesch S, Szymanski S, Berciano J, Infante J, Buerk K, Masciullo M, Di Fabio R, Depondt C, Ratka S, Stevanin G, Klockgether T, Brice A, Golmard JL. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. J Med Genet. 2014 Jul;51(7):479-86. doi: 10.1136/jmedgenet-2013-102200. Epub 2014 Apr 29. Erratum In: J Med Genet. 2014 Sep;51(9):613. Bela, Melegh [corrected to Melegh, Bela].\"},{\"pmid\":\"22491195\",\"type\":\"DERIVED\",\"citation\":\"Tezenas du Montcel S, Charles P, Goizet C, Marelli C, Ribai P, Vincitorio C, Anheim M, Guyant-Marechal L, Le Bayon A, Vandenberghe N, Tchikviladze M, Devos D, Le Ber I, N\\'Guyen K, Cazeneuve C, Tallaksen C, Brice A, Durr A. Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. Arch Neurol. 2012 Apr;69(4):500-8. doi: 10.1001/archneurol.2011.2713.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03235258\",\"briefTitle\":\"Cohort of HIV-infected Children\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2004-07\"},\"completionDateStruct\":{\"date\":\"2020-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-08-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"26762993\",\"type\":\"RESULT\",\"citation\":\"Frange P, Faye A, Avettand-Fenoel V, Bellaton E, Descamps D, Angin M, David A, Caillat-Zucman S, Peytavin G, Dollfus C, Le Chenadec J, Warszawski J, Rouzioux C, Saez-Cirion A; ANRS EPF-CO10 Pediatric Cohort and the ANRS EP47 VISCONTI study group. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. Lancet HIV. 2016 Jan;3(1):e49-54. doi: 10.1016/S2352-3018(15)00232-5. Epub 2015 Dec 9.\"},{\"pmid\":\"24945880\",\"type\":\"RESULT\",\"citation\":\"Aupiais C, Faye A, Le Chenadec J, Rouzioux C, Bouallag N, Laurent C, Blanche S, Dollfus C, Warszawski J; ANRS EPF-CO10 French Pediatric Cohort. Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children. Pediatr Infect Dis J. 2014 Dec;33(12):1237-45. doi: 10.1097/INF.0000000000000450.\"},{\"pmid\":\"24705410\",\"type\":\"RESULT\",\"citation\":\"Sofeu CL, Warszawski J, Ateba Ndongo F, Penda IC, Tetang Ndiang S, Guemkam G, Makwet N, Owona F, Kfutwah A, Tchendjou P, Texier G, Tchuente M, Faye A, Tejiokem MC; ANRS-PEDIACAM Study Group. Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon. PLoS One. 2014 Apr 3;9(4):e93554. doi: 10.1371/journal.pone.0093554. eCollection 2014.\"},{\"pmid\":\"24253249\",\"type\":\"RESULT\",\"citation\":\"Blanche S, Scott-Algara D, Le Chenadec J, Didier C, Montange T, Avettand-Fenoel V, Rouzioux C, Melard A, Viard JP, Dollfus C, Bouallag N, Warszawski J, Buseyne F. Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study. Clin Infect Dis. 2014 Feb;58(4):573-87. doi: 10.1093/cid/cit729. Epub 2013 Nov 18.\"},{\"pmid\":\"22427678\",\"type\":\"RESULT\",\"citation\":\"Avettand-Fenoel V, Blanche S, Le Chenadec J, Scott-Algara D, Dollfus C, Viard JP, Bouallag N, Benmebarek Y, Riviere Y, Warszawski J, Rouzioux C, Buseyne F. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. J Infect Dis. 2012 May 15;205(10):1520-8. doi: 10.1093/infdis/jis233. Epub 2012 Mar 15.\"},{\"pmid\":\"22198788\",\"type\":\"RESULT\",\"citation\":\"Goetghebuer T, Le Chenadec J, Haelterman E, Galli L, Dollfus C, Thorne C, Judd A, Keiser O, Ramos JT, Levy J, Warszawski J; European Infant Collaboration Group. Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. Clin Infect Dis. 2012 Mar;54(6):878-81. doi: 10.1093/cid/cir950. Epub 2011 Dec 23.\"},{\"pmid\":\"21971357\",\"type\":\"RESULT\",\"citation\":\"Judd A; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord. Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens. AIDS. 2011 Nov 28;25(18):2279-87. doi: 10.1097/QAD.0b013e32834d614c.\"},{\"pmid\":\"21511330\",\"type\":\"RESULT\",\"citation\":\"Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE); Castro H, Judd A, Gibb DM, Butler K, Lodwick RK, van Sighem A, Ramos JT, Warsawski J, Thorne C, Noguera-Julian A, Obel N, Costagliola D, Tookey PA, Colin C, Kjaer J, Grarup J, Chene G, Phillips A. Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Lancet. 2011 May 7;377(9777):1580-7. doi: 10.1016/S0140-6736(11)60208-0. Epub 2011 Apr 20.\"},{\"pmid\":\"20536367\",\"type\":\"RESULT\",\"citation\":\"Dollfus C, Le Chenadec J, Faye A, Blanche S, Briand N, Rouzioux C, Warszawski J. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Clin Infect Dis. 2010 Jul 15;51(2):214-24. doi: 10.1086/653674.\"},{\"pmid\":\"19194272\",\"type\":\"RESULT\",\"citation\":\"Goetghebuer T, Haelterman E, Le Chenadec J, Dollfus C, Gibb D, Judd A, Green H, Galli L, Ramos JT, Giaquinto C, Warszawski J, Levy J; European Infant Collaboration group. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS. 2009 Mar 13;23(5):597-604. doi: 10.1097/QAD.0b013e328326ca37.\"},{\"pmid\":\"18614870\",\"type\":\"RESULT\",\"citation\":\"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group; Sabin CA, Smith CJ, d\\'Arminio Monforte A, Battegay M, Gabiano C, Galli L, Geelen S, Gibb D, Guiguet M, Judd A, Leport C, Dabis F, Pantazis N, Porter K, Raffi F, Thorne C, Torti C, Walker S, Warszawski J, Wintergerst U, Chene G, Lundgren J. Response to combination antiretroviral therapy: variation by age. AIDS. 2008 Jul 31;22(12):1463-73. doi: 10.1097/QAD.0b013e3282f88d02.\"},{\"pmid\":\"17712765\",\"type\":\"RESULT\",\"citation\":\"Warszawski J, Lechenadec J, Faye A, Dollfus C, Firtion G, Meyer L, Douard D, Monpoux F, Tricoire J, Benmebarek Y, Rouzioux C, Blanche S. Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort. Clin Infect Dis. 2007 Sep 15;45(6):785-94. doi: 10.1086/521165. Epub 2007 Aug 14.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02428816\",\"briefTitle\":\"Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-01-24\"},\"completionDateStruct\":{\"date\":\"2016-07-28\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-04-29\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02886416\",\"briefTitle\":\"Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-08\"},\"completionDateStruct\":{\"date\":\"2017-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-09-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01899196\",\"briefTitle\":\"Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-07\"},\"completionDateStruct\":{\"date\":\"2016-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-07-15\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04684758\",\"briefTitle\":\"HIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE Study\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2021-04-14\"},\"completionDateStruct\":{\"date\":\"2022-06-30\"},\"studyFirstPostDateStruct\":{\"date\":\"2020-12-28\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02116374\",\"briefTitle\":\"Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-12\"},\"completionDateStruct\":{\"date\":\"2016-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-04-16\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03459157\",\"briefTitle\":\"Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-11-20\"},\"completionDateStruct\":{\"date\":\"2021-06-30\"},\"studyFirstPostDateStruct\":{\"date\":\"2018-03-08\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Expertise France\"},{\"name\":\"Universit\\xc3\\xa9 Montpellier\"},{\"name\":\"SESSTIM (IRD, Inserm, Universit\\xc3\\xa9 Aix-Marseille)\"},{\"name\":\"Coalition Internationale Sida\"},{\"name\":\"Institut de M\\xc3\\xa9decine Tropicale, Anvers, Belgique\"},{\"name\":\"ARCAD-SIDA MALI\"},{\"name\":\"Association African Solidarit\\xc3\\xa9\"},{\"name\":\"Centre de Recherche Internationale pour la Sant\\xc3\\xa9, Universit\\xc3\\xa9 de Ouagadougou\"},{\"name\":\"Espace Confiance, C\\xc3\\xb4te d\\'Ivoire\"},{\"name\":\"Espoir Vie-Togo - ONG\"},{\"name\":\"Laboratoire BIOLIM, Universit\\xc3\\xa9 de Lom\\xc3\\xa9\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"34048794\",\"type\":\"DERIVED\",\"citation\":\"Laurent C, Dembele Keita B, Yaya I, Le Guicher G, Sagaon-Teyssier L, Agboyibor MK, Coulibaly A, Traore I, Malan JB, De Baetselier I, Eubanks A, Riegel L, Rojas Castro D, Faye-Kette H, Kone A, Diande S, Dagnra CA, Serrano L, Diallo F, Mensah E, Dah TTE, Anoma C, Vuylsteke B, Spire B; CohMSM-PrEP Study Group. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. Lancet HIV. 2021 Jul;8(7):e420-e428. doi: 10.1016/S2352-3018(21)00005-9. Epub 2021 May 25.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01579435\",\"briefTitle\":\"Experimental Therapeutics in Essential Tremor Using Transcranial Direct Current Stimulation\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-04\"},\"completionDateStruct\":{\"date\":\"2013-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-04-18\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01493934\",\"briefTitle\":\"Development of a Fast Measurement Technique of Insulin Resistance in Human\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-04\"},\"completionDateStruct\":{\"date\":\"2013-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-12-16\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02192658\",\"briefTitle\":\"Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-11\"},\"completionDateStruct\":{\"date\":\"2016-07\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-07-17\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Handicap International\"},{\"name\":\"Institut de Recherche pour le Developpement\"},{\"name\":\"Institut de Formation et de Recherche D\\xc3\\xa9mographique\"},{\"name\":\"Forum Camerounais de Psychologie\"},{\"name\":\"Centre de Recherche Internationale pour la Sant\\xc3\\xa9 de l\\'Universit\\xc3\\xa9 de Ouagadougou\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"26846895\",\"type\":\"DERIVED\",\"citation\":\"De Beaudrap P, Pasquier E, Tchoumkeu A, Touko A, Essomba F, Brus A, Desgrees du Lou A, Aderemi TJ, Hanass-Hancock J, Eide AH, Mont D, Mac-Seing M, Beninguisse G. HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations. BMJ Open. 2016 Feb 4;6(2):e008934. doi: 10.1136/bmjopen-2015-008934.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03071458\",\"briefTitle\":\"Mutational Landscape in Hepatocellular Carcinoma\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2008-01\"},\"completionDateStruct\":{\"date\":\"2015-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-03-07\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02527096\",\"briefTitle\":\"A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir\\xc2\\xae) and Dolutegravir (Tivicay\\xc2\\xae) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-09-17\"},\"completionDateStruct\":{\"date\":\"2017-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-08-18\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"ViiV Healthcare\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02057796\",\"briefTitle\":\"Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-09\"},\"completionDateStruct\":{\"date\":\"2018-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-02-07\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"32558469\",\"type\":\"DERIVED\",\"citation\":\"Blanc FX, Badje AD, Bonnet M, Gabillard D, Messou E, Muzoora C, Samreth S, Nguyen BD, Borand L, Domergue A, Rapoud D, Natukunda N, Thai S, Juchet S, Eholie SP, Lawn SD, Domoua SK, Anglaret X, Laureillard D; STATIS ANRS 12290 Trial Team. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults. N Engl J Med. 2020 Jun 18;382(25):2397-2410. doi: 10.1056/NEJMoa1910708.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03537196\",\"briefTitle\":\"DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2018-11-13\"},\"completionDateStruct\":{\"date\":\"2022-12-30\"},\"studyFirstPostDateStruct\":{\"date\":\"2018-05-25\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"25086286\",\"type\":\"BACKGROUND\",\"citation\":\"Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014 Nov;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. Epub 2014 Jul 30.\"},{\"pmid\":\"23172780\",\"type\":\"BACKGROUND\",\"citation\":\"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.\"},{\"pmid\":\"22828983\",\"type\":\"BACKGROUND\",\"citation\":\"Sereno L, Mesquita F, Kato M, Jacka D, Nguyen TT, Nguyen TN. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam. J Int Assoc Physicians AIDS Care (Chic). 2012 Sep-Oct;11(5):311-20. doi: 10.1177/1545109712453939. Epub 2012 Jul 24.\"},{\"pmid\":\"20041309\",\"type\":\"BACKGROUND\",\"citation\":\"Clatts MC, Colon-Lopez V, Giang LM, Goldsamt LA. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health. 2010 Mar;87(2):278-291. doi: 10.1007/s11524-009-9417-9.\"},{\"pmid\":\"22098550\",\"type\":\"BACKGROUND\",\"citation\":\"Gish RG, Bui TD, Nguyen CT, Nguyen DT, Tran HV, Tran DM, Trinh HN; International Group for Liver Health in Viet Nam. Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action. J Gastroenterol Hepatol. 2012 Feb;27(2):238-47. doi: 10.1111/j.1440-1746.2011.06974.x.\"},{\"pmid\":\"20196807\",\"type\":\"BACKGROUND\",\"citation\":\"Kallman JB, Tran S, Arsalla A, Haddad D, Stepanova M, Fang Y, Wrobel VJ, Srishord M, Younossi ZM. Vietnamese community screening for hepatitis B virus and hepatitis C virus. J Viral Hepat. 2011 Jan;18(1):70-6. doi: 10.1111/j.1365-2893.2010.01278.x.\"},{\"pmid\":\"19839502\",\"type\":\"BACKGROUND\",\"citation\":\"Pham DA, Leuangwutiwong P, Jittmittraphap A, Luplertlop N, Bach HK, Akkarathamrongsin S, Theamboonlers A, Poovorawan Y. High prevalence of Hepatitis C virus genotype 6 in Vietnam. Asian Pac J Allergy Immunol. 2009 Jun-Sep;27(2-3):153-60.\"},{\"pmid\":\"20572071\",\"type\":\"BACKGROUND\",\"citation\":\"Tanimoto T, Nguyen HC, Ishizaki A, Chung PT, Hoang TT, Nguyen VT, Kageyama S, Oka S, Pham VT, Ichimura H. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. J Med Virol. 2010 Aug;82(8):1355-63. doi: 10.1002/jmv.21787.\"},{\"pmid\":\"23675659\",\"type\":\"BACKGROUND\",\"citation\":\"Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl J Med. 2013 May 16;368(20):1907-17. doi: 10.1056/NEJMra1213651.\"},{\"pmid\":\"25920094\",\"type\":\"BACKGROUND\",\"citation\":\"Pawlotsky JM, Feld JJ, Zeuzem S, Hoofnagle JH. From non-A, non-B hepatitis to hepatitis C virus cure. J Hepatol. 2015 Apr;62(1 Suppl):S87-99. doi: 10.1016/j.jhep.2015.02.006.\"},{\"pmid\":\"23553643\",\"type\":\"BACKGROUND\",\"citation\":\"Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, Foster GR, Dillon JF, Goldberg DJ, Dore GJ, Hickman M. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013 Nov;58(5):1598-609. doi: 10.1002/hep.26431. Epub 2013 Aug 26.\"},{\"pmid\":\"23728143\",\"type\":\"BACKGROUND\",\"citation\":\"Grebely J, Matthews GV, Lloyd AR, Dore GJ. Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements. Clin Infect Dis. 2013 Oct;57(7):1014-20. doi: 10.1093/cid/cit377. Epub 2013 May 31.\"},{\"pmid\":\"27667367\",\"type\":\"BACKGROUND\",\"citation\":\"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol. 2017 Jan;66(1):153-194. doi: 10.1016/j.jhep.2016.09.001. Epub 2016 Sep 22. No abstract available.\"},{\"pmid\":\"25245939\",\"type\":\"BACKGROUND\",\"citation\":\"Bruggmann P, Grebely J. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. Int J Drug Policy. 2015 Feb;26 Suppl 1:S22-6. doi: 10.1016/j.drugpo.2014.08.014. Epub 2014 Aug 30.\"},{\"pmid\":\"27178119\",\"type\":\"BACKGROUND\",\"citation\":\"Des Jarlais D, Duong HT, Pham Minh K, Khuat OH, Nham TT, Arasteh K, Feelemyer J, Heckathorn DD, Peries M, Moles JP, Laureillard D, Nagot N; (The Drive Study Team). Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. AIDS Care. 2016 Oct;28(10):1312-5. doi: 10.1080/09540121.2016.1178698. Epub 2016 May 13.\"},{\"pmid\":\"27227200\",\"type\":\"BACKGROUND\",\"citation\":\"Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version. Geneva: World Health Organization; 2016 Apr. Available from http://www.ncbi.nlm.nih.gov/books/NBK362924/\"},{\"pmid\":\"27148964\",\"type\":\"BACKGROUND\",\"citation\":\"Nguyen Truong T, Laureillard D, Lacombe K, Duong Thi H, Pham Thi Hanh P, Truong Thi Xuan L, Chu Thi N, Luong Que A, Vu Hai V, Nagot N, Tuaillon E, Dominguez S, Lemoine M. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262). PLoS One. 2016 May 5;11(5):e0153744. doi: 10.1371/journal.pone.0153744. eCollection 2016.\"},{\"pmid\":\"23884064\",\"type\":\"BACKGROUND\",\"citation\":\"Martin NK, Hickman M, Hutchinson SJ, Goldberg DJ, Vickerman P. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis. 2013 Aug;57 Suppl 2(Suppl 2):S39-45. doi: 10.1093/cid/cit296. Erratum In: Clin Infect Dis. 2014 Apr;58(8):1203.\"},{\"pmid\":\"27427455\",\"type\":\"BACKGROUND\",\"citation\":\"Altice FL, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoriak S, Taxman FS, El-Bassel N, Martin NK, Booth R, Stover H, Dolan K, Vickerman P. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet. 2016 Sep 17;388(10050):1228-48. doi: 10.1016/S0140-6736(16)30856-X. Epub 2016 Jul 14.\"},{\"pmid\":\"22564041\",\"type\":\"BACKGROUND\",\"citation\":\"Vickerman P, Martin N, Turner K, Hickman M. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Addiction. 2012 Nov;107(11):1984-95. doi: 10.1111/j.1360-0443.2012.03932.x. Epub 2012 Jul 12.\"},{\"pmid\":\"26298331\",\"type\":\"BACKGROUND\",\"citation\":\"Smith DJ, Combellick J, Jordan AE, Hagan H. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis. Int J Drug Policy. 2015 Oct;26(10):911-21. doi: 10.1016/j.drugpo.2015.07.004. Epub 2015 Jul 26.\"},{\"pmid\":\"27349488\",\"type\":\"BACKGROUND\",\"citation\":\"Conti F, Buonfiglioli F, Scuteri A, Crespi C, Bolondi L, Caraceni P, Foschi FG, Lenzi M, Mazzella G, Verucchi G, Andreone P, Brillanti S. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol. 2016 Oct;65(4):727-733. doi: 10.1016/j.jhep.2016.06.015. Epub 2016 Jun 24.\"},{\"pmid\":\"33208326\",\"type\":\"DERIVED\",\"citation\":\"Rapoud D, Quillet C, Pham Minh K, Vu Hai V, Nguyen Thanh B, Nham Thi Tuyet T, Tran Thi H, Moles JP, Vallo R, Michel L, Feelemyer J, Weiss L, Lemoine M, Vickerman P, Fraser H, Duong Thi H, Khuat Thi Hai O, Des Jarlais D, Nagot N, Laureillard D; DRIVE-C Study Group. Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C). BMJ Open. 2020 Nov 18;10(11):e039234. doi: 10.1136/bmjopen-2020-039234.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00265642\",\"briefTitle\":\"Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2006-10\"},\"completionDateStruct\":{\"date\":\"2013-11\"},\"studyFirstPostDateStruct\":{\"date\":\"2005-12-15\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Sanofi\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01592175\",\"briefTitle\":\"Magnetoencephalography (MEG), Attention and Conscience\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-03-08\"},\"completionDateStruct\":{\"date\":\"2013-07-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-05-07\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03193099\",\"briefTitle\":\"Decoding Presymptomatic White Matter Changes in Huntington Disease\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-07-11\"},\"completionDateStruct\":{\"date\":\"2019-12-30\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-06-20\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"University College, London\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01725542\",\"briefTitle\":\"Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-12\"},\"completionDateStruct\":{\"date\":\"2014-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-11-14\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Bristol-Myers Squibb\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"25977266\",\"type\":\"DERIVED\",\"citation\":\"Piroth L, Paniez H, Taburet AM, Vincent C, Rosenthal E, Lacombe K, Billaud E, Rey D, Zucman D, Bailly F, Bronowicki JP, Simony M, Diallo A, Izopet J, Aboulker JP, Meyer L, Molina JM; ANRS HC30 QUADRIH Study Group. High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study. Clin Infect Dis. 2015 Sep 1;61(5):817-25. doi: 10.1093/cid/civ381. Epub 2015 May 14.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02038842\",\"briefTitle\":\"Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-03\"},\"completionDateStruct\":{\"date\":\"2016-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-01-17\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01094899\",\"briefTitle\":\"Abnormal Structure and Bone Density in Diabetes\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2010-03-10\"},\"completionDateStruct\":{\"date\":\"2014-07-10\"},\"studyFirstPostDateStruct\":{\"date\":\"2010-03-29\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04265742\",\"briefTitle\":\"Microbiota and Bone Fragility:Study of the Relation Between Gut Microbiota and Bone Microarchitecture\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2019-02-08\"},\"completionDateStruct\":{\"date\":\"2022-02-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2020-02-12\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Merck Sharp & Dohme LLC\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01569399\",\"briefTitle\":\"Efficacity of rTMS in Alcohol Dependance\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-02-11\"},\"completionDateStruct\":{\"date\":\"2016-08\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-04-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00918307\",\"briefTitle\":\"Efficacy and Safety of Varenicline Among HIV-infected Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2009-10\"},\"completionDateStruct\":{\"date\":\"2014-07\"},\"studyFirstPostDateStruct\":{\"date\":\"2009-06-11\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Pfizer\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"34611902\",\"type\":\"DERIVED\",\"citation\":\"Hartmann-Boyce J, Theodoulou A, Farley A, Hajek P, Lycett D, Jones LL, Kudlek L, Heath L, Hajizadeh A, Schenkels M, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD006219. doi: 10.1002/14651858.CD006219.pub4.\"},{\"pmid\":\"29329763\",\"type\":\"DERIVED\",\"citation\":\"Mercie P, Arsandaux J, Katlama C, Ferret S, Beuscart A, Spadone C, Duvivier C, Reynes J, Wirth N, Moinot L, Benard A, Zucman D, Duval X, Molina JM, Spire B, Fagard C, Chene G; ANRS 144 Inter-ACTIV study group. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. Lancet HIV. 2018 Mar;5(3):e126-e135. doi: 10.1016/S2352-3018(18)30002-X. Epub 2018 Jan 9.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02082171\",\"briefTitle\":\"Multidomain Intervention to Prevent Disability in Elders\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-10-16\"},\"completionDateStruct\":{\"date\":\"2016-01-27\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-03-10\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"National Research Agency, France\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02150993\",\"briefTitle\":\"First-Line Treatment for HIV-2\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-01-26\"},\"completionDateStruct\":{\"date\":\"2019-05-15\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-05-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01331811\",\"briefTitle\":\"Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-04\"},\"completionDateStruct\":{\"date\":\"2014-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-04-08\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Institut Pasteur, Cambodia\"},{\"name\":\"National Pediatric Hospital, Cambodia\"},{\"name\":\"Angkor Hospital for Children\"},{\"name\":\"Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam\"},{\"name\":\"Pediatric Hospital Nhi Dong 1, Ho Chi Minh City, Vietnam\"},{\"name\":\"Number 2 Children\\'s Hospital, Ho Chi Minh City\"},{\"name\":\"H\\xc3\\xb4pital Necker-Enfants Malades, Paris, France\"},{\"name\":\"Groupe Hospitalier Pitie-Salpetriere\"},{\"name\":\"CHRU Arnaud de Villeveuve, Montpellier, France\"},{\"name\":\"IRD, Yaounde, Cameroon\"},{\"name\":\"Fondation Chantal Biya,Yaounde, Cameroon\"},{\"name\":\"CHU Sour\\xc3\\xb4 Sanou, Bobo Dioulasso, Burkina Faso\"},{\"name\":\"Centre Muraz\"},{\"name\":\"Centre Pasteur du Cameroun\"},{\"name\":\"Centre Hospitalier D\\'essos\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"31455612\",\"type\":\"DERIVED\",\"citation\":\"Marcy O, Borand L, Ung V, Msellati P, Tejiokem M, Huu KT, Do Chau V, Ngoc Tran D, Ateba-Ndongo F, Tetang-Ndiang S, Nacro B, Sanogo B, Neou L, Goyet S, Dim B, Pean P, Quillet C, Fournier I, Berteloot L, Carcelain G, Godreuil S, Blanche S, Delacourt C; ANRS 12229 PAANTHER 01 STUDY GROUP. A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis. Pediatrics. 2019 Sep;144(3):e20182065. doi: 10.1542/peds.2018-2065.\"},{\"pmid\":\"30689814\",\"type\":\"DERIVED\",\"citation\":\"Borand L, de Lauzanne A, Nguyen NL, Cheng S, Pham TH, Eyangoh S, Ouedraogo AS, Ung V, Msellati P, Tejiokem M, Nacro B, Inghammar M, Dim B, Delacourt C, Godreuil S, Blanche S, Marcy O; Pediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER) Study Group. Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis. Clin Infect Dis. 2019 May 2;68(10):1750-1753. doi: 10.1093/cid/ciy897.\"},{\"pmid\":\"29174612\",\"type\":\"DERIVED\",\"citation\":\"Marcy O, Tejiokem M, Msellati P, Truong Huu K, Do Chau V, Tran Ngoc D, Nacro B, Ateba-Ndongo F, Tetang-Ndiang S, Ung V, Dim B, Neou L, Berteloot L, Borand L, Delacourt C, Blanche S; ANRS 12229 PAANTHER 01 Study Group. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Lancet HIV. 2018 Feb;5(2):e87-e95. doi: 10.1016/S2352-3018(17)30206-0. Epub 2017 Nov 23.\"},{\"pmid\":\"26908804\",\"type\":\"DERIVED\",\"citation\":\"Marcy O, Ung V, Goyet S, Borand L, Msellati P, Tejiokem M, Nguyen Thi NL, Nacro B, Cheng S, Eyangoh S, Pham TH, Ouedraogo AS, Tarantola A, Godreuil S, Blanche S, Delacourt C. Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children. Clin Infect Dis. 2016 May 1;62(9):1161-1168. doi: 10.1093/cid/ciw036. Epub 2016 Feb 7.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02567071\",\"briefTitle\":\"Natural Microbiota Restoration After C-section Birth\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-04-06\"},\"completionDateStruct\":{\"date\":\"2019-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-10-02\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04392388\",\"briefTitle\":\"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2020-05-01\"},\"completionDateStruct\":{\"date\":\"2023-04-11\"},\"studyFirstPostDateStruct\":{\"date\":\"2020-05-18\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01534728\",\"briefTitle\":\"Identification of Hepatitis C Virus (HCV) Specific T Cells\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-02\"},\"completionDateStruct\":{\"date\":\"2014-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-02-17\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02453061\",\"briefTitle\":\"A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington\\'s Disease\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-06-29\"},\"completionDateStruct\":{\"date\":\"2019-12-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-05-25\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Ultragenyx Pharmaceutical Inc\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"31381524\",\"type\":\"DERIVED\",\"citation\":\"Rodrigues FB, Ferreira JJ, Wild EJ. Huntington\\'s Disease Clinical Trials Corner: June 2019. J Huntingtons Dis. 2019;8(3):363-371. doi: 10.3233/JHD-199003.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02833961\",\"briefTitle\":\"Diffusion Spectroscopy in Stroke\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-07-28\"},\"completionDateStruct\":{\"date\":\"2019-10-25\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-07-14\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04288128\",\"briefTitle\":\"Integrated Functional Evaluation of the Cerebellum\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2020-05-28\"},\"completionDateStruct\":{\"date\":\"2022-06-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2020-02-28\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Biogen\"},{\"name\":\"Ionis Pharmaceuticals, Inc.\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02214511\",\"briefTitle\":\"Biomarkers of Social Sensitivity in Major Depression\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-10-23\"},\"completionDateStruct\":{\"date\":\"2017-03-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-08-12\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00928187\",\"briefTitle\":\"Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaound\\xc3\\xa9)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2009-11\"},\"completionDateStruct\":{\"date\":\"2015-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2009-06-25\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Gilead Sciences\"},{\"name\":\"Janssen Pharmaceutica\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"31273686\",\"type\":\"DERIVED\",\"citation\":\"Boyer S, Nishimwe ML, Sagaon-Teyssier L, March L, Koulla-Shiro S, Bousmah MQ, Toby R, Mpoudi-Etame MP, Ngom Gueye NF, Sawadogo A, Kouanfack C, Ciaffi L, Spire B, Delaporte E; 2-Lady Group. Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. Pharmacoecon Open. 2020 Mar;4(1):45-60. doi: 10.1007/s41669-019-0157-9.\"}]}},\"hasResults\":true},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00116454\",\"briefTitle\":\"Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2005-07\"},\"completionDateStruct\":{\"date\":\"2013-08\"},\"studyFirstPostDateStruct\":{\"date\":\"2005-06-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03324633\",\"briefTitle\":\"Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2005-06\"},\"completionDateStruct\":{\"date\":\"2022-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-10-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Bristol-Myers Squibb\"},{\"name\":\"GlaxoSmithKline\"},{\"name\":\"Merck Serono International SA\"},{\"name\":\"Roche Pharma AG\"},{\"name\":\"Schering-Plough\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"27317796\",\"type\":\"RESULT\",\"citation\":\"Sogni P, Gilbert C, Lacombe K, Piroth L, Rosenthal E, Miailhes P, Gervais A, Esterle L, Chas J, Poizot-Martin I, Dominguez S, Simon A, Morlat P, Neau D, Zucman D, Bouchaud O, Lascoux-Combe C, Bani-Sadr F, Alric L, Goujard C, Vittecoq D, Billaud E, Aumaitre H, Boue F, Valantin MA, Dabis F, Salmon D, Wittkop L. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. Clin Infect Dis. 2016 Sep 15;63(6):763-770. doi: 10.1093/cid/ciw379. Epub 2016 Jun 17.\"},{\"pmid\":\"27177169\",\"type\":\"RESULT\",\"citation\":\"Marcellin F, Protopopescu C, Poizot-Martin I, Miailhes P, Esterle L, Wittkop L, Spire B, Bocquier A, Salmon-Ceron D, Dabis F, Carrieri MP; HEPAVIH ANRS CO13 Study Group. Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort). Eur J Gastroenterol Hepatol. 2016 Sep;28(9):1003-7. doi: 10.1097/MEG.0000000000000664.\"},{\"pmid\":\"27073179\",\"type\":\"RESULT\",\"citation\":\"Marcellin F, Lions C, Rosenthal E, Roux P, Sogni P, Wittkop L, Protopopescu C, Spire B, Salmon-Ceron D, Dabis F, Carrieri MP; HEPAVIH ANRS CO13 Study Group*. No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). Drug Alcohol Rev. 2017 Mar;36(2):227-238. doi: 10.1111/dar.12398. Epub 2016 Apr 13.\"},{\"pmid\":\"25778750\",\"type\":\"RESULT\",\"citation\":\"Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F; ANRS CO13 HEPAVIH Study Group. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). Clin Infect Dis. 2015 Jul 1;61(1):40-8. doi: 10.1093/cid/civ217. Epub 2015 Mar 16.\"},{\"pmid\":\"25015913\",\"type\":\"RESULT\",\"citation\":\"Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP; HEPAVIH (ANRS CO13) Study Group. High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort. Clin Infect Dis. 2014 Oct 15;59(8):1190-2. doi: 10.1093/cid/ciu525. Epub 2014 Jul 11. No abstract available.\"},{\"pmid\":\"26528903\",\"type\":\"RESULT\",\"citation\":\"Salmon D, Bani-Sadr F, Gilbert C, Rosenthal E, Valantin MA, Simon A, Neau D, Morlat P, Loko MA, Wittkop L, Dabis F; ANRS CO13HEPAVIH study group. HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients. J Clin Virol. 2015 Dec;73:32-35. doi: 10.1016/j.jcv.2015.10.010. Epub 2015 Oct 19.\"},{\"pmid\":\"26372388\",\"type\":\"RESULT\",\"citation\":\"ANRS CO13 HEPAVIH Cohort. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients. AIDS. 2015 Sep 10;29(14):1821-30. doi: 10.1097/QAD.0000000000000787.\"},{\"pmid\":\"24166726\",\"type\":\"RESULT\",\"citation\":\"Roux P, Lions C, Cohen J, Winnock M, Salmon-Ceron D, Bani-Sadr F, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO13-HEPAVIH Study Group. Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort. Antivir Ther. 2014;19(2):171-8. doi: 10.3851/IMP2699. Epub 2013 Oct 28.\"},{\"pmid\":\"24580042\",\"type\":\"RESULT\",\"citation\":\"Marcellin F, Roux P, Winnock M, Lions C, Dabis F, Salmon-Ceron D, Loko MA, Spire B, Carrieri MP. Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort. Expert Rev Gastroenterol Hepatol. 2014 May;8(4):351-8. doi: 10.1586/17474124.2014.888949. Epub 2014 Mar 3.\"},{\"pmid\":\"23978720\",\"type\":\"RESULT\",\"citation\":\"Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study. J Hepatol. 2014 Jan;60(1):46-53. doi: 10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24.\"},{\"pmid\":\"24499953\",\"type\":\"RESULT\",\"citation\":\"Bani-Sadr F, Loko MA, Pambrun E, Winnock M, Carrieri P, Gilbert C, Duvivier C, Bouchaud O, Gervais A, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response. AIDS. 2014 May 15;28(8):1155-60. doi: 10.1097/QAD.0000000000000218.\"},{\"pmid\":\"23461846\",\"type\":\"RESULT\",\"citation\":\"Winnock M, Bani-Sadr F, Pambrun E, Loko MA, Carrieri P, Neau D, Morlat P, Marchou B, Dabis F, Salmon D; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) CO13 HEPAVIH Study Group. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians\\' perceptions. HIV Med. 2013 Aug;14(7):430-6. doi: 10.1111/hiv.12023. Epub 2013 Mar 5.\"},{\"pmid\":\"23421419\",\"type\":\"RESULT\",\"citation\":\"Marcellin F, Lions C, Winnock M, Salmon D, Durant J, Spire B, Mora M, Loko MA, Dabis F, Dominguez S, Roux P, Carrieri MP; ANRS CO13 HEPAVIH Study Group. Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician\\'s perceptions (HEPAVIH ARNS CO13 cohort). Addiction. 2013 Jul;108(7):1250-8. doi: 10.1111/add.12149. Epub 2013 Mar 21.\"},{\"pmid\":\"22285372\",\"type\":\"RESULT\",\"citation\":\"Trimoulet P, Merchadou L, Winnock M, Loko MA, Fleury H, Salmon D, Dabis F, Neau D; ANRS CO 13 HEPAVIH Study Group. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples? J Virol Methods. 2012 Apr;181(1):131-3. doi: 10.1016/j.jviromet.2012.01.006. Epub 2012 Jan 20.\"},{\"pmid\":\"22781224\",\"type\":\"RESULT\",\"citation\":\"Solas C, Pambrun E, Winnock M, Salmon D, Poizot-Martin I, Dominguez S, Bani-Sadr F, Izopet J, Garraffo R, Peytavin G; ANRS CO-13 HEPAVIH Study Group. Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction? AIDS. 2012 Nov 13;26(17):2193-9. doi: 10.1097/QAD.0b013e32835763a4.\"},{\"pmid\":\"22409788\",\"type\":\"RESULT\",\"citation\":\"Salmon-Ceron D, Cohen J, Winnock M, Roux P, Sadr FB, Rosenthal E, Martin IP, Loko MA, Mora M, Sogni P, Spire B, Dabis F, Carrieri MP; HEPAVIH group. Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients\\' beliefs (ANRS CO13 HEPAVIH cohort, France). BMC Health Serv Res. 2012 Mar 12;12:59. doi: 10.1186/1472-6963-12-59.\"},{\"pmid\":\"22173166\",\"type\":\"RESULT\",\"citation\":\"Salmon D, Bani-Sadr F, Loko MA, Stitou H, Gervais A, Durant J, Rosenthal E, Quertainmont Y, Barange K, Vittecoq D, Shoai-Tehrani M, Alvarez M, Winnock M, Trinchet JC, Dabis F, Sogni P. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. J Hepatol. 2012 Apr;56(4):862-8. doi: 10.1016/j.jhep.2011.11.009. Epub 2011 Dec 13.\"},{\"pmid\":\"21819472\",\"type\":\"RESULT\",\"citation\":\"Roux P, Fugon L, Winnock M, Salmon-Ceron D, Lacombe K, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO-13-HEPAVIH Study Group. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. Addiction. 2012 Jan;107(1):152-9. doi: 10.1111/j.1360-0443.2011.03608.x. Epub 2011 Oct 12.\"},{\"pmid\":\"23052829\",\"type\":\"RESULT\",\"citation\":\"Loko MA, Bani-Sadr F, Valantin MA, Lascoux-Combe C, Fontaine H, Bonnard P, Gervais A, Bouchaud O, Garipuy D, Quertainmont Y, Vittecoq D, Tehrani MS, Winnock M, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. Antivir Ther. 2012;17(7):1335-43. doi: 10.3851/IMP2419. Epub 2012 Oct 10.\"},{\"pmid\":\"22535683\",\"type\":\"RESULT\",\"citation\":\"Carrieri MP, Sogni P, Cohen J, Loko MA, Winnock M, Spire B; HEPAVIH Study Group. Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13). Hepatology. 2012 Nov;56(5):2010. doi: 10.1002/hep.25813. No abstract available.\"},{\"pmid\":\"21888878\",\"type\":\"RESULT\",\"citation\":\"Carrieri MP, Cohen J, Salmon-Ceron D, Winnock M. Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH. J Hepatol. 2012 Mar;56(3):745-7. doi: 10.1016/j.jhep.2011.08.005. Epub 2011 Aug 31. No abstract available.\"},{\"pmid\":\"23226258\",\"type\":\"RESULT\",\"citation\":\"Abravanel F, Raymond S, Pambrun E, Winnock M, Bonnard P, Sogni P, Trimoulet P, Dabis F, Salmon-Ceron D, Izopet J; ANRS CO13 HEPAVIH Study Group. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients. PLoS One. 2012;7(11):e50289. doi: 10.1371/journal.pone.0050289. Epub 2012 Nov 30.\"},{\"pmid\":\"21920402\",\"type\":\"RESULT\",\"citation\":\"Winnock M, Bani-Sadr F, Pambrun E, Loko MA, Lascoux-Combe C, Garipuy D, Rosenthal E, Carrieri P, Dabis F, Salmon D. Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. Vaccine. 2011 Nov 3;29(47):8656-60. doi: 10.1016/j.vaccine.2011.08.125. Epub 2011 Sep 13.\"},{\"pmid\":\"21239121\",\"type\":\"RESULT\",\"citation\":\"Roux P, Cohen J, Lascoux-Combe C, Sogni P, Winnock M, Salmon-Ceron D, Spire B, Dabis F, Carrieri MP; ANRS-CO13-HEPAVIH study group. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician. Drug Alcohol Depend. 2011 Jul 1;116(1-3):228-32. doi: 10.1016/j.drugalcdep.2010.09.025. Epub 2011 Jan 15.\"},{\"pmid\":\"21692942\",\"type\":\"RESULT\",\"citation\":\"Loko MA, Bani-Sadr F, Winnock M, Lacombe K, Carrieri P, Neau D, Morlat P, Serfaty L, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients. J Viral Hepat. 2011 Jul;18(7):e307-14. doi: 10.1111/j.1365-2893.2010.01417.x. Epub 2011 Jan 11.\"},{\"pmid\":\"20969743\",\"type\":\"RESULT\",\"citation\":\"Loko MA, Salmon D, Carrieri P, Winnock M, Mora M, Merchadou L, Gillet S, Pambrun E, Delaune J, Valantin MA, Poizot-Martin I, Neau D, Bonnard P, Rosenthal E, Barange K, Morlat P, Lacombe K, Gervais A, Rouges F, See AB, Lascoux-Combe C, Vittecoq D, Goujard C, Duvivier C, Spire B, Izopet J, Sogni P, Serfaty L, Benhamou Y, Bani-Sadr F, Dabis F; ANRS CO 13 HEPAVIH Study Group. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. BMC Infect Dis. 2010 Oct 22;10:303. doi: 10.1186/1471-2334-10-303.\"},{\"pmid\":\"20876416\",\"type\":\"RESULT\",\"citation\":\"Carrieri MP, Cohen J, Winnock M, Salmon D. Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers. Arch Intern Med. 2010 Sep 27;170(17):1607; author reply 1608-9. doi: 10.1001/archinternmed.2010.330. No abstract available.\"},{\"pmid\":\"20493576\",\"type\":\"RESULT\",\"citation\":\"Cales P, Halfon P, Batisse D, Carrat F, Perre P, Penaranda G, Guyader D, d\\'Alteroche L, Fouchard-Hubert I, Michelet C, Veillon P, Lambert J, Weiss L, Salmon D, Cacoub P. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. J Hepatol. 2010 Aug;53(2):238-44. doi: 10.1016/j.jhep.2010.03.007. Epub 2010 Apr 18.\"},{\"pmid\":\"28942916\",\"type\":\"RESULT\",\"citation\":\"Carrieri MP, Protopopescu C, Marcellin F, Rosellini S, Wittkop L, Esterle L, Zucman D, Raffi F, Rosenthal E, Poizot-Martin I, Salmon-Ceron D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. J Hepatol. 2017 Dec;67(6):1157-1167. doi: 10.1016/j.jhep.2017.08.005. Epub 2017 Sep 21.\"},{\"pmid\":\"28780609\",\"type\":\"RESULT\",\"citation\":\"Yaya I, Roux P, Marcellin F, Salmon-Ceron D, Carrieri MP. Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort). Dig Dis Sci. 2017 Oct;62(10):2943-2944. doi: 10.1007/s10620-017-4703-y. Epub 2017 Aug 5. No abstract available.\"},{\"pmid\":\"28430385\",\"type\":\"RESULT\",\"citation\":\"Knight R, Roux P, Vilotitch A, Marcellin F, Rosenthal E, Esterle L, Boue F, Rey D, Piroth L, Dominguez S, Sogni P, Salmon-Ceron D, Spire B, Carrieri MP; ANRS CO13-HEPAVIH Study Group. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort. Addiction. 2017 Sep;112(9):1669-1679. doi: 10.1111/add.13851. Epub 2017 Jun 6.\"},{\"pmid\":\"28418984\",\"type\":\"RESULT\",\"citation\":\"Marcellin F, Protopopescu C, Esterle L, Wittkop L, Piroth L, Aumaitre H, Bouchaud O, Goujard C, Vittecoq D, Dabis F, Salmon-Ceron D, Spire B, Roux P, Carrieri MP; ANRS CO13-HEPAVIH Study Group. Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). Eur J Gastroenterol Hepatol. 2017 Jul;29(7):786-791. doi: 10.1097/MEG.0000000000000883.\"},{\"pmid\":\"28235612\",\"type\":\"RESULT\",\"citation\":\"Piroth L, Wittkop L, Lacombe K, Rosenthal E, Gilbert C, Miailhes P, Carrieri P, Chas J, Poizot-Martin I, Gervais A, Dominguez S, Neau D, Zucman D, Billaud E, Morlat P, Aumaitre H, Lascoux-Combe C, Simon A, Bouchaud O, Teicher E, Bani-Sadr F, Alric L, Vittecoq D, Boue F, Duvivier C, Valantin MA, Esterle L, Dabis F, Sogni P, Salmon D; ANRS CO13 HEPAVIH study group. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort. J Hepatol. 2017 Jul;67(1):23-31. doi: 10.1016/j.jhep.2017.02.012. Epub 2017 Feb 22.\"},{\"pmid\":\"27339598\",\"type\":\"RESULT\",\"citation\":\"Ulveling D, Le Clerc S, Cobat A, Labib T, Noirel J, Laville V, Coulonges C, Carpentier W, Nalpas B, Heim MH, Poynard T, Cerny A, Pol S, Bochud PY, Dabis F, Theodorou I, Levy Y, Salmon D, Abel L, Dominguez S, Zagury JF; HEPAVIH ANRS CO13 Cohort Study Group; Swiss Hepatitis C Cohort Study Group; French ANRS HC EP 26 Genoscan Study Group. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. Hepatology. 2016 Nov;64(5):1462-1472. doi: 10.1002/hep.28695. Epub 2016 Jul 29.\"},{\"pmid\":\"34212476\",\"type\":\"DERIVED\",\"citation\":\"Chalouni M, Wittkop L, Bani-Sadr F, Lacombe K, Esterle L, Gilbert C, Miailhes P, Zucman D, Valantin MA, Bregigeon-Ronot S, Morlat P, Billaud E, Piroth L, Naqvi A, Sogni P, Salmon D; ANRS CO13 HEPAVIH Cohort Study Group. Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants. HIV Med. 2021 Oct;22(9):791-804. doi: 10.1111/hiv.13127. Epub 2021 Jul 1.\"},{\"pmid\":\"32798585\",\"type\":\"DERIVED\",\"citation\":\"Chalouni M, Pol S, Sogni P, Fontaine H, Lacombe K, Marc-Lacombe J, Esterle L, Dorival C, Bourliere M, Bani-Sadr F, de Ledinghen V, Zucman D, Larrey D, Salmon D, Carrat F, Wittkop L; ANRS CO13 HEPAVIH and ANRS CO22 HEPATHER cohort study groups. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death. J Hepatol. 2021 Jan;74(1):37-47. doi: 10.1016/j.jhep.2020.08.008. Epub 2020 Aug 14.\"},{\"pmid\":\"30570526\",\"type\":\"DERIVED\",\"citation\":\"Poizot-Martin I, Rosenthal E, Gilbert C, Cano CE, Simon A, Lascoux-Combe C, Alric L, Gervais A, Neau D, Esterle L, Salmon D, Sogni P, Wittkop L; ANRS CO13 HEPAVIH Study Group. Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):461-466. doi: 10.1097/QAI.0000000000001940.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02027233\",\"briefTitle\":\"Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-01\"},\"completionDateStruct\":{\"date\":\"2022-12-31\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-01-06\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02931097\",\"briefTitle\":\"DBS of the MLR for Gait and Balance Disorders in PD Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-10\"},\"completionDateStruct\":{\"date\":\"2020-10\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-10-12\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02408354\",\"briefTitle\":\"Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-04-15\"},\"completionDateStruct\":{\"date\":\"2017-04-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-04-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"28969699\",\"type\":\"DERIVED\",\"citation\":\"Hainque E, Caillet S, Leroy S, Flamand-Roze C, Adanyeguh I, Charbonnier-Beaupel F, Retail M, Le Toullec B, Atencio M, Rivaud-Pechoux S, Brochard V, Habarou F, Ottolenghi C, Cormier F, Meneret A, Ruiz M, Doulazmi M, Roubergue A, Corvol JC, Vidailhet M, Mochel F, Roze E. A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood. Orphanet J Rare Dis. 2017 Oct 2;12(1):160. doi: 10.1186/s13023-017-0713-2.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03954054\",\"briefTitle\":\"Therapeutic Education for Harm Reduction in People With Alcohol Use Disorder\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2019-10-28\"},\"completionDateStruct\":{\"date\":\"2021-07-31\"},\"studyFirstPostDateStruct\":{\"date\":\"2019-05-17\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Regional Agency for Health PACA\"},{\"name\":\"SESSTIM UMR1252 (Aix-Marseille Univ, INSERM, IRD)\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"35012570\",\"type\":\"DERIVED\",\"citation\":\"Antwerpes S, Costa M, Coste M, Bureau M, Maradan G, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Barre T, Casanova D, Carrieri P. Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). Harm Reduct J. 2022 Jan 10;19(1):2. doi: 10.1186/s12954-021-00587-0.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02027051\",\"briefTitle\":\"Etude g\\xc3\\xa9n\\xc3\\xa9tique Des Arm\\xc3\\xa9niens\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-01\"},\"completionDateStruct\":{\"date\":\"2017-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-01-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02157311\",\"briefTitle\":\"4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-07\"},\"completionDateStruct\":{\"date\":\"2016-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-06-06\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"29186458\",\"type\":\"DERIVED\",\"citation\":\"de Truchis P, Assoumou L, Landman R, Mathez D, Le Du D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C; ANRS 162-4D Study Group. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. J Antimicrob Chemother. 2018 Mar 1;73(3):738-747. doi: 10.1093/jac/dkx434.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01495897\",\"briefTitle\":\"Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor Study\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2011-03\"},\"completionDateStruct\":{\"date\":\"2014-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-12-20\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04409405\",\"briefTitle\":\"Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d\\'Ebola)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2020-04-16\"},\"completionDateStruct\":{\"date\":\"2021-10-18\"},\"studyFirstPostDateStruct\":{\"date\":\"2020-06-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Institut National de Recherche Biom\\xc3\\xa9dicale. Kinshasa, R\\xc3\\xa9publique D\\xc3\\xa9mocratique du Congo\"},{\"name\":\"Institut de Recherche pour le Developpement\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03137797\",\"briefTitle\":\"Cohort of Patients Naive of Antiretroviral Treatment at Enrollment\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2004-02\"},\"completionDateStruct\":{\"date\":\"2016-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2017-05-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"22267473\",\"type\":\"BACKGROUND\",\"citation\":\"Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C; ANRS COPANA Cohort Study Group. Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. Antivir Ther. 2012;17(1):91-100. doi: 10.3851/IMP1916.\"},{\"pmid\":\"22008658\",\"type\":\"BACKGROUND\",\"citation\":\"Dray-Spira R, Legeai C, Le Den M, Boue F, Lascoux-Combe C, Simon A, May T, Goujard C, Meyer L; ANRS-COPANA Cohort Study Group. Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use. AIDS. 2012 Jan 14;26(2):207-15. doi: 10.1097/QAD.0b013e32834dcf61.\"},{\"pmid\":\"23079802\",\"type\":\"BACKGROUND\",\"citation\":\"Rachas A, Warszawski J, Le Chenadec J, Legeai C, Teglas JP, Goujard C, Rouzioux C, Mandelbrot L, Tubiana R, Meyer L. Does pregnancy affect the early response to cART? AIDS. 2013 Jan 28;27(3):357-67. doi: 10.1097/QAD.0b013e32835ac8bc.\"},{\"pmid\":\"23936509\",\"type\":\"BACKGROUND\",\"citation\":\"Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Goujard C, Meyer L; ANRS PRIMO and COPANA Cohorts. Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts. PLoS One. 2013 Aug 1;8(8):e71473. doi: 10.1371/journal.pone.0071473. Print 2013. Erratum In: PLoS One. 2013;8(11). doi:10.1371/annotation/aed12a66-9c76-4e49-806b-881a2fe23bba. Goujard, Cecile [added].\"},{\"pmid\":\"24058636\",\"type\":\"BACKGROUND\",\"citation\":\"Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, Carlier R, Capeau J, Goujard C, Meyer L, Viard JP; ANRS-COPANA Cohort Study Group. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 <<COPANA>> cohort study. PLoS One. 2013 Sep 18;8(9):e74868. doi: 10.1371/journal.pone.0074868. eCollection 2013.\"},{\"pmid\":\"24465584\",\"type\":\"BACKGROUND\",\"citation\":\"Boufassa F, Lechenadec J, Meyer L, Costagliola D, Hunt PW, Pereyra F, Deeks S, Pancino G, Taulera O, Lichterfeld M, Delobel P, Saez-Cirion A, Lambotte O; ANRS CO18 HIV Controllers Cohort; Cascade Collaboration in Eurocoord; SCOPE Cohort; International HIV Controllers Study. Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration. PLoS One. 2014 Jan 17;9(1):e85516. doi: 10.1371/journal.pone.0085516. eCollection 2014.\"},{\"pmid\":\"25573889\",\"type\":\"BACKGROUND\",\"citation\":\"El Khoury P, Ghislain M, Villard EF, Le Goff W, Lascoux-Combe C, Yeni P, Meyer L, Vigouroux C, Goujard C, Guerin M. Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART. J Lipid Res. 2015 Mar;56(3):692-702. doi: 10.1194/jlr.M054510. Epub 2015 Jan 8.\"},{\"pmid\":\"26636578\",\"type\":\"BACKGROUND\",\"citation\":\"Ghislain M, Bastard JP, Meyer L, Capeau J, Fellahi S, Gerard L, May T, Simon A, Vigouroux C, Goujard C; ANRS-COPANA Cohort Study Group. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities. PLoS One. 2015 Dec 4;10(12):e0144317. doi: 10.1371/journal.pone.0144317. eCollection 2015.\"},{\"pmid\":\"27509048\",\"type\":\"BACKGROUND\",\"citation\":\"Ploquin MJ, Madec Y, Casrouge A, Huot N, Passaes C, Lecuroux C, Essat A, Boufassa F, Jacquelin B, Jochems SP, Petitjean G, Angin M, Gartner K, Garcia-Tellez T, Noel N, Booiman T, Boeser-Nunnink BD, Roques P, Saez-Cirion A, Vaslin B, Dereudre-Bosquet N, Barre-Sinoussi F, Ghislain M, Rouzioux C, Lambotte O, Albert ML, Goujard C, Kootstra N, Meyer L, Muller-Trutwin MC. Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset. PLoS Pathog. 2016 Aug 10;12(8):e1005774. doi: 10.1371/journal.ppat.1005774. eCollection 2016 Aug.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02052271\",\"briefTitle\":\"Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-06-03\"},\"completionDateStruct\":{\"date\":\"2018-03-27\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-02-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT03831906\",\"briefTitle\":\"Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2019-03-20\"},\"completionDateStruct\":{\"date\":\"2021-06-30\"},\"studyFirstPostDateStruct\":{\"date\":\"2019-02-06\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"UNITAID\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"33743621\",\"type\":\"BACKGROUND\",\"citation\":\"Vessiere A, Font H, Gabillard D, Adonis-Koffi L, Borand L, Chabala C, Khosa C, Mavale S, Moh R, Mulenga V, Mwanga-Amumpere J, Taguebue JV, Eang MT, Delacourt C, Seddon JA, Lounnas M, Godreuil S, Wobudeya E, Bonnet M, Marcy O. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial. BMC Pediatr. 2021 Mar 20;21(1):136. doi: 10.1186/s12887-021-02576-5.\"},{\"pmid\":\"36395782\",\"type\":\"DERIVED\",\"citation\":\"Marcy O, Wobudeya E, Font H, Vessiere A, Chabala C, Khosa C, Taguebue JV, Moh R, Mwanga-Amumpaire J, Lounnas M, Mulenga V, Mavale S, Chilundo J, Rego D, Nduna B, Shankalala P, Chirwa U, De Lauzanne A, Dim B, Tiogouo Ngouana E, Folquet Amorrissani M, Cisse L, Amon Tanoh Dick F, Komena EA, Kwedi Nolna S, Businge G, Natukunda N, Cumbe S, Mbekeka P, Kim A, Kheang C, Pol S, Maleche-Obimbo E, Seddon JA, Mao TE, Graham SM, Delacourt C, Borand L, Bonnet M; TB-Speed Pneumonia Study Group. Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial. Lancet Infect Dis. 2023 Mar;23(3):341-351. doi: 10.1016/S1473-3099(22)00668-5. Epub 2022 Nov 14.\"},{\"pmid\":\"32853411\",\"type\":\"DERIVED\",\"citation\":\"Kay AW, Gonzalez Fernandez L, Takwoingi Y, Eisenhut M, Detjen AK, Steingart KR, Mandalakas AM. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD013359. doi: 10.1002/14651858.CD013359.pub2.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01164436\",\"briefTitle\":\"Cohort of HIV Associated Lymphomas\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2008-06\"},\"completionDateStruct\":{\"date\":\"2017-06\"},\"studyFirstPostDateStruct\":{\"date\":\"2010-07-16\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"},\"collaborators\":[{\"name\":\"Dr Yassine Taoufik Dr Houria Chavez H\\xc3\\xb4pital Bic\\xc3\\xaatre CIB Paris Sud France\"},{\"name\":\"Dr Guislaine Garcelain H\\xc3\\xb4pital Piti\\xc3\\xa9 Slap\\xc3\\xa9tri\\xc3\\xa8re Paris France\"},{\"name\":\"University Hospital, Grenoble\"},{\"name\":\"Dr Ir\\xc3\\xa8ne Joab H\\xc3\\xb4pital Paul Brousse Villejuif France\"},{\"name\":\"Dr Alex Duval Fondation Jean Dausset CEPH\"},{\"name\":\"Hopital Antoine Beclere\"}]},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02656407\",\"briefTitle\":\"Intraoperative Functional Ultrasound\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-02-11\"},\"completionDateStruct\":{\"date\":\"2018-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-01-15\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"25955583\",\"type\":\"BACKGROUND\",\"citation\":\"Demene C, Deffieux T, Pernot M, Osmanski BF, Biran V, Gennisson JL, Sieu LA, Bergel A, Franqui S, Correas JM, Cohen I, Baud O, Tanter M. Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity. IEEE Trans Med Imaging. 2015 Nov;34(11):2271-85. doi: 10.1109/TMI.2015.2428634. Epub 2015 Apr 30.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02906137\",\"briefTitle\":\"Gut-Associated Lymphocyte Trafficking\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2017-02-06\"},\"completionDateStruct\":{\"date\":\"2020-02-25\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-09-19\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02102737\",\"briefTitle\":\"Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-05-13\"},\"completionDateStruct\":{\"date\":\"2018-03\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-04-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01492985\",\"briefTitle\":\"Lipopeptide Immunisation With GTU-multiHIV Trial\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-07\"},\"completionDateStruct\":{\"date\":\"2017-04-08\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-12-15\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"33568510\",\"type\":\"DERIVED\",\"citation\":\"Levy Y, Lacabaratz C, Lhomme E, Wiedemann A, Bauduin C, Fenwick C, Foucat E, Surenaud M, Guillaumat L, Boilet V, Rieux V, Bouchaud O, Girard PM, Molina JM, Morlat P, Hocqueloux L, Richert L, Pantaleo G, Lelievre JD, Thiebaut R. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial. J Virol. 2021 Apr 12;95(9):e02165-20. doi: 10.1128/JVI.02165-20. Print 2021 Apr 12.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02346409\",\"briefTitle\":\"Cerebello-thalamo-cortical Coupling in Essential Tremor\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-02-04\"},\"completionDateStruct\":{\"date\":\"2018-02-16\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-01-27\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02014883\",\"briefTitle\":\"Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-12-04\"},\"completionDateStruct\":{\"date\":\"2019-07-04\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-12-18\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"Ultragenyx Pharmaceutical Inc\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"26536893\",\"type\":\"DERIVED\",\"citation\":\"Mochel F, Hainque E, Gras D, Adanyeguh IM, Caillet S, Heron B, Roubertie A, Kaphan E, Valabregue R, Rinaldi D, Vuillaumier S, Schiffmann R, Ottolenghi C, Hogrel JY, Servais L, Roze E. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency. J Neurol Neurosurg Psychiatry. 2016 May;87(5):550-3. doi: 10.1136/jnnp-2015-311475. Epub 2015 Nov 3.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01693861\",\"briefTitle\":\"\\\\\"Cancersensor\\\\\" Chemotherapy\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-10\"},\"completionDateStruct\":{\"date\":\"2015-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-09-26\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01463956\",\"briefTitle\":\"Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-01-06\"},\"completionDateStruct\":{\"date\":\"2015-01-22\"},\"studyFirstPostDateStruct\":{\"date\":\"2011-11-02\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"French National Agency for Research on AIDS and Viral Hepatitis\"},\"collaborators\":[{\"name\":\"Merck Sharp & Dohme LLC\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT05090956\",\"briefTitle\":\"Developpement of 3T MRI Protocol\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-06-08\"},\"completionDateStruct\":{\"date\":\"2020-01-29\"},\"studyFirstPostDateStruct\":{\"date\":\"2021-10-25\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01698411\",\"briefTitle\":\"Study of the Influence of Sleep on Hemodynamic Parameters in Patients With Sleep Disorders\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-10\"},\"completionDateStruct\":{\"date\":\"2015-02\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-10-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04396288\",\"briefTitle\":\"Ultrasound Imaging-based Measurement of Intra-osseous Vascular Response\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2021-09-14\"},\"completionDateStruct\":{\"date\":\"2024-01-30\"},\"studyFirstPostDateStruct\":{\"date\":\"2020-05-20\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT05472051\",\"briefTitle\":\"Health and Migration Trajectories of Housekeepers in Bamako\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2022-02-28\"},\"completionDateStruct\":{\"date\":\"2023-06-22\"},\"studyFirstPostDateStruct\":{\"date\":\"2022-07-25\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"ANRS, Emerging Infectious Diseases\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01880151\",\"briefTitle\":\"Neuroelectrical Biomarkers for Alzheimer\\'s Disease Stages\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-07-12\"},\"completionDateStruct\":{\"date\":\"2019-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-06-18\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT00495651\",\"briefTitle\":\"Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2008-03\"},\"completionDateStruct\":{\"date\":\"2015-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2007-07-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"French National Agency for Research on AIDS and Viral Hepatitis\"},\"collaborators\":[{\"name\":\"Gilead Sciences\"},{\"name\":\"Merck Sharp & Dohme LLC\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"35093007\",\"type\":\"DERIVED\",\"citation\":\"Moh DR, Ntakpe JB, Gabillard D, Yayo-Emieme AA, Badje A, Kouame GM, d\\'Aquin TT, Danel C, Anglaret X, Eholie SP. Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults. BMC Infect Dis. 2022 Jan 29;22(1):100. doi: 10.1186/s12879-022-07082-2.\"},{\"pmid\":\"29297443\",\"type\":\"DERIVED\",\"citation\":\"Moh R, Badje A, N\\'takpe JB, Kouame GM, Gabillard D, Ouassa T, Ouattara E, Le Carrou J, Bohoussou F, Messou E, Eholie S, Anglaret X, Danel C. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults. Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1237-1244. doi: 10.5588/ijtld.17.0016.\"},{\"pmid\":\"29020361\",\"type\":\"DERIVED\",\"citation\":\"Kouame GM, Boyd A, Moh R, Badje A, Gabillard D, Ouattara E, Ntakpe JB, Emieme A, Maylin S, Chekaraou MA, Eholie SP, Zoulim F, Lacombe K, Anglaret X, Danel C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 12136 Temprano and ANRS 12240 VarBVA Study Groups. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Clin Infect Dis. 2018 Jan 6;66(1):112-120. doi: 10.1093/cid/cix747.\"},{\"pmid\":\"26193126\",\"type\":\"DERIVED\",\"citation\":\"TEMPRANO ANRS 12136 Study Group; Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpe JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouame A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibe B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouame E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundze S, Hawerlander D, Ani A, Dembele F, Kone F, Guehi C, Kanga C, Koule S, Seri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoue G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semde C, Kouame A, Massumbuko JM, Chene G, Dosso M, Domoua SK, N\\'Dri-Yoman T, Salamon R, Eholie SP, Anglaret X. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.\"},{\"pmid\":\"25330161\",\"type\":\"DERIVED\",\"citation\":\"Danel C, Kabran M, Inwoley A, Badje A, Herrmann JL, Moh R, Lecarrou J, Gabillard D, Ntakpe JB, Deschamps N, Ouattara E, Perronne C, Eholie S, Anglaret X. Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Cote d\\'Ivoire, West Africa. PLoS One. 2014 Oct 16;9(10):e107245. doi: 10.1371/journal.pone.0107245. eCollection 2014.\"},{\"pmid\":\"24985779\",\"type\":\"DERIVED\",\"citation\":\"Jean K, Gabillard D, Moh R, Danel C, Desgrees-du-Lou A, N\\'takpe JB, Le Carrou J, Badje A, Eholie S, Lert F, Anglaret X, Dray-Spira R. Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Cote d\\'Ivoire. J Int AIDS Soc. 2014 Jun 30;17(1):18977. doi: 10.7448/IAS.17.1.18977. eCollection 2014.\"},{\"pmid\":\"23639243\",\"type\":\"DERIVED\",\"citation\":\"Ouattara E, Danel C, Moh R, Gabillard D, Peytavin G, Konan R, Carrou JL, Bohoussou F, Eholie SP, Anglaret X. Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. J Int AIDS Soc. 2013 Apr 30;16(1):18059. doi: 10.7448/IAS.16.1.18059.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02721745\",\"briefTitle\":\"Cause and Consequence of Neural Fatigue\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-05-23\"},\"completionDateStruct\":{\"date\":\"2020-12\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-03-29\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02960698\",\"briefTitle\":\"Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-10-14\"},\"completionDateStruct\":{\"date\":\"2018-04-24\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-11-10\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02101398\",\"briefTitle\":\"Study of the Effect of Transcranial Stimulations in Aphasic Subject Within a Year of Their Stroke\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-10-02\"},\"completionDateStruct\":{\"date\":\"2016-07\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-04-02\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02481453\",\"briefTitle\":\"Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2015-07-15\"},\"completionDateStruct\":{\"date\":\"2018-01-22\"},\"studyFirstPostDateStruct\":{\"date\":\"2015-06-25\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"20413309\",\"type\":\"BACKGROUND\",\"citation\":\"Benveniste O, Hilton-Jones D. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. Neuromuscul Disord. 2010 Jun;20(6):414-21. doi: 10.1016/j.nmd.2010.03.014. Epub 2010 Apr 21. No abstract available.\"},{\"pmid\":\"24975859\",\"type\":\"BACKGROUND\",\"citation\":\"Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA. Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology. 2014 Jul 29;83(5):426-33. doi: 10.1212/WNL.0000000000000642. Epub 2014 Jun 27.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02976298\",\"briefTitle\":\"Effects of Cerebellum or Supplementary Motor Area Functional Inactivation on Gait and Balance Control\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-02\"},\"completionDateStruct\":{\"date\":\"2015-01\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-11-29\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01688453\",\"briefTitle\":\"Overweight Management and Social Inequalities\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2012-04\"},\"completionDateStruct\":{\"date\":\"2015-11\"},\"studyFirstPostDateStruct\":{\"date\":\"2012-09-19\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"34087324\",\"type\":\"DERIVED\",\"citation\":\"Manneville F, Omorou AY, Legrand K, Lecomte E, Rydberg JA, Briancon S, Guillemin F; PRALIMAP Trial Group. Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents. Prev Med. 2021 Sep;150:106668. doi: 10.1016/j.ypmed.2021.106668. Epub 2021 Jun 1.\"},{\"pmid\":\"32097754\",\"type\":\"DERIVED\",\"citation\":\"Omorou AY, Manneville F, Langlois J, Legrand K, Bohme P, Muller L, Guillemin F, Briancon S, Lecomte E; PRALIMAP-INES Trial Group. Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity. Prev Med. 2020 May;134:106043. doi: 10.1016/j.ypmed.2020.106043. Epub 2020 Feb 22.\"},{\"pmid\":\"29934380\",\"type\":\"DERIVED\",\"citation\":\"Saez L, Legrand K, Alleyrat C, Ramisasoa S, Langlois J, Muller L, Omorou AY, De Lavenne R, Kivits J, Lecomte E, Briancon S; PRALIMAP-INES Trial Group. Using facilitator-receiver peer dyads matched according to socioeconomic status to promote behaviour change in overweight adolescents: a feasibility study. BMJ Open. 2018 Jun 22;8(6):e019731. doi: 10.1136/bmjopen-2017-019731.\"},{\"pmid\":\"29776897\",\"type\":\"DERIVED\",\"citation\":\"Saez L, Langlois J, Legrand K, Quinet MH, Lecomte E, Omorou AY, Briancon S; PRALIMAP-INES Trial Group. Reach and Acceptability of a Mobile Reminder Strategy and Facebook Group Intervention for Weight Management in Less Advantaged Adolescents: Insights From the PRALIMAP-INES Trial. JMIR Mhealth Uhealth. 2018 May 18;6(5):e110. doi: 10.2196/mhealth.7657.\"},{\"pmid\":\"29696179\",\"type\":\"DERIVED\",\"citation\":\"Legrand K, Lecomte E, Langlois J, Muller L, Saez L, Quinet MH, Bohme P, Spitz E, Omorou AY, Briancon S; PRALIMAP-INES trial group. Reducing social inequalities in access to overweight and obesity care management for adolescents: The PRALIMAP-INES trial protocol and inclusion data analysis. Contemp Clin Trials Commun. 2017 Jun 16;7:141-157. doi: 10.1016/j.conctc.2017.05.010. eCollection 2017 Sep.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02658253\",\"briefTitle\":\"Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2016-01\"},\"completionDateStruct\":{\"date\":\"2019-02-21\"},\"studyFirstPostDateStruct\":{\"date\":\"2016-01-18\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"EVI Industries, Inc.\"},{\"name\":\"Recherche Clinique Paris Descartes Necker Cochin Sainte Anne\"},{\"name\":\"Centre national de recherche et de formation sur le paludisme\"},{\"name\":\"EUCLID Clinical Trial Platform\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"33717176\",\"type\":\"DERIVED\",\"citation\":\"Gamain B, Chene A, Viebig NK, Tuikue Ndam N, Nielsen MA. Progress and Insights Toward an Effective Placental Malaria Vaccine. Front Immunol. 2021 Feb 25;12:634508. doi: 10.3389/fimmu.2021.634508. eCollection 2021.\"},{\"pmid\":\"32032566\",\"type\":\"DERIVED\",\"citation\":\"Sirima SB, Richert L, Chene A, Konate AT, Campion C, Dechavanne S, Semblat JP, Benhamouda N, Bahuaud M, Loulergue P, Ouedraogo A, Nebie I, Kabore M, Kargougou D, Barry A, Ouattara SM, Boilet V, Allais F, Roguet G, Havelange N, Lopez-Perez E, Kuppers A, Konate E, Roussillon C, Kante M, Belarbi L, Diarra A, Henry N, Soulama I, Ouedraogo A, Esperou H, Leroy O, Batteux F, Tartour E, Viebig NK, Thiebaut R, Launay O, Gamain B. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. Lancet Infect Dis. 2020 May;20(5):585-597. doi: 10.1016/S1473-3099(19)30739-X. Epub 2020 Feb 4.\"}]}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01842477\",\"briefTitle\":\"Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2013-05\"},\"completionDateStruct\":{\"date\":\"2016-02-05\"},\"studyFirstPostDateStruct\":{\"date\":\"2013-04-29\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"},\"referencesModule\":{}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT02172677\",\"briefTitle\":\"The Influence of Collective Schemas on Individual Memory\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2014-10\"},\"completionDateStruct\":{\"date\":\"2016-10-14\"},\"studyFirstPostDateStruct\":{\"date\":\"2014-06-24\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"},\"collaborators\":[{\"name\":\"La R\\xc3\\xa9gion Basse-Normandie\"},{\"name\":\"Universit\\xc3\\xa9 de Caen Normandie\"},{\"name\":\"University Hospital, Caen\"},{\"name\":\"Ecole Pratique des Hautes Etudes\"},{\"name\":\"Equipement d\\'Excellence Matrice\"}]},\"designModule\":{\"studyType\":\"INTERVENTIONAL\"}},\"hasResults\":false},\\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT01037777\",\"briefTitle\":\"RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7\"},\"statusModule\":{\"overallStatus\":\"COMPLETED\",\"startDateStruct\":{\"date\":\"2009-05-07\"},\"completionDateStruct\":{\"date\":\"2017-12-14\"},\"studyFirstPostDateStruct\":{\"date\":\"2009-12-23\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France\"}},\"designModule\":{\"studyType\":\"OBSERVATIONAL\"},\"referencesModule\":{\"references\":[{\"pmid\":\"35264424\",\"type\":\"DERIVED\",\"citation\":\"Wilke C, Mengel D, Schols L, Hengel H, Rakowicz M, Klockgether T, Durr A, Filla A, Melegh B, Schule R, Reetz K, Jacobi H, Synofzik M. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1. Neurology. 2022 May 17;98(20):e1985-e1996. doi: 10.1212/WNL.0000000000200257. Epub 2022 Mar 9.\"},{\"pmid\":\"32822634\",\"type\":\"DERIVED\",\"citation\":\"Jacobi H, du Montcel ST, Romanzetti S, Harmuth F, Mariotti C, Nanetti L, Rakowicz M, Makowicz G, Durr A, Monin ML, Filla A, Roca A, Schols L, Hengel H, Infante J, Kang JS, Timmann D, Casali C, Masciullo M, Baliko L, Melegh B, Nachbauer W, Burk-Gergs K, Schulz JB, Riess O, Reetz K, Klockgether T. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study. Lancet Neurol. 2020 Sep;19(9):738-747. doi: 10.1016/S1474-4422(20)30235-0.\"},{\"pmid\":\"24780882\",\"type\":\"DERIVED\",\"citation\":\"Tezenas du Montcel S, Durr A, Rakowicz M, Nanetti L, Charles P, Sulek A, Mariotti C, Rola R, Schols L, Bauer P, Dufaure-Gare I, Jacobi H, Forlani S, Schmitz-Hubsch T, Filla A, Timmann D, van de Warrenburg BP, Marelli C, Kang JS, Giunti P, Cook A, Baliko L, Melegh B, Boesch S, Szymanski S, Berciano J, Infante J, Buerk K, Masciullo M, Di Fabio R, Depondt C, Ratka S, Stevanin G, Klockgether T, Brice A, Golmard JL. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. J Med Genet. 2014 Jul;51(7):479-86. doi: 10.1136/jmedgenet-2013-102200. Epub 2014 Apr 29. Erratum In: J Med Genet. 2014 Sep;51(9):613. Bela, Melegh [corrected to Melegh, Bela].\"},{\"pmid\":\"23707147\",\"type\":\"DERIVED\",\"citation\":\"Jacobi H, Reetz K, du Montcel ST, Bauer P, Mariotti C, Nanetti L, Rakowicz M, Sulek A, Durr A, Charles P, Filla A, Antenora A, Schols L, Schicks J, Infante J, Kang JS, Timmann D, Di Fabio R, Masciullo M, Baliko L, Melegh B, Boesch S, Burk K, Peltz A, Schulz JB, Dufaure-Gare I, Klockgether T. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet Neurol. 2013 Jul;12(7):650-8. doi: 10.1016/S1474-4422(13)70104-2. Epub 2013 May 22. Erratum In: Lancet Neurol. 2013 Jul;12(7):630.\"}]}},\"hasResults\":false}\\n]}', created_at='2024-05-16 09:28:40.339709+00:00', elapsed=datetime.timedelta(microseconds=726246), encoding='utf-8', expires='2024-05-17 09:28:40.339709+00:00', headers={'Alt-Svc': 'h3=\":443\"; ma=2592000,h3-29=\":443\"; ma=2592000', 'Content-Encoding': 'gzip', 'Date': 'Thu, 16 May 2024 09:28:40 GMT', 'Server': 'istio-envoy', 'Strict-Transport-Security': 'max-age=31536000; includeSubDomains; preload', 'Transfer-Encoding': 'chunked', 'Vary': 'Accept-Encoding', 'Via': '1.1 google', 'X-Frame-Options': 'SAMEORIGIN', 'X-UA-Compatible': 'IE=Edge', 'X-XSS-Protection': '1; mode=block', 'content-type': 'application/json', 'etag': '\"2.6.0/0.27.1/lw7q4fon-gzip\"', 'set-cookie': 'ncbi_sid=E173A43CCF12C130_6C38SID; Max-Age=31536000; Domain=.nih.gov; Path=/; $x-enc=URI_ENCODING', 'x-envoy-upstream-service-time': '86'}, reason='OK', request=CachedRequest(body=b'', headers={'Accept': '*/*', 'Accept-Encoding': 'gzip, deflate', 'Connection': 'keep-alive', 'User-Agent': 'python-requests/2.31.0'}, method='GET', url='https://clinicaltrials.gov/api/v2/studies?countTotal=true&fields=NCTId%2CBriefTitle%2COverallStatus%2CStudyType%2CLeadSponsorName%2CCollaboratorName%2CStudyFirstPostDate%2CStartDate%2CCompletionDate%2CReferencePMID%2CReferenceCitation%2CReferenceType%2ChasResults&filter.advanced=AREA%5BCompletionDate%5DRANGE%5B01%2F01%2F2013%2C+MAX%5D&filter.overallStatus=COMPLETED&format=json&pageSize=1000&query.lead=anrs+OR+inserm+OR+institut+national+de+la+sant%C3%A9+et+de+la+recherche+m%C3%A9dicale+OR+french+national+agency+for+research+on+aids+and+viral+hepatitis'), status_code=200, url='https://clinicaltrials.gov/api/v2/studies?countTotal=true&fields=NCTId%2CBriefTitle%2COverallStatus%2CStudyType%2CLeadSponsorName%2CCollaboratorName%2CStudyFirstPostDate%2CStartDate%2CCompletionDate%2CReferencePMID%2CReferenceCitation%2CReferenceType%2ChasResults&filter.advanced=AREA%5BCompletionDate%5DRANGE%5B01%2F01%2F2013%2C+MAX%5D&filter.overallStatus=COMPLETED&format=json&pageSize=1000&query.lead=anrs+OR+inserm+OR+institut+national+de+la+sant%C3%A9+et+de+la+recherche+m%C3%A9dicale+OR+french+national+agency+for+research+on+aids+and+viral+hepatitis')"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response = requests.get(query_url)\n",
    "response.raise_for_status()\n",
    "response"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "83cb6e68-fe6d-4fd8-90f8-bcd57450af69",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Studies returned: 200\n"
     ]
    }
   ],
   "source": [
    "print(f'Studies returned: {response.json()[\"totalCount\"]}')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "044debef-36e1-4a84-a483-1e2804c4f79d",
   "metadata": {},
   "source": [
    "### Traitement du JSON retourné:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "9032d2aa-2d5c-4b9f-ba47-a0e591129dc9",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "e105fd04-80ac-436b-846c-def4df8c2591",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# print(json.dumps(response.json(), indent=2))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f8239b23-3a6b-4541-a657-98ee97e80ea5",
   "metadata": {},
   "source": [
    "***La structure du JSON est bien trop imbriquée pour le normaliser avec Pandas, du coup on l'applatit à la main:***"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1de1fc10-a370-4b0d-8dfc-eaa17dfab0f2",
   "metadata": {},
   "source": [
    "A partir du JSON on construit un dictionnaire équivalent mais beaucoup plus \"plat\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "0abd0476-5bc8-44d7-bcf2-a83fd3917852",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Si la liste des collaborateurs est vide on renvoie None, sinon on concatène les valeurs de la liste\n",
    "# sous la forme \"collaborateur_0 | collaborateur_1 | ...\"\n",
    "def concatenate_collaborator_list(collaborator_list):\n",
    "    if collaborator_list == []:\n",
    "        return None\n",
    "    else:\n",
    "        return ' | '.join(collaborator_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "c0192b08-9e25-4254-a542-b5b8d55d1388",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "studies_list = []\n",
    "for study in response.json()['studies']:\n",
    "    study_pro = study['protocolSection']\n",
    "    study_dict = {\n",
    "        'NCTId': study_pro['identificationModule']['nctId'],\n",
    "        'BriefTitle': study_pro['identificationModule']['briefTitle'],\n",
    "        'LeadSponsorName': study_pro['sponsorCollaboratorsModule']['leadSponsor']['name'],\n",
    "        'CollaboratorName': concatenate_collaborator_list(\n",
    "            [\n",
    "                c['name']\n",
    "                for c in (\n",
    "                    study_pro['sponsorCollaboratorsModule'].get('collaborators', [])  # can be missing\n",
    "                )\n",
    "            ]\n",
    "        ),\n",
    "        'OverallStatus': study_pro['statusModule']['overallStatus'],\n",
    "        'StudyType': study_pro['designModule']['studyType'],\n",
    "        'HasResults': study['hasResults'],\n",
    "        'StudyFirstPostDate': study_pro['statusModule']['studyFirstPostDateStruct']['date'],\n",
    "        'StartDate': study_pro['statusModule'].get('startDateStruct', {}).get('date', None),  # can be missing\n",
    "        # 'PrimaryCompletionDate' : study_pro[\"statusModule\"].get('primaryCompletionDateStruct', {}).get('date', None), # can be missing\n",
    "        'CompletionDate': study_pro['statusModule'].get('completionDateStruct', {}).get('date', None),  # can be missing\n",
    "        'Reference': study_pro.get('referencesModule', {}).get('references', []),  # can be missing\n",
    "    }\n",
    "    studies_list.append(study_dict)\n",
    "\n",
    "# print(json.dumps(studies_list, indent=2))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "79beae31-da09-4108-8900-26d423062495",
   "metadata": {},
   "source": [
    "On vérifie que l'on n'a pas perdu de NCTId en route:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "591c6902-e73c-4db6-b27c-89d68e06e2c0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre de NCTId: 200\n"
     ]
    }
   ],
   "source": [
    "print(f'Nombre de NCTId: {len(studies_list)}')\n",
    "assert response.json()['totalCount'] == len(studies_list)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2536328d-746c-4fab-8245-d498eaa2fc55",
   "metadata": {},
   "source": [
    "### Import dans Pandas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "d63775da-9863-4d80-becc-d9cb776e75f2",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "a6866a1d-8c4a-4992-815c-66faf4a42a46",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>Reference</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>[{'pmid': '33355914', 'type': 'DERIVED', 'cita...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01882062</td>\n",
       "      <td>Proof of Concept of an Anaplerotic Study Using...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2013-06-20</td>\n",
       "      <td>2013-05</td>\n",
       "      <td>2013-07</td>\n",
       "      <td>[{'pmid': '25568297', 'type': 'RESULT', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03671291</td>\n",
       "      <td>Missed Opportunities to Pre-exposure Prophylax...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>University Hospital, Marseille | University Ho...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-09-14</td>\n",
       "      <td>2019-04-03</td>\n",
       "      <td>2021-10-03</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>Epicardial vs. Transvenous ICDs in Children</td>\n",
       "      <td>Paris Cardiovascular Research Center (Inserm U...</td>\n",
       "      <td>Hôpital Necker-Enfants Malades</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2022-04-27</td>\n",
       "      <td>2003-01-01</td>\n",
       "      <td>2022-04-01</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01703962</td>\n",
       "      <td>Non Invasive IDentification of Gliomas With ID...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2012-10-11</td>\n",
       "      <td>2012-03-14</td>\n",
       "      <td>2014-03-20</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>NCT01688453</td>\n",
       "      <td>Overweight Management and Social Inequalities</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2012-09-19</td>\n",
       "      <td>2012-04</td>\n",
       "      <td>2015-11</td>\n",
       "      <td>[{'pmid': '34087324', 'type': 'DERIVED', 'cita...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>[{'pmid': '33717176', 'type': 'DERIVED', 'cita...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>NCT01842477</td>\n",
       "      <td>Evaluation of Efficacy and Safety of Autologou...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-04-29</td>\n",
       "      <td>2013-05</td>\n",
       "      <td>2016-02-05</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>198</th>\n",
       "      <td>NCT02172677</td>\n",
       "      <td>The Influence of Collective Schemas on Individ...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>La Région Basse-Normandie | Université de Caen...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-06-24</td>\n",
       "      <td>2014-10</td>\n",
       "      <td>2016-10-14</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>[{'pmid': '35264424', 'type': 'DERIVED', 'cita...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>200 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "1    NCT01882062  Proof of Concept of an Anaplerotic Study Using...   \n",
       "2    NCT03671291  Missed Opportunities to Pre-exposure Prophylax...   \n",
       "3    NCT05349162        Epicardial vs. Transvenous ICDs in Children   \n",
       "4    NCT01703962  Non Invasive IDentification of Gliomas With ID...   \n",
       "..           ...                                                ...   \n",
       "195  NCT01688453      Overweight Management and Social Inequalities   \n",
       "196  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "197  NCT01842477  Evaluation of Efficacy and Safety of Autologou...   \n",
       "198  NCT02172677  The Influence of Collective Schemas on Individ...   \n",
       "199  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0                   ANRS, Emerging Infectious Diseases   \n",
       "1    Institut National de la Santé Et de la Recherc...   \n",
       "2    French National Agency for Research on AIDS an...   \n",
       "3    Paris Cardiovascular Research Center (Inserm U...   \n",
       "4    Institut National de la Santé Et de la Recherc...   \n",
       "..                                                 ...   \n",
       "195  Institut National de la Santé Et de la Recherc...   \n",
       "196  Institut National de la Santé Et de la Recherc...   \n",
       "197  Institut National de la Santé Et de la Recherc...   \n",
       "198  Institut National de la Santé Et de la Recherc...   \n",
       "199  Institut National de la Santé Et de la Recherc...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "1                                                 None     COMPLETED   \n",
       "2    University Hospital, Marseille | University Ho...     COMPLETED   \n",
       "3                       Hôpital Necker-Enfants Malades     COMPLETED   \n",
       "4                                                 None     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "195                                               None     COMPLETED   \n",
       "196  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "197                                               None     COMPLETED   \n",
       "198  La Région Basse-Normandie | Université de Caen...     COMPLETED   \n",
       "199                                               None     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate   StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "1    INTERVENTIONAL        True         2013-06-20     2013-05        2013-07   \n",
       "2    INTERVENTIONAL       False         2018-09-14  2019-04-03     2021-10-03   \n",
       "3     OBSERVATIONAL       False         2022-04-27  2003-01-01     2022-04-01   \n",
       "4     OBSERVATIONAL       False         2012-10-11  2012-03-14     2014-03-20   \n",
       "..              ...         ...                ...         ...            ...   \n",
       "195  INTERVENTIONAL       False         2012-09-19     2012-04        2015-11   \n",
       "196  INTERVENTIONAL       False         2016-01-18     2016-01     2019-02-21   \n",
       "197  INTERVENTIONAL       False         2013-04-29     2013-05     2016-02-05   \n",
       "198  INTERVENTIONAL       False         2014-06-24     2014-10     2016-10-14   \n",
       "199   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "\n",
       "                                             Reference  \n",
       "0    [{'pmid': '33355914', 'type': 'DERIVED', 'cita...  \n",
       "1    [{'pmid': '25568297', 'type': 'RESULT', 'citat...  \n",
       "2                                                   []  \n",
       "3                                                   []  \n",
       "4                                                   []  \n",
       "..                                                 ...  \n",
       "195  [{'pmid': '34087324', 'type': 'DERIVED', 'cita...  \n",
       "196  [{'pmid': '33717176', 'type': 'DERIVED', 'cita...  \n",
       "197                                                 []  \n",
       "198                                                 []  \n",
       "199  [{'pmid': '35264424', 'type': 'DERIVED', 'cita...  \n",
       "\n",
       "[200 rows x 11 columns]"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct = pd.json_normalize(data=studies_list)\n",
    "df_ct"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bcf7da5f-f67d-4cf6-ab62-136eae59d865",
   "metadata": {},
   "source": [
    "#### On \"explose\" la colonne \"References\":\n",
    "\n",
    "Pour chaque NCTId, la colonne réferences contient potentiellement une liste de plusieurs références.  \n",
    "Si par exemple, on a 3 références, on veut se retrouver avec 3 lignes, chacune indexée par le même NCTId et contenant une unique réference.  \n",
    "\n",
    "*Avant*:  \n",
    "**`NCTId    References`**  \n",
    "`NCT0001, [Ref1, Ref2, Ref3]`   \n",
    "\n",
    "*Après*:  \n",
    "**`NCTId    References`**  \n",
    "`NCT0001,   Ref1`  \n",
    "`NCT0001,   Ref2`  \n",
    "`NCT0001,   Ref3`   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "3af5b2f7-9a14-4d85-823f-5335ec9d66e7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>Reference</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>{'pmid': '33355914', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>{'pmid': '33010241', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>{'pmid': '31339676', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01882062</td>\n",
       "      <td>{'pmid': '25568297', 'type': 'RESULT', 'citati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03671291</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477</th>\n",
       "      <td>NCT02172677</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>478</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>{'pmid': '35264424', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>479</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>{'pmid': '32822634', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>480</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>{'pmid': '24780882', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>481</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>{'pmid': '23707147', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>482 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                          Reference\n",
       "0    NCT02777229  {'pmid': '33355914', 'type': 'DERIVED', 'citat...\n",
       "1    NCT02777229  {'pmid': '33010241', 'type': 'DERIVED', 'citat...\n",
       "2    NCT02777229  {'pmid': '31339676', 'type': 'DERIVED', 'citat...\n",
       "3    NCT01882062  {'pmid': '25568297', 'type': 'RESULT', 'citati...\n",
       "4    NCT03671291                                                NaN\n",
       "..           ...                                                ...\n",
       "477  NCT02172677                                                NaN\n",
       "478  NCT01037777  {'pmid': '35264424', 'type': 'DERIVED', 'citat...\n",
       "479  NCT01037777  {'pmid': '32822634', 'type': 'DERIVED', 'citat...\n",
       "480  NCT01037777  {'pmid': '24780882', 'type': 'DERIVED', 'citat...\n",
       "481  NCT01037777  {'pmid': '23707147', 'type': 'DERIVED', 'citat...\n",
       "\n",
       "[482 rows x 2 columns]"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct = df_ct.explode('Reference', ignore_index=True)\n",
    "df_ct.loc[:, ['NCTId', 'Reference']]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8a141674-4974-432d-8c4a-4b1c0b9f9970",
   "metadata": {},
   "source": [
    "Pour chaque NCTId, la colonne réference contient maintenant un dictionnaire de la forme:  \n",
    "`{  \n",
    "\"pmid\": \"17545707\",  \n",
    "\"type\": \"BACKGROUND\",  \n",
    "\"citation\": \"...\",  \n",
    "}`\n",
    "\n",
    "Dont on veut extraire de nouvelles colonnes en utilant les clés du dictionnaire:  \n",
    "**`pmid     type        citation`**  \n",
    "`17545707, BACKGROUND, \"...\"`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "0b7f8365-bbf5-4e6a-96b0-23946df93a8b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>33355914</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>33010241</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>31339676</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>NAMSAL ANRS 12313 Study Group; Kouanfack C, Mp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>25568297</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>478</th>\n",
       "      <td>35264424</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Wilke C, Mengel D, Schols L, Hengel H, Rakowic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>479</th>\n",
       "      <td>32822634</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Jacobi H, du Montcel ST, Romanzetti S, Harmuth...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>480</th>\n",
       "      <td>24780882</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Tezenas du Montcel S, Durr A, Rakowicz M, Nane...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>481</th>\n",
       "      <td>23707147</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Jacobi H, Reetz K, du Montcel ST, Bauer P, Mar...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>482 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         pmid     type                                           citation\n",
       "0    33355914  DERIVED  Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lant...\n",
       "1    33010241  DERIVED  Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-...\n",
       "2    31339676  DERIVED  NAMSAL ANRS 12313 Study Group; Kouanfack C, Mp...\n",
       "3    25568297   RESULT  Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, ...\n",
       "4         NaN      NaN                                                NaN\n",
       "..        ...      ...                                                ...\n",
       "477       NaN      NaN                                                NaN\n",
       "478  35264424  DERIVED  Wilke C, Mengel D, Schols L, Hengel H, Rakowic...\n",
       "479  32822634  DERIVED  Jacobi H, du Montcel ST, Romanzetti S, Harmuth...\n",
       "480  24780882  DERIVED  Tezenas du Montcel S, Durr A, Rakowicz M, Nane...\n",
       "481  23707147  DERIVED  Jacobi H, Reetz K, du Montcel ST, Bauer P, Mar...\n",
       "\n",
       "[482 rows x 3 columns]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct_references = pd.json_normalize(df_ct.pop('Reference'))\n",
    "df_ct_references"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cb7ea35e-3816-48f8-b91a-526e99768b8e",
   "metadata": {},
   "source": [
    "On réassemble la dataFrame complète:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "0f55da6b-f2f3-4554-88b0-dac5850614d4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>33355914</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>33010241</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>31339676</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>NAMSAL ANRS 12313 Study Group; Kouanfack C, Mp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01882062</td>\n",
       "      <td>Proof of Concept of an Anaplerotic Study Using...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2013-06-20</td>\n",
       "      <td>2013-05</td>\n",
       "      <td>2013-07</td>\n",
       "      <td>25568297</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03671291</td>\n",
       "      <td>Missed Opportunities to Pre-exposure Prophylax...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>University Hospital, Marseille | University Ho...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-09-14</td>\n",
       "      <td>2019-04-03</td>\n",
       "      <td>2021-10-03</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477</th>\n",
       "      <td>NCT02172677</td>\n",
       "      <td>The Influence of Collective Schemas on Individ...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>La Région Basse-Normandie | Université de Caen...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-06-24</td>\n",
       "      <td>2014-10</td>\n",
       "      <td>2016-10-14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>478</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>35264424</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Wilke C, Mengel D, Schols L, Hengel H, Rakowic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>479</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>32822634</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Jacobi H, du Montcel ST, Romanzetti S, Harmuth...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>480</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>24780882</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Tezenas du Montcel S, Durr A, Rakowicz M, Nane...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>481</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>23707147</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Jacobi H, Reetz K, du Montcel ST, Bauer P, Mar...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>482 rows × 13 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "1    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "2    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "3    NCT01882062  Proof of Concept of an Anaplerotic Study Using...   \n",
       "4    NCT03671291  Missed Opportunities to Pre-exposure Prophylax...   \n",
       "..           ...                                                ...   \n",
       "477  NCT02172677  The Influence of Collective Schemas on Individ...   \n",
       "478  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "479  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "480  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "481  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0                   ANRS, Emerging Infectious Diseases   \n",
       "1                   ANRS, Emerging Infectious Diseases   \n",
       "2                   ANRS, Emerging Infectious Diseases   \n",
       "3    Institut National de la Santé Et de la Recherc...   \n",
       "4    French National Agency for Research on AIDS an...   \n",
       "..                                                 ...   \n",
       "477  Institut National de la Santé Et de la Recherc...   \n",
       "478  Institut National de la Santé Et de la Recherc...   \n",
       "479  Institut National de la Santé Et de la Recherc...   \n",
       "480  Institut National de la Santé Et de la Recherc...   \n",
       "481  Institut National de la Santé Et de la Recherc...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "1    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "2    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "3                                                 None     COMPLETED   \n",
       "4    University Hospital, Marseille | University Ho...     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "477  La Région Basse-Normandie | Université de Caen...     COMPLETED   \n",
       "478                                               None     COMPLETED   \n",
       "479                                               None     COMPLETED   \n",
       "480                                               None     COMPLETED   \n",
       "481                                               None     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate   StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "1    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "2    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "3    INTERVENTIONAL        True         2013-06-20     2013-05        2013-07   \n",
       "4    INTERVENTIONAL       False         2018-09-14  2019-04-03     2021-10-03   \n",
       "..              ...         ...                ...         ...            ...   \n",
       "477  INTERVENTIONAL       False         2014-06-24     2014-10     2016-10-14   \n",
       "478   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "479   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "480   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "481   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "\n",
       "         pmid     type                                           citation  \n",
       "0    33355914  DERIVED  Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lant...  \n",
       "1    33010241  DERIVED  Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-...  \n",
       "2    31339676  DERIVED  NAMSAL ANRS 12313 Study Group; Kouanfack C, Mp...  \n",
       "3    25568297   RESULT  Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, ...  \n",
       "4         NaN      NaN                                                NaN  \n",
       "..        ...      ...                                                ...  \n",
       "477       NaN      NaN                                                NaN  \n",
       "478  35264424  DERIVED  Wilke C, Mengel D, Schols L, Hengel H, Rakowic...  \n",
       "479  32822634  DERIVED  Jacobi H, du Montcel ST, Romanzetti S, Harmuth...  \n",
       "480  24780882  DERIVED  Tezenas du Montcel S, Durr A, Rakowicz M, Nane...  \n",
       "481  23707147  DERIVED  Jacobi H, Reetz K, du Montcel ST, Bauer P, Mar...  \n",
       "\n",
       "[482 rows x 13 columns]"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct = df_ct.join(\n",
    "    df_ct_references,\n",
    "    validate = 'one_to_one',\n",
    ")\n",
    "df_ct"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0e42f325-90f5-415a-a500-e4caea12146a",
   "metadata": {},
   "source": [
    "***On reconstruit l'index :***"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "a76d82bd-7c03-4a42-bca1-1d56efa90532",
   "metadata": {},
   "outputs": [],
   "source": [
    "# df_studies_v2.set_index('NCTId', inplace = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cd0416a3-4af4-45d2-b4a0-167004409a31",
   "metadata": {},
   "source": [
    "***On précise les types :***"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "b191aeb2-c4cb-431d-a7d1-074f30454ad7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 482 entries, 0 to 481\n",
      "Data columns (total 13 columns):\n",
      " #   Column              Non-Null Count  Dtype   \n",
      "---  ------              --------------  -----   \n",
      " 0   NCTId               482 non-null    string  \n",
      " 1   BriefTitle          482 non-null    string  \n",
      " 2   LeadSponsorName     482 non-null    string  \n",
      " 3   CollaboratorName    217 non-null    string  \n",
      " 4   OverallStatus       482 non-null    category\n",
      " 5   StudyType           482 non-null    category\n",
      " 6   HasResults          482 non-null    boolean \n",
      " 7   StudyFirstPostDate  482 non-null    string  \n",
      " 8   StartDate           482 non-null    string  \n",
      " 9   CompletionDate      482 non-null    string  \n",
      " 10  pmid                364 non-null    string  \n",
      " 11  type                364 non-null    category\n",
      " 12  citation            364 non-null    string  \n",
      "dtypes: boolean(1), category(3), string(9)\n",
      "memory usage: 36.7 KB\n"
     ]
    }
   ],
   "source": [
    "df_ct = df_ct.convert_dtypes()\n",
    "df_ct = df_ct.astype({\"OverallStatus\" : 'category', \"StudyType\" : 'category', \"type\": 'category',})\n",
    "# df_ct = df_ct.astype({'OverallStatus': 'category', 'StudyType': 'category'})\n",
    "df_ct.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "c5c3a664-539b-40d0-af12-fdc0d7f7f3ff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>33355914</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>33010241</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>31339676</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>NAMSAL ANRS 12313 Study Group; Kouanfack C, Mp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01882062</td>\n",
       "      <td>Proof of Concept of an Anaplerotic Study Using...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2013-06-20</td>\n",
       "      <td>2013-05</td>\n",
       "      <td>2013-07</td>\n",
       "      <td>25568297</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03671291</td>\n",
       "      <td>Missed Opportunities to Pre-exposure Prophylax...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>University Hospital, Marseille | University Ho...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-09-14</td>\n",
       "      <td>2019-04-03</td>\n",
       "      <td>2021-10-03</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477</th>\n",
       "      <td>NCT02172677</td>\n",
       "      <td>The Influence of Collective Schemas on Individ...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>La Région Basse-Normandie | Université de Caen...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-06-24</td>\n",
       "      <td>2014-10</td>\n",
       "      <td>2016-10-14</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>478</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>35264424</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Wilke C, Mengel D, Schols L, Hengel H, Rakowic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>479</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>32822634</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Jacobi H, du Montcel ST, Romanzetti S, Harmuth...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>480</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>24780882</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Tezenas du Montcel S, Durr A, Rakowicz M, Nane...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>481</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>23707147</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Jacobi H, Reetz K, du Montcel ST, Bauer P, Mar...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>482 rows × 13 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "1    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "2    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "3    NCT01882062  Proof of Concept of an Anaplerotic Study Using...   \n",
       "4    NCT03671291  Missed Opportunities to Pre-exposure Prophylax...   \n",
       "..           ...                                                ...   \n",
       "477  NCT02172677  The Influence of Collective Schemas on Individ...   \n",
       "478  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "479  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "480  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "481  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0                   ANRS, Emerging Infectious Diseases   \n",
       "1                   ANRS, Emerging Infectious Diseases   \n",
       "2                   ANRS, Emerging Infectious Diseases   \n",
       "3    Institut National de la Santé Et de la Recherc...   \n",
       "4    French National Agency for Research on AIDS an...   \n",
       "..                                                 ...   \n",
       "477  Institut National de la Santé Et de la Recherc...   \n",
       "478  Institut National de la Santé Et de la Recherc...   \n",
       "479  Institut National de la Santé Et de la Recherc...   \n",
       "480  Institut National de la Santé Et de la Recherc...   \n",
       "481  Institut National de la Santé Et de la Recherc...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "1    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "2    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "3                                                 <NA>     COMPLETED   \n",
       "4    University Hospital, Marseille | University Ho...     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "477  La Région Basse-Normandie | Université de Caen...     COMPLETED   \n",
       "478                                               <NA>     COMPLETED   \n",
       "479                                               <NA>     COMPLETED   \n",
       "480                                               <NA>     COMPLETED   \n",
       "481                                               <NA>     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate   StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "1    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "2    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "3    INTERVENTIONAL        True         2013-06-20     2013-05        2013-07   \n",
       "4    INTERVENTIONAL       False         2018-09-14  2019-04-03     2021-10-03   \n",
       "..              ...         ...                ...         ...            ...   \n",
       "477  INTERVENTIONAL       False         2014-06-24     2014-10     2016-10-14   \n",
       "478   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "479   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "480   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "481   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "\n",
       "         pmid     type                                           citation  \n",
       "0    33355914  DERIVED  Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lant...  \n",
       "1    33010241  DERIVED  Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-...  \n",
       "2    31339676  DERIVED  NAMSAL ANRS 12313 Study Group; Kouanfack C, Mp...  \n",
       "3    25568297   RESULT  Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, ...  \n",
       "4        <NA>     <NA>                                               <NA>  \n",
       "..        ...      ...                                                ...  \n",
       "477      <NA>     <NA>                                               <NA>  \n",
       "478  35264424  DERIVED  Wilke C, Mengel D, Schols L, Hengel H, Rakowic...  \n",
       "479  32822634  DERIVED  Jacobi H, du Montcel ST, Romanzetti S, Harmuth...  \n",
       "480  24780882  DERIVED  Tezenas du Montcel S, Durr A, Rakowicz M, Nane...  \n",
       "481  23707147  DERIVED  Jacobi H, Reetz K, du Montcel ST, Bauer P, Mar...  \n",
       "\n",
       "[482 rows x 13 columns]"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a7b5fc9d-ac46-475b-b842-6fb462dd4860",
   "metadata": {},
   "source": [
    "#### Export en CSV :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "48250189-42cc-4bc8-ab9d-f143850c541d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# df_ct.to_csv(\n",
    "#     'Data/outputs/extract_CT_api_v2.csv',\n",
    "#     sep=';',\n",
    "#     index=False,\n",
    "#     encoding='utf-8-sig',\n",
    "# )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f4754b32-ee8e-4b1c-b634-7177c4e273ab",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "5dc82c20-529d-463f-a5ae-7a8ba6a07684",
   "metadata": {},
   "source": [
    "# PubMed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cde7add4-bea7-4155-a522-a4bc75979ebd",
   "metadata": {},
   "source": [
    "### Utilisation d'une clé pour l'API Pubmed : "
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "id": "9679e4c2-6f3c-4754-bd37-44646d6f7633",
   "metadata": {},
   "source": [
    "Il est recommandé d'utiliser une clé pour accéder à l'API Pubmed, ce qui permet de lancer jusqu'à 10 requêtes par seconde.  \n",
    "Sans clé, la limite est de 3 requêtes par seconde.  \n",
    "\n",
    "> E-utils users are allowed 3 requests/second without an API key. Create an API key to increase your e-utils limit to 10 requests/second.\n",
    "\n",
    "**En pratique, l'API Pubmed étant beaucoup plus lente, cela ne semble pas changer grand chose.**\n",
    "\n",
    "Pour récupérer sa clé, se rendre sur la page en étant loggué:\n",
    "https://account.ncbi.nlm.nih.gov/settings/\n",
    "\n",
    "Une fois la clé récupérée, l'ajouter aux variables d'environnement avec la commande suivante dans un Terminal:\n",
    "\n",
    "**Windows :** \n",
    "\n",
    "`setx NCBI_API_KEY “123456\"`\n",
    "\n",
    "**Linux/MacOS :**\n",
    "\n",
    "`export NCBI_API_KEY=123456`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "ccc06834-ea85-48c2-b66b-f9ef01329ec7",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "\n",
    "assert os.getenv('NCBI_API_KEY', None) is not None"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7103b475-2af0-4a49-9581-4f8196e29d87",
   "metadata": {},
   "source": [
    "### Récupération des PMIDs via PubMed:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9bc92598-3bee-4975-8fd2-efe55de4050d",
   "metadata": {},
   "source": [
    "Pour chaque NCTId de CT, on récupère les PMIDs des publications associées via PubMed:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "36cb49cf-5ccb-47a6-a4c2-0e722e985c38",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200/200..."
     ]
    }
   ],
   "source": [
    "# Liste unique des NCTId extraits de ClinicalTrial\n",
    "nctids = df_ct.loc[:, 'NCTId'].unique()\n",
    "num_nctids = len(nctids)\n",
    "session = requests.Session()\n",
    "\n",
    "pmids_pubmed_dict = {}\n",
    "for i, nctid in enumerate(nctids):\n",
    "    # Display the progress on a single line\n",
    "    print(f'\\r{i+1}/{num_nctids}...', end='', flush=True)\n",
    "\n",
    "    # Query Pubmed's API\n",
    "    query_url = f'https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&retmode=json&term={nctid}&api_key={os.getenv('NCBI_API_KEY')}'\n",
    "    response = session.get(query_url)\n",
    "    response.raise_for_status()\n",
    "    \n",
    "    pmids = response.json()['esearchresult']['idlist']\n",
    "    pmids_pubmed_dict[nctid] = set(pmids)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "6724fc4b-eff7-4c44-b5c8-63a4045f9507",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# pmids_pubmed_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "351d2549-e3c2-4331-b90b-3ea14530008e",
   "metadata": {},
   "source": [
    "**On veut fusionner la liste PMIDs que l'on vient de récupérer sur PubMed, à la liste des PMIDs déjà récupérés via CT.**"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4c8b94f1-2851-40b8-9ed2-77348b74477e",
   "metadata": {},
   "source": [
    "On met les PMIDs de CT sous la même forme:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "6ddaabb3-f3ce-4a4d-9ef9-4d391c7205df",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "pmids_ct_dict = {}\n",
    "for nctid in nctids:\n",
    "    pmids = df_ct[df_ct.loc[:, 'NCTId'] == nctid].loc[:, 'pmid'].dropna()\n",
    "    pmids_ct_dict[nctid] = set(pmids)\n",
    "# pmids_ct_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bead8f40-8dab-40f8-8650-87043c1c803a",
   "metadata": {},
   "source": [
    "Pour un NCTDId donné, on fait l'union des deux ensembles de PMIDs:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "1d60a430-c91c-4094-8a93-7d948dc0c29c",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "pmids_complete_dict = {}\n",
    "for nctid in nctids:\n",
    "    # L'ensemble des PMIds présents dans PubMed et CT\n",
    "    pmids_complete_dict[nctid] = pmids_pubmed_dict[nctid] | pmids_ct_dict[nctid]\n",
    "# pmids_complete_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a808cce0-ad9a-4236-a7d7-5bf8a796eca9",
   "metadata": {},
   "source": [
    "#### Verifications:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "d181cb92-9626-406f-b36d-b15845b45b0d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre total de publications issus de CT: 364\n"
     ]
    }
   ],
   "source": [
    "num_pmids_ct = sum((len(v) for v in pmids_ct_dict.values()))\n",
    "print(f'Nombre total de publications issus de CT: {num_pmids_ct}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "880fadf5-199b-49b8-b81b-99f7ba7b2343",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre total de publications après consultation PubMed: 394\n"
     ]
    }
   ],
   "source": [
    "num_pmids_complete = sum((len(v) for v in pmids_complete_dict.values()))\n",
    "print(f'Nombre total de publications après consultation PubMed: {num_pmids_complete}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "ed3165a6-3f0a-4b95-b7c0-b2caf0167cc7",
   "metadata": {},
   "outputs": [],
   "source": [
    "pmids_pubmed_only_dict = {}\n",
    "for nctid in nctids:\n",
    "    # L'ensemble des PMIds présents dans PubMed uniquement\n",
    "    pmids_pubmed_only_dict[nctid] = pmids_pubmed_dict[nctid] - pmids_ct_dict[nctid]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "c9201565-039e-469b-979b-2a496d4a03ae",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre de nouveaux PMIDs trouvés via Pubmed: 30\n"
     ]
    }
   ],
   "source": [
    "num_pmids_pubmed_only = sum((len(v) for v in pmids_pubmed_only_dict.values()))\n",
    "print(f'Nombre de nouveaux PMIDs trouvés via Pubmed: {num_pmids_pubmed_only}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "3dcf6bbb-ad35-4d3e-9224-f13dc3052571",
   "metadata": {},
   "outputs": [],
   "source": [
    "assert num_pmids_complete - num_pmids_ct == num_pmids_pubmed_only"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "eab933fe-2aa5-4ece-a4e6-9a07bec66d04",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NCTId des nouveaux PMIDs trouvés via Pubmed:\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'NCT02777229': {'37851566', '38156046'},\n",
       " 'NCT05349162': {'36735263'},\n",
       " 'NCT01703962': {'37668523'},\n",
       " 'NCT01453192': {'30688008'},\n",
       " 'NCT01473472': {'36601747'},\n",
       " 'NCT03335995': {'37497675'},\n",
       " 'NCT02212379': {'31269208'},\n",
       " 'NCT01426243': {'26314624'},\n",
       " 'NCT03870438': {'38484756'},\n",
       " 'NCT00640263': {'34425825'},\n",
       " 'NCT05311865': {'36438274', '37795682'},\n",
       " 'NCT03078439': {'38408861'},\n",
       " 'NCT04315948': {'36695483', '38552208'},\n",
       " 'NCT03215732': {'37143029'},\n",
       " 'NCT01089387': {'26439886'},\n",
       " 'NCT03005652': {'38100477'},\n",
       " 'NCT02405013': {'36686592'},\n",
       " 'NCT01801618': {'29662875'},\n",
       " 'NCT02057796': {'36883573'},\n",
       " 'NCT02150993': {'38740027'},\n",
       " 'NCT04392388': {'34293141'},\n",
       " 'NCT02833961': {'36318030'},\n",
       " 'NCT04288128': {'38419144', '38421662'},\n",
       " 'NCT04409405': {'38043556'},\n",
       " 'NCT02481453': {'38273639'},\n",
       " 'NCT01688453': {'35272723'}}"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print('NCTId des nouveaux PMIDs trouvés via Pubmed:')\n",
    "{k: v for k, v in pmids_pubmed_only_dict.items() if v != set()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "b28d3dd2-8dd8-4231-b29b-aa55563d4336",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre d'études sans PMIDs issus de CT: 118\n"
     ]
    }
   ],
   "source": [
    "num_nctid_empty_ct = sum((1 for v in pmids_ct_dict.values() if v == set()))\n",
    "print(f\"Nombre d'études sans PMIDs issus de CT: {num_nctid_empty_ct}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "0e4ba4ae-ce84-4b25-82ea-98e4c8972a7b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre d'études sans PMIDs après consultation PubMed: 105\n"
     ]
    }
   ],
   "source": [
    "num_nctid_empty_pubmed = sum((1 for v in pmids_complete_dict.values() if v == set()))\n",
    "print(f\"Nombre d'études sans PMIDs après consultation PubMed: {num_nctid_empty_pubmed}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "0f2f7862-2d98-4e8a-a707-fa4be829e133",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NCTIds qui n'avait aucun PMIDs sous CT, mais enrichis via Pubmed:\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'NCT01801618': {'29662875'},\n",
       " 'NCT01703962': {'37668523'},\n",
       " 'NCT02833961': {'36318030'},\n",
       " 'NCT02405013': {'36686592'},\n",
       " 'NCT02150993': {'38740027'},\n",
       " 'NCT02212379': {'31269208'},\n",
       " 'NCT04288128': {'38419144', '38421662'},\n",
       " 'NCT01453192': {'30688008'},\n",
       " 'NCT04409405': {'38043556'},\n",
       " 'NCT03078439': {'38408861'},\n",
       " 'NCT05311865': {'36438274', '37795682'},\n",
       " 'NCT04392388': {'34293141'},\n",
       " 'NCT05349162': {'36735263'}}"
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print(\"NCTIds qui n'avait aucun PMIDs sous CT, mais enrichis via Pubmed:\")\n",
    "nctids_previously_empty = {k for k, v in pmids_ct_dict.items() if v == set()} - {k for k, v in pmids_complete_dict.items() if v == set()}\n",
    "{k: pmids_complete_dict[k] for k in nctids_previously_empty}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "a9f76a73-72da-4319-a441-365a7cd8f9db",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "13"
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(nctids_previously_empty)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "9b818f69-9f1e-4778-9c2e-603ca9fd378e",
   "metadata": {},
   "outputs": [],
   "source": [
    "assert num_nctid_empty_ct - num_nctid_empty_pubmed == len(nctids_previously_empty)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7ccd4072-b497-4a87-baf0-67b55c8a4845",
   "metadata": {},
   "source": [
    "### Enrichissement des PMIDs via l'API Pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6fffb32b-b3d8-4814-ae72-9d2656a6ecc0",
   "metadata": {},
   "source": [
    "Pour chaque PMID récupéré, on l'enrichit avec les données de PubMed tel que le titre, les auteurs, ...:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "7476b831-b2de-4e50-92af-7b17ec286350",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Si la liste des auteurs est vide on renvoie None, sinon on concatène les valeurs de la liste\n",
    "# sous la forme \"auteur0; auteur1 ...\"\n",
    "def concatenate_authors_list(authors_list):\n",
    "    if authors_list == []:\n",
    "        return None\n",
    "    else:\n",
    "        return '; '.join([author['name'] for author in authors_list])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "14bd2b9b-7f4a-4f50-b651-0cb302ccabcf",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "394 / 394..."
     ]
    }
   ],
   "source": [
    "# We return a list of dictionnaries, each dictionnary containing the NCTId and the publication associated with it\n",
    "# total_publications_list = [{'NCTId': '...', 'publications': [{'pmid': '...', 'title': '...'}, {'pmid': '...', 'title': '...'}]}, {'NCTId': ...}]\n",
    "total_publications_list = []\n",
    "\n",
    "books_list = []\n",
    "counter = 0  # To keep track of progress of pmids\n",
    "session = requests.Session()\n",
    "\n",
    "# For each NTCID...\n",
    "for nctid, pmids in pmids_complete_dict.items():\n",
    "    # [{'pmid': '...', 'title': '...'}, {'pmid': '...', 'title': '...'}]\n",
    "    publications_list = []\n",
    "\n",
    "    # If the set of pmids is not empty\n",
    "    if (pmids != set()):\n",
    "        # Query Pubmed's API with several pmids at the same time\n",
    "        pmids_str = ','.join(pmids)\n",
    "        query_url = f'https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id={pmids_str}&api_key={os.getenv('NCBI_API_KEY')}'\n",
    "        response = session.get(query_url)\n",
    "        response.raise_for_status()\n",
    "        result = response.json()['result']\n",
    "    \n",
    "        # We process each PMID...\n",
    "        for pmid in result['uids']:\n",
    "            # Check that the pmid returned by Pubmed was part of the query\n",
    "            assert (pmid in pmids)\n",
    "            \n",
    "            publication = result[pmid]\n",
    "            \n",
    "            # Display the progress on a single line\n",
    "            print(f'\\r{counter+1} / {num_pmids_complete}...', end='', flush=True)\n",
    "\n",
    "            # We are not interested by articles with type 'book'\n",
    "            # TODO: book special case ?\n",
    "            if publication['doctype'] == 'citation':\n",
    "                \n",
    "                # Find the DOI amongst the different ids\n",
    "                doi = None\n",
    "                for id in publication['articleids']:\n",
    "                    if id['idtype'] == 'doi':\n",
    "                        doi = id['value']\n",
    "                        break\n",
    "\n",
    "                # Add the infos for the publication\n",
    "                publications_list.append(\n",
    "                    {\n",
    "                        'pmid': pmid,\n",
    "                        'title': publication['title'],\n",
    "                        'authors' : concatenate_authors_list(publication['authors']),\n",
    "                        'doi': doi,\n",
    "                        'date': publication['sortpubdate'],\n",
    "                        'publication_types': publication['pubtype'],\n",
    "                    }\n",
    "                )\n",
    "            else:\n",
    "                # type different from 'article', gets ignored\n",
    "                books_list.append((nctid, pmid))\n",
    "\n",
    "            counter += 1\n",
    "\n",
    "    publication_dict = {'NCTId': nctid, 'publications': publications_list}\n",
    "    total_publications_list.append(publication_dict)\n",
    "\n",
    "# total_publications_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "66dc9fed-b144-47c8-9637-0685aed7d3da",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[('NCT03537196', '27227200')]\n"
     ]
    }
   ],
   "source": [
    "print(books_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "3f26319c-fb30-4810-8f0e-2ee72592866e",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# print(json.dumps(total_publications_list, indent=2))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c57b84a6-8c2d-4b97-af3a-4ee12c51b69c",
   "metadata": {},
   "source": [
    "Publications sans DOI:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "85f0cd7d-2ba9-4f83-b327-307e54ee6de7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "PMID without DOI: 19839502\n"
     ]
    }
   ],
   "source": [
    "# PMID without DOI\n",
    "for study in total_publications_list:\n",
    "    for publi in study['publications']:\n",
    "        if publi['doi'] is None:\n",
    "            print(f'PMID without DOI: {publi['pmid']}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "e319963c-1e2c-4dde-aae6-c86f161be7ba",
   "metadata": {},
   "outputs": [],
   "source": [
    "# The number of NCTId didn't change\n",
    "assert len(total_publications_list) == len(studies_list)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "22ec89f9-6196-4a75-b71f-ef5b6aad595d",
   "metadata": {},
   "source": [
    "### Import dans Pandas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "eef6d4fe-795d-447a-8184-61e8f6522c0d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>publications</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>[{'pmid': '33355914', 'title': 'Cost-Utility A...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01882062</td>\n",
       "      <td>[{'pmid': '25568297', 'title': 'Triheptanoin i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03671291</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>[{'pmid': '36735263', 'title': 'Epicardial vs....</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01703962</td>\n",
       "      <td>[{'pmid': '37668523', 'title': 'Neurochemical ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>NCT01688453</td>\n",
       "      <td>[{'pmid': '34087324', 'title': 'Sociodemograph...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>[{'pmid': '32032566', 'title': 'PRIMVAC vaccin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>NCT01842477</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>198</th>\n",
       "      <td>NCT02172677</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>[{'pmid': '32822634', 'title': 'Conversion of ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>200 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                       publications\n",
       "0    NCT02777229  [{'pmid': '33355914', 'title': 'Cost-Utility A...\n",
       "1    NCT01882062  [{'pmid': '25568297', 'title': 'Triheptanoin i...\n",
       "2    NCT03671291                                                 []\n",
       "3    NCT05349162  [{'pmid': '36735263', 'title': 'Epicardial vs....\n",
       "4    NCT01703962  [{'pmid': '37668523', 'title': 'Neurochemical ...\n",
       "..           ...                                                ...\n",
       "195  NCT01688453  [{'pmid': '34087324', 'title': 'Sociodemograph...\n",
       "196  NCT02658253  [{'pmid': '32032566', 'title': 'PRIMVAC vaccin...\n",
       "197  NCT01842477                                                 []\n",
       "198  NCT02172677                                                 []\n",
       "199  NCT01037777  [{'pmid': '32822634', 'title': 'Conversion of ...\n",
       "\n",
       "[200 rows x 2 columns]"
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed = pd.DataFrame.from_records(total_publications_list)\n",
    "df_pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c8f8e322-5468-427d-951a-52769f39d215",
   "metadata": {},
   "source": [
    "#### On \"explose\" la colonne \"publications\":\n",
    "\n",
    "Pour chaque NCTId, la colonne 'publications' contient potentiellement une liste de plusieurs publications.  \n",
    "Si par exemple, on a 3 publications, on veut se retrouver avec 3 lignes, chacune indexée par le même NCTId et contenant une unique publication.  \n",
    "\n",
    "*Avant*:  \n",
    "**`NCTId    Reference`**  \n",
    "`NCT0001, [Pub1, Pub2, Pub3]`   \n",
    "\n",
    "*Après*:  \n",
    "**`NCTId    Reference`**  \n",
    "`NCT0001,   Pub1`  \n",
    "`NCT0001,   Pub2`  \n",
    "`NCT0001,   Pub3`   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "2d2b41c7-a86c-40d8-804a-dc5fe197aca1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>publications</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>{'pmid': '33355914', 'title': 'Cost-Utility An...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>{'pmid': '33010241', 'title': 'Dolutegravir-ba...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>{'pmid': '38156046', 'title': 'Durability of t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>{'pmid': '37851566', 'title': 'Improvements in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>{'pmid': '31339676', 'title': 'Dolutegravir-Ba...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493</th>\n",
       "      <td>NCT02172677</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>{'pmid': '32822634', 'title': 'Conversion of i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>{'pmid': '35264424', 'title': 'Levels of Neuro...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>{'pmid': '23707147', 'title': 'Biological and ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>{'pmid': '24780882', 'title': 'Prediction of t...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>498 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                       publications\n",
       "0    NCT02777229  {'pmid': '33355914', 'title': 'Cost-Utility An...\n",
       "1    NCT02777229  {'pmid': '33010241', 'title': 'Dolutegravir-ba...\n",
       "2    NCT02777229  {'pmid': '38156046', 'title': 'Durability of t...\n",
       "3    NCT02777229  {'pmid': '37851566', 'title': 'Improvements in...\n",
       "4    NCT02777229  {'pmid': '31339676', 'title': 'Dolutegravir-Ba...\n",
       "..           ...                                                ...\n",
       "493  NCT02172677                                                NaN\n",
       "494  NCT01037777  {'pmid': '32822634', 'title': 'Conversion of i...\n",
       "495  NCT01037777  {'pmid': '35264424', 'title': 'Levels of Neuro...\n",
       "496  NCT01037777  {'pmid': '23707147', 'title': 'Biological and ...\n",
       "497  NCT01037777  {'pmid': '24780882', 'title': 'Prediction of t...\n",
       "\n",
       "[498 rows x 2 columns]"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed = df_pubmed.explode('publications', ignore_index=True)\n",
    "df_pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f9457360-7404-4027-a392-4f0f72e765fa",
   "metadata": {},
   "source": [
    "On vérifie que l'on a retrouvé plus de publications avec PubMed + CT que CT tout seul:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "9439fcc7-84f2-4cbe-ace4-b278cf26bac9",
   "metadata": {},
   "outputs": [],
   "source": [
    "assert len(df_pubmed) >= len(df_ct)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6d4bd8f4-3e7b-4845-8016-ce08f3d86aa3",
   "metadata": {},
   "source": [
    "Pour chaque NCTId, la colonne 'publications' contient maintenant un dictionnaire de la forme:  \n",
    "`{  \n",
    "\"pmid\": \"17545707\",  \n",
    "\"title\": \"Haematological ...\",  \n",
    "\"authors\": \"Smith DJ; ...\",  \n",
    "}`\n",
    "\n",
    "Dont on veut extraire de nouvelles colonnes en utilant les clés du dictionnaire:  \n",
    "**`pmid      title                 authors`**  \n",
    "`17545707, \"Haematological ...\", \"Smith DJ; ...\"`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "de0d46f5-ad8f-47ba-9cb2-900c74ceda72",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pmid</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>date</th>\n",
       "      <th>publication_types</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>33355914</td>\n",
       "      <td>Cost-Utility Analysis of a Dolutegravir-Based ...</td>\n",
       "      <td>Bousmah MA; Nishimwe ML; Tovar-Sanchez T; Lant...</td>\n",
       "      <td>10.1007/s40273-020-00987-3</td>\n",
       "      <td>2021/03/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>33010241</td>\n",
       "      <td>Dolutegravir-based and low-dose efavirenz-base...</td>\n",
       "      <td>Calmy A; Tovar Sanchez T; Kouanfack C; Mpoudi-...</td>\n",
       "      <td>10.1016/S2352-3018(20)30238-1</td>\n",
       "      <td>2020/10/01 00:00</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>38156046</td>\n",
       "      <td>Durability of the Efficacy and Safety of Dolut...</td>\n",
       "      <td>Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...</td>\n",
       "      <td>10.1093/ofid/ofad582</td>\n",
       "      <td>2023/11/20 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>37851566</td>\n",
       "      <td>Improvements in Patient-Reported Outcomes Foll...</td>\n",
       "      <td>Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...</td>\n",
       "      <td>10.1097/QAI.0000000000003273</td>\n",
       "      <td>2023/11/01 00:00</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>31339676</td>\n",
       "      <td>Dolutegravir-Based or Low-Dose Efavirenz-Based...</td>\n",
       "      <td>NAMSAL ANRS 12313 Study Group; Kouanfack C; Mp...</td>\n",
       "      <td>10.1056/NEJMoa1904340</td>\n",
       "      <td>2019/08/29 00:00</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>32822634</td>\n",
       "      <td>Conversion of individuals at risk for spinocer...</td>\n",
       "      <td>Jacobi H; du Montcel ST; Romanzetti S; Harmuth...</td>\n",
       "      <td>10.1016/S1474-4422(20)30235-0</td>\n",
       "      <td>2020/09/01 00:00</td>\n",
       "      <td>[Clinical Trial, Journal Article, Multicenter ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>35264424</td>\n",
       "      <td>Levels of Neurofilament Light at the Preataxic...</td>\n",
       "      <td>Wilke C; Mengel D; Schöls L; Hengel H; Rakowic...</td>\n",
       "      <td>10.1212/WNL.0000000000200257</td>\n",
       "      <td>2022/05/17 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>23707147</td>\n",
       "      <td>Biological and clinical characteristics of ind...</td>\n",
       "      <td>Jacobi H; Reetz K; du Montcel ST; Bauer P; Mar...</td>\n",
       "      <td>10.1016/S1474-4422(13)70104-2</td>\n",
       "      <td>2013/07/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>24780882</td>\n",
       "      <td>Prediction of the age at onset in spinocerebel...</td>\n",
       "      <td>Tezenas du Montcel S; Durr A; Rakowicz M; Nane...</td>\n",
       "      <td>10.1136/jmedgenet-2013-102200</td>\n",
       "      <td>2014/07/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>498 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         pmid                                              title  \\\n",
       "0    33355914  Cost-Utility Analysis of a Dolutegravir-Based ...   \n",
       "1    33010241  Dolutegravir-based and low-dose efavirenz-base...   \n",
       "2    38156046  Durability of the Efficacy and Safety of Dolut...   \n",
       "3    37851566  Improvements in Patient-Reported Outcomes Foll...   \n",
       "4    31339676  Dolutegravir-Based or Low-Dose Efavirenz-Based...   \n",
       "..        ...                                                ...   \n",
       "493       NaN                                                NaN   \n",
       "494  32822634  Conversion of individuals at risk for spinocer...   \n",
       "495  35264424  Levels of Neurofilament Light at the Preataxic...   \n",
       "496  23707147  Biological and clinical characteristics of ind...   \n",
       "497  24780882  Prediction of the age at onset in spinocerebel...   \n",
       "\n",
       "                                               authors  \\\n",
       "0    Bousmah MA; Nishimwe ML; Tovar-Sanchez T; Lant...   \n",
       "1    Calmy A; Tovar Sanchez T; Kouanfack C; Mpoudi-...   \n",
       "2    Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...   \n",
       "3    Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...   \n",
       "4    NAMSAL ANRS 12313 Study Group; Kouanfack C; Mp...   \n",
       "..                                                 ...   \n",
       "493                                                NaN   \n",
       "494  Jacobi H; du Montcel ST; Romanzetti S; Harmuth...   \n",
       "495  Wilke C; Mengel D; Schöls L; Hengel H; Rakowic...   \n",
       "496  Jacobi H; Reetz K; du Montcel ST; Bauer P; Mar...   \n",
       "497  Tezenas du Montcel S; Durr A; Rakowicz M; Nane...   \n",
       "\n",
       "                               doi              date  \\\n",
       "0       10.1007/s40273-020-00987-3  2021/03/01 00:00   \n",
       "1    10.1016/S2352-3018(20)30238-1  2020/10/01 00:00   \n",
       "2             10.1093/ofid/ofad582  2023/11/20 00:00   \n",
       "3     10.1097/QAI.0000000000003273  2023/11/01 00:00   \n",
       "4            10.1056/NEJMoa1904340  2019/08/29 00:00   \n",
       "..                             ...               ...   \n",
       "493                            NaN               NaN   \n",
       "494  10.1016/S1474-4422(20)30235-0  2020/09/01 00:00   \n",
       "495   10.1212/WNL.0000000000200257  2022/05/17 00:00   \n",
       "496  10.1016/S1474-4422(13)70104-2  2013/07/01 00:00   \n",
       "497  10.1136/jmedgenet-2013-102200  2014/07/01 00:00   \n",
       "\n",
       "                                     publication_types  \n",
       "0                                    [Journal Article]  \n",
       "1    [Journal Article, Multicenter Study, Randomize...  \n",
       "2                                    [Journal Article]  \n",
       "3       [Randomized Controlled Trial, Journal Article]  \n",
       "4    [Journal Article, Multicenter Study, Randomize...  \n",
       "..                                                 ...  \n",
       "493                                                NaN  \n",
       "494  [Clinical Trial, Journal Article, Multicenter ...  \n",
       "495                                  [Journal Article]  \n",
       "496                                  [Journal Article]  \n",
       "497                                  [Journal Article]  \n",
       "\n",
       "[498 rows x 6 columns]"
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed_publications = pd.json_normalize(df_pubmed.pop('publications'))\n",
    "df_pubmed_publications"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7d9d8656-c1b0-459b-aebb-7846b57288a6",
   "metadata": {},
   "source": [
    "On réassemble la dataFrame complète:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "cce27392-459f-45e0-b262-300df63184b2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>pmid</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>date</th>\n",
       "      <th>publication_types</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>33355914</td>\n",
       "      <td>Cost-Utility Analysis of a Dolutegravir-Based ...</td>\n",
       "      <td>Bousmah MA; Nishimwe ML; Tovar-Sanchez T; Lant...</td>\n",
       "      <td>10.1007/s40273-020-00987-3</td>\n",
       "      <td>2021/03/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>33010241</td>\n",
       "      <td>Dolutegravir-based and low-dose efavirenz-base...</td>\n",
       "      <td>Calmy A; Tovar Sanchez T; Kouanfack C; Mpoudi-...</td>\n",
       "      <td>10.1016/S2352-3018(20)30238-1</td>\n",
       "      <td>2020/10/01 00:00</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>38156046</td>\n",
       "      <td>Durability of the Efficacy and Safety of Dolut...</td>\n",
       "      <td>Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...</td>\n",
       "      <td>10.1093/ofid/ofad582</td>\n",
       "      <td>2023/11/20 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>37851566</td>\n",
       "      <td>Improvements in Patient-Reported Outcomes Foll...</td>\n",
       "      <td>Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...</td>\n",
       "      <td>10.1097/QAI.0000000000003273</td>\n",
       "      <td>2023/11/01 00:00</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>31339676</td>\n",
       "      <td>Dolutegravir-Based or Low-Dose Efavirenz-Based...</td>\n",
       "      <td>NAMSAL ANRS 12313 Study Group; Kouanfack C; Mp...</td>\n",
       "      <td>10.1056/NEJMoa1904340</td>\n",
       "      <td>2019/08/29 00:00</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493</th>\n",
       "      <td>NCT02172677</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>32822634</td>\n",
       "      <td>Conversion of individuals at risk for spinocer...</td>\n",
       "      <td>Jacobi H; du Montcel ST; Romanzetti S; Harmuth...</td>\n",
       "      <td>10.1016/S1474-4422(20)30235-0</td>\n",
       "      <td>2020/09/01 00:00</td>\n",
       "      <td>[Clinical Trial, Journal Article, Multicenter ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>35264424</td>\n",
       "      <td>Levels of Neurofilament Light at the Preataxic...</td>\n",
       "      <td>Wilke C; Mengel D; Schöls L; Hengel H; Rakowic...</td>\n",
       "      <td>10.1212/WNL.0000000000200257</td>\n",
       "      <td>2022/05/17 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>23707147</td>\n",
       "      <td>Biological and clinical characteristics of ind...</td>\n",
       "      <td>Jacobi H; Reetz K; du Montcel ST; Bauer P; Mar...</td>\n",
       "      <td>10.1016/S1474-4422(13)70104-2</td>\n",
       "      <td>2013/07/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>24780882</td>\n",
       "      <td>Prediction of the age at onset in spinocerebel...</td>\n",
       "      <td>Tezenas du Montcel S; Durr A; Rakowicz M; Nane...</td>\n",
       "      <td>10.1136/jmedgenet-2013-102200</td>\n",
       "      <td>2014/07/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>498 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId      pmid                                              title  \\\n",
       "0    NCT02777229  33355914  Cost-Utility Analysis of a Dolutegravir-Based ...   \n",
       "1    NCT02777229  33010241  Dolutegravir-based and low-dose efavirenz-base...   \n",
       "2    NCT02777229  38156046  Durability of the Efficacy and Safety of Dolut...   \n",
       "3    NCT02777229  37851566  Improvements in Patient-Reported Outcomes Foll...   \n",
       "4    NCT02777229  31339676  Dolutegravir-Based or Low-Dose Efavirenz-Based...   \n",
       "..           ...       ...                                                ...   \n",
       "493  NCT02172677       NaN                                                NaN   \n",
       "494  NCT01037777  32822634  Conversion of individuals at risk for spinocer...   \n",
       "495  NCT01037777  35264424  Levels of Neurofilament Light at the Preataxic...   \n",
       "496  NCT01037777  23707147  Biological and clinical characteristics of ind...   \n",
       "497  NCT01037777  24780882  Prediction of the age at onset in spinocerebel...   \n",
       "\n",
       "                                               authors  \\\n",
       "0    Bousmah MA; Nishimwe ML; Tovar-Sanchez T; Lant...   \n",
       "1    Calmy A; Tovar Sanchez T; Kouanfack C; Mpoudi-...   \n",
       "2    Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...   \n",
       "3    Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...   \n",
       "4    NAMSAL ANRS 12313 Study Group; Kouanfack C; Mp...   \n",
       "..                                                 ...   \n",
       "493                                                NaN   \n",
       "494  Jacobi H; du Montcel ST; Romanzetti S; Harmuth...   \n",
       "495  Wilke C; Mengel D; Schöls L; Hengel H; Rakowic...   \n",
       "496  Jacobi H; Reetz K; du Montcel ST; Bauer P; Mar...   \n",
       "497  Tezenas du Montcel S; Durr A; Rakowicz M; Nane...   \n",
       "\n",
       "                               doi              date  \\\n",
       "0       10.1007/s40273-020-00987-3  2021/03/01 00:00   \n",
       "1    10.1016/S2352-3018(20)30238-1  2020/10/01 00:00   \n",
       "2             10.1093/ofid/ofad582  2023/11/20 00:00   \n",
       "3     10.1097/QAI.0000000000003273  2023/11/01 00:00   \n",
       "4            10.1056/NEJMoa1904340  2019/08/29 00:00   \n",
       "..                             ...               ...   \n",
       "493                            NaN               NaN   \n",
       "494  10.1016/S1474-4422(20)30235-0  2020/09/01 00:00   \n",
       "495   10.1212/WNL.0000000000200257  2022/05/17 00:00   \n",
       "496  10.1016/S1474-4422(13)70104-2  2013/07/01 00:00   \n",
       "497  10.1136/jmedgenet-2013-102200  2014/07/01 00:00   \n",
       "\n",
       "                                     publication_types  \n",
       "0                                    [Journal Article]  \n",
       "1    [Journal Article, Multicenter Study, Randomize...  \n",
       "2                                    [Journal Article]  \n",
       "3       [Randomized Controlled Trial, Journal Article]  \n",
       "4    [Journal Article, Multicenter Study, Randomize...  \n",
       "..                                                 ...  \n",
       "493                                                NaN  \n",
       "494  [Clinical Trial, Journal Article, Multicenter ...  \n",
       "495                                  [Journal Article]  \n",
       "496                                  [Journal Article]  \n",
       "497                                  [Journal Article]  \n",
       "\n",
       "[498 rows x 7 columns]"
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed = df_pubmed.join(\n",
    "    df_pubmed_publications,\n",
    "    validate = 'one_to_one',\n",
    ")\n",
    "df_pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cb881be8-1255-4040-bad6-6e2952e20a06",
   "metadata": {},
   "source": [
    "### Jointure des DataFrame de CT et Pubmed:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "f4df0c6f-686a-4553-b2c4-de58040349af",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>date</th>\n",
       "      <th>publication_types</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>33355914</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Cost-Utility Analysis of a Dolutegravir-Based ...</td>\n",
       "      <td>Bousmah MA; Nishimwe ML; Tovar-Sanchez T; Lant...</td>\n",
       "      <td>10.1007/s40273-020-00987-3</td>\n",
       "      <td>2021/03/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>33010241</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Dolutegravir-based and low-dose efavirenz-base...</td>\n",
       "      <td>Calmy A; Tovar Sanchez T; Kouanfack C; Mpoudi-...</td>\n",
       "      <td>10.1016/S2352-3018(20)30238-1</td>\n",
       "      <td>2020/10/01 00:00</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38156046</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Durability of the Efficacy and Safety of Dolut...</td>\n",
       "      <td>Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...</td>\n",
       "      <td>10.1093/ofid/ofad582</td>\n",
       "      <td>2023/11/20 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37851566</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Improvements in Patient-Reported Outcomes Foll...</td>\n",
       "      <td>Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...</td>\n",
       "      <td>10.1097/QAI.0000000000003273</td>\n",
       "      <td>2023/11/01 00:00</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>31339676</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Dolutegravir-Based or Low-Dose Efavirenz-Based...</td>\n",
       "      <td>NAMSAL ANRS 12313 Study Group; Kouanfack C; Mp...</td>\n",
       "      <td>10.1056/NEJMoa1904340</td>\n",
       "      <td>2019/08/29 00:00</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493</th>\n",
       "      <td>NCT02172677</td>\n",
       "      <td>The Influence of Collective Schemas on Individ...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>La Région Basse-Normandie | Université de Caen...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-06-24</td>\n",
       "      <td>2014-10</td>\n",
       "      <td>2016-10-14</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>32822634</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Conversion of individuals at risk for spinocer...</td>\n",
       "      <td>Jacobi H; du Montcel ST; Romanzetti S; Harmuth...</td>\n",
       "      <td>10.1016/S1474-4422(20)30235-0</td>\n",
       "      <td>2020/09/01 00:00</td>\n",
       "      <td>[Clinical Trial, Journal Article, Multicenter ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>35264424</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Levels of Neurofilament Light at the Preataxic...</td>\n",
       "      <td>Wilke C; Mengel D; Schöls L; Hengel H; Rakowic...</td>\n",
       "      <td>10.1212/WNL.0000000000200257</td>\n",
       "      <td>2022/05/17 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>23707147</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Biological and clinical characteristics of ind...</td>\n",
       "      <td>Jacobi H; Reetz K; du Montcel ST; Bauer P; Mar...</td>\n",
       "      <td>10.1016/S1474-4422(13)70104-2</td>\n",
       "      <td>2013/07/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>24780882</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Prediction of the age at onset in spinocerebel...</td>\n",
       "      <td>Tezenas du Montcel S; Durr A; Rakowicz M; Nane...</td>\n",
       "      <td>10.1136/jmedgenet-2013-102200</td>\n",
       "      <td>2014/07/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>498 rows × 17 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "1    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "2    NCT02777229                                               <NA>   \n",
       "3    NCT02777229                                               <NA>   \n",
       "4    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "..           ...                                                ...   \n",
       "493  NCT02172677  The Influence of Collective Schemas on Individ...   \n",
       "494  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "495  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "496  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "497  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0                   ANRS, Emerging Infectious Diseases   \n",
       "1                   ANRS, Emerging Infectious Diseases   \n",
       "2                                                 <NA>   \n",
       "3                                                 <NA>   \n",
       "4                   ANRS, Emerging Infectious Diseases   \n",
       "..                                                 ...   \n",
       "493  Institut National de la Santé Et de la Recherc...   \n",
       "494  Institut National de la Santé Et de la Recherc...   \n",
       "495  Institut National de la Santé Et de la Recherc...   \n",
       "496  Institut National de la Santé Et de la Recherc...   \n",
       "497  Institut National de la Santé Et de la Recherc...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "1    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "2                                                 <NA>          <NA>   \n",
       "3                                                 <NA>          <NA>   \n",
       "4    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "493  La Région Basse-Normandie | Université de Caen...     COMPLETED   \n",
       "494                                               <NA>     COMPLETED   \n",
       "495                                               <NA>     COMPLETED   \n",
       "496                                               <NA>     COMPLETED   \n",
       "497                                               <NA>     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate   StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "1    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "2              <NA>        <NA>               <NA>        <NA>           <NA>   \n",
       "3              <NA>        <NA>               <NA>        <NA>           <NA>   \n",
       "4    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "..              ...         ...                ...         ...            ...   \n",
       "493  INTERVENTIONAL       False         2014-06-24     2014-10     2016-10-14   \n",
       "494   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "495   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "496   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "497   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "\n",
       "         pmid     type                                              title  \\\n",
       "0    33355914  DERIVED  Cost-Utility Analysis of a Dolutegravir-Based ...   \n",
       "1    33010241  DERIVED  Dolutegravir-based and low-dose efavirenz-base...   \n",
       "2    38156046     <NA>  Durability of the Efficacy and Safety of Dolut...   \n",
       "3    37851566     <NA>  Improvements in Patient-Reported Outcomes Foll...   \n",
       "4    31339676  DERIVED  Dolutegravir-Based or Low-Dose Efavirenz-Based...   \n",
       "..        ...      ...                                                ...   \n",
       "493      <NA>     <NA>                                                NaN   \n",
       "494  32822634  DERIVED  Conversion of individuals at risk for spinocer...   \n",
       "495  35264424  DERIVED  Levels of Neurofilament Light at the Preataxic...   \n",
       "496  23707147  DERIVED  Biological and clinical characteristics of ind...   \n",
       "497  24780882  DERIVED  Prediction of the age at onset in spinocerebel...   \n",
       "\n",
       "                                               authors  \\\n",
       "0    Bousmah MA; Nishimwe ML; Tovar-Sanchez T; Lant...   \n",
       "1    Calmy A; Tovar Sanchez T; Kouanfack C; Mpoudi-...   \n",
       "2    Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...   \n",
       "3    Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...   \n",
       "4    NAMSAL ANRS 12313 Study Group; Kouanfack C; Mp...   \n",
       "..                                                 ...   \n",
       "493                                                NaN   \n",
       "494  Jacobi H; du Montcel ST; Romanzetti S; Harmuth...   \n",
       "495  Wilke C; Mengel D; Schöls L; Hengel H; Rakowic...   \n",
       "496  Jacobi H; Reetz K; du Montcel ST; Bauer P; Mar...   \n",
       "497  Tezenas du Montcel S; Durr A; Rakowicz M; Nane...   \n",
       "\n",
       "                               doi              date  \\\n",
       "0       10.1007/s40273-020-00987-3  2021/03/01 00:00   \n",
       "1    10.1016/S2352-3018(20)30238-1  2020/10/01 00:00   \n",
       "2             10.1093/ofid/ofad582  2023/11/20 00:00   \n",
       "3     10.1097/QAI.0000000000003273  2023/11/01 00:00   \n",
       "4            10.1056/NEJMoa1904340  2019/08/29 00:00   \n",
       "..                             ...               ...   \n",
       "493                            NaN               NaN   \n",
       "494  10.1016/S1474-4422(20)30235-0  2020/09/01 00:00   \n",
       "495   10.1212/WNL.0000000000200257  2022/05/17 00:00   \n",
       "496  10.1016/S1474-4422(13)70104-2  2013/07/01 00:00   \n",
       "497  10.1136/jmedgenet-2013-102200  2014/07/01 00:00   \n",
       "\n",
       "                                     publication_types  \n",
       "0                                    [Journal Article]  \n",
       "1    [Journal Article, Multicenter Study, Randomize...  \n",
       "2                                    [Journal Article]  \n",
       "3       [Randomized Controlled Trial, Journal Article]  \n",
       "4    [Journal Article, Multicenter Study, Randomize...  \n",
       "..                                                 ...  \n",
       "493                                                NaN  \n",
       "494  [Clinical Trial, Journal Article, Multicenter ...  \n",
       "495                                  [Journal Article]  \n",
       "496                                  [Journal Article]  \n",
       "497                                  [Journal Article]  \n",
       "\n",
       "[498 rows x 17 columns]"
      ]
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final = df_ct.merge(\n",
    "    df_pubmed, \n",
    "    on = ['NCTId', 'pmid'], \n",
    "    how = 'right',\n",
    "    validate = 'one_to_one',\n",
    ")\n",
    "\n",
    "# Remove 'citation' column\n",
    "df_final = df_final.drop(columns='citation')\n",
    "\n",
    "df_final"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d9e57d72-548d-43df-a342-ee08c83dd14c",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "7d497973-5788-41e4-a541-c326b32ffb83",
   "metadata": {},
   "source": [
    "Les nouveaux PMIDs trouvés via Pubmed, n'ont aucune des infos associées avec CT présentes: BriefTitle, LeadSponsorName, etc ..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "e83f92d2-39b0-4653-8ab5-9766b16f4da4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT01703962</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>NCT01453192</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>NCT01473472</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>NCT03335995</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>NCT02212379</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>NCT01426243</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>NCT03870438</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId BriefTitle LeadSponsorName CollaboratorName OverallStatus  \\\n",
       "2    NCT02777229       <NA>            <NA>             <NA>          <NA>   \n",
       "3    NCT02777229       <NA>            <NA>             <NA>          <NA>   \n",
       "7    NCT05349162       <NA>            <NA>             <NA>          <NA>   \n",
       "8    NCT01703962       <NA>            <NA>             <NA>          <NA>   \n",
       "15   NCT01453192       <NA>            <NA>             <NA>          <NA>   \n",
       "52   NCT01473472       <NA>            <NA>             <NA>          <NA>   \n",
       "61   NCT03335995       <NA>            <NA>             <NA>          <NA>   \n",
       "91   NCT02212379       <NA>            <NA>             <NA>          <NA>   \n",
       "94   NCT01426243       <NA>            <NA>             <NA>          <NA>   \n",
       "143  NCT03870438       <NA>            <NA>             <NA>          <NA>   \n",
       "\n",
       "    StudyType  HasResults StudyFirstPostDate StartDate CompletionDate  type  \n",
       "2        <NA>        <NA>               <NA>      <NA>           <NA>  <NA>  \n",
       "3        <NA>        <NA>               <NA>      <NA>           <NA>  <NA>  \n",
       "7        <NA>        <NA>               <NA>      <NA>           <NA>  <NA>  \n",
       "8        <NA>        <NA>               <NA>      <NA>           <NA>  <NA>  \n",
       "15       <NA>        <NA>               <NA>      <NA>           <NA>  <NA>  \n",
       "52       <NA>        <NA>               <NA>      <NA>           <NA>  <NA>  \n",
       "61       <NA>        <NA>               <NA>      <NA>           <NA>  <NA>  \n",
       "91       <NA>        <NA>               <NA>      <NA>           <NA>  <NA>  \n",
       "94       <NA>        <NA>               <NA>      <NA>           <NA>  <NA>  \n",
       "143      <NA>        <NA>               <NA>      <NA>           <NA>  <NA>  "
      ]
     },
     "execution_count": 71,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Index of empty rows we need to fill\n",
    "index_empty_rows = df_final.loc[:, 'BriefTitle'].isna()\n",
    "\n",
    "# Columns we need to fill\n",
    "columns_to_fill = [\n",
    "    'BriefTitle',\n",
    "    'LeadSponsorName',\n",
    "    'CollaboratorName',\n",
    "    'OverallStatus',\n",
    "    'StudyType',\n",
    "    'HasResults',\n",
    "    'StudyFirstPostDate',\n",
    "    'StartDate',\n",
    "    'CompletionDate',\n",
    "    'type',\n",
    "]\n",
    "\n",
    "df_final.loc[index_empty_rows, ['NCTId'] + columns_to_fill].head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2d9866a6",
   "metadata": {},
   "source": [
    "On rajoute un type 'PUBMED' pour les PMIDs issues de PubMed uniquement:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "05507df2",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Add new 'PUBMED' category\n",
    "df_final['type'] = df_final['type'].cat.add_categories('PUBMED').astype('category')\n",
    "\n",
    "# We add a 'PUBMED' type to the PMIDs extracted from Pubmed exclusively\n",
    "df_final.loc[index_empty_rows, 'type'] = 'PUBMED'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "id": "50ec3c16",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT01703962</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>NCT01453192</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>NCT01473472</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>NCT03335995</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>NCT02212379</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>NCT01426243</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>NCT03870438</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId BriefTitle LeadSponsorName CollaboratorName OverallStatus  \\\n",
       "2    NCT02777229       <NA>            <NA>             <NA>          <NA>   \n",
       "3    NCT02777229       <NA>            <NA>             <NA>          <NA>   \n",
       "7    NCT05349162       <NA>            <NA>             <NA>          <NA>   \n",
       "8    NCT01703962       <NA>            <NA>             <NA>          <NA>   \n",
       "15   NCT01453192       <NA>            <NA>             <NA>          <NA>   \n",
       "52   NCT01473472       <NA>            <NA>             <NA>          <NA>   \n",
       "61   NCT03335995       <NA>            <NA>             <NA>          <NA>   \n",
       "91   NCT02212379       <NA>            <NA>             <NA>          <NA>   \n",
       "94   NCT01426243       <NA>            <NA>             <NA>          <NA>   \n",
       "143  NCT03870438       <NA>            <NA>             <NA>          <NA>   \n",
       "\n",
       "    StudyType  HasResults StudyFirstPostDate StartDate CompletionDate    type  \n",
       "2        <NA>        <NA>               <NA>      <NA>           <NA>  PUBMED  \n",
       "3        <NA>        <NA>               <NA>      <NA>           <NA>  PUBMED  \n",
       "7        <NA>        <NA>               <NA>      <NA>           <NA>  PUBMED  \n",
       "8        <NA>        <NA>               <NA>      <NA>           <NA>  PUBMED  \n",
       "15       <NA>        <NA>               <NA>      <NA>           <NA>  PUBMED  \n",
       "52       <NA>        <NA>               <NA>      <NA>           <NA>  PUBMED  \n",
       "61       <NA>        <NA>               <NA>      <NA>           <NA>  PUBMED  \n",
       "91       <NA>        <NA>               <NA>      <NA>           <NA>  PUBMED  \n",
       "94       <NA>        <NA>               <NA>      <NA>           <NA>  PUBMED  \n",
       "143      <NA>        <NA>               <NA>      <NA>           <NA>  PUBMED  "
      ]
     },
     "execution_count": 73,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final.loc[index_empty_rows, ['NCTId'] + columns_to_fill].head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fc08104a-116a-4a29-9212-2e5b60fbee3f",
   "metadata": {},
   "source": [
    "On va remplir ces colonnes avec les infos contenus dans la DataFrame CT:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "e2bb2823",
   "metadata": {},
   "outputs": [],
   "source": [
    "# NCTIds of empty rows\n",
    "NCTIds_empty_rows = df_final.loc[index_empty_rows, 'NCTId']\n",
    "\n",
    "# Columns we wish to copy\n",
    "columns_to_copy = [\n",
    "    'BriefTitle',\n",
    "    'LeadSponsorName',\n",
    "    'CollaboratorName',\n",
    "    'OverallStatus',\n",
    "    'StudyType',\n",
    "    'HasResults',\n",
    "    'StudyFirstPostDate',\n",
    "    'StartDate',\n",
    "    'CompletionDate',\n",
    "]\n",
    "\n",
    "# We copy the missing values from the CT dataframe\n",
    "for index, nctid in NCTIds_empty_rows.items():\n",
    "    # For an NCTId, we look in the CT dataframe for the first row with this NCTDId\n",
    "    # and copy the missings columns\n",
    "    df_final.loc[index, columns_to_copy] = df_ct.loc[\n",
    "        df_ct.loc[:, 'NCTId'] == nctid, columns_to_copy\n",
    "    ].iloc[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "cce5605e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>Epicardial vs. Transvenous ICDs in Children</td>\n",
       "      <td>Paris Cardiovascular Research Center (Inserm U...</td>\n",
       "      <td>Hôpital Necker-Enfants Malades</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2022-04-27</td>\n",
       "      <td>2003-01-01</td>\n",
       "      <td>2022-04-01</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT01703962</td>\n",
       "      <td>Non Invasive IDentification of Gliomas With ID...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2012-10-11</td>\n",
       "      <td>2012-03-14</td>\n",
       "      <td>2014-03-20</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>NCT01453192</td>\n",
       "      <td>Renal Transplantation and Raltegravir in HIV-I...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2011-10-17</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2015-11</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>NCT01473472</td>\n",
       "      <td>On Demand Antiretroviral Pre-exposure Prophyla...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2011-11-17</td>\n",
       "      <td>2012-01</td>\n",
       "      <td>2016-12-15</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>NCT03335995</td>\n",
       "      <td>Stroke Prognosis in Intensive CarE</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2017-11-08</td>\n",
       "      <td>2017-10-18</td>\n",
       "      <td>2020-11-18</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>NCT02212379</td>\n",
       "      <td>Capacity of the Dual Combination Raltegravir/E...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC | Janssen-Cilag Ltd.</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2014-08-08</td>\n",
       "      <td>2015-01</td>\n",
       "      <td>2018-04</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>NCT01426243</td>\n",
       "      <td>The Yellow Fever Vaccine Immunity in HIV Infec...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2011-08-31</td>\n",
       "      <td>2011-07</td>\n",
       "      <td>2017-12</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>NCT03870438</td>\n",
       "      <td>Prevention of Mother-to-child Transmission of ...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>University Teaching Hospital, Lusaka, Zambia |...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2019-03-12</td>\n",
       "      <td>2019-12-14</td>\n",
       "      <td>2022-10-31</td>\n",
       "      <td>PUBMED</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "2    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "3    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "7    NCT05349162        Epicardial vs. Transvenous ICDs in Children   \n",
       "8    NCT01703962  Non Invasive IDentification of Gliomas With ID...   \n",
       "15   NCT01453192  Renal Transplantation and Raltegravir in HIV-I...   \n",
       "52   NCT01473472  On Demand Antiretroviral Pre-exposure Prophyla...   \n",
       "61   NCT03335995                 Stroke Prognosis in Intensive CarE   \n",
       "91   NCT02212379  Capacity of the Dual Combination Raltegravir/E...   \n",
       "94   NCT01426243  The Yellow Fever Vaccine Immunity in HIV Infec...   \n",
       "143  NCT03870438  Prevention of Mother-to-child Transmission of ...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "2                   ANRS, Emerging Infectious Diseases   \n",
       "3                   ANRS, Emerging Infectious Diseases   \n",
       "7    Paris Cardiovascular Research Center (Inserm U...   \n",
       "8    Institut National de la Santé Et de la Recherc...   \n",
       "15                  ANRS, Emerging Infectious Diseases   \n",
       "52                  ANRS, Emerging Infectious Diseases   \n",
       "61   Institut National de la Santé Et de la Recherc...   \n",
       "91                  ANRS, Emerging Infectious Diseases   \n",
       "94   French National Agency for Research on AIDS an...   \n",
       "143                 ANRS, Emerging Infectious Diseases   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "2    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "3    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "7                       Hôpital Necker-Enfants Malades     COMPLETED   \n",
       "8                                                 <NA>     COMPLETED   \n",
       "15                             Merck Sharp & Dohme LLC     COMPLETED   \n",
       "52                                                <NA>     COMPLETED   \n",
       "61                                                <NA>     COMPLETED   \n",
       "91        Merck Sharp & Dohme LLC | Janssen-Cilag Ltd.     COMPLETED   \n",
       "94                                                <NA>     COMPLETED   \n",
       "143  University Teaching Hospital, Lusaka, Zambia |...     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate   StartDate CompletionDate  \\\n",
       "2    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "3    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "7     OBSERVATIONAL       False         2022-04-27  2003-01-01     2022-04-01   \n",
       "8     OBSERVATIONAL       False         2012-10-11  2012-03-14     2014-03-20   \n",
       "15   INTERVENTIONAL       False         2011-10-17     2011-12        2015-11   \n",
       "52   INTERVENTIONAL       False         2011-11-17     2012-01     2016-12-15   \n",
       "61    OBSERVATIONAL       False         2017-11-08  2017-10-18     2020-11-18   \n",
       "91   INTERVENTIONAL        True         2014-08-08     2015-01        2018-04   \n",
       "94   INTERVENTIONAL       False         2011-08-31     2011-07        2017-12   \n",
       "143  INTERVENTIONAL       False         2019-03-12  2019-12-14     2022-10-31   \n",
       "\n",
       "       type  \n",
       "2    PUBMED  \n",
       "3    PUBMED  \n",
       "7    PUBMED  \n",
       "8    PUBMED  \n",
       "15   PUBMED  \n",
       "52   PUBMED  \n",
       "61   PUBMED  \n",
       "91   PUBMED  \n",
       "94   PUBMED  \n",
       "143  PUBMED  "
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final.loc[index_empty_rows, ['NCTId'] + columns_to_fill].head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d4c772a3-370d-44e0-aa17-911fde201acc",
   "metadata": {},
   "source": [
    "# Verification du status Open Access via l'API d'Unpaywall:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6a3a98bf-8789-440d-80f8-90d249c9c325",
   "metadata": {},
   "source": [
    "Ne pas oublier que le DOI peut être vide :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "82977170-c66d-43dd-beaf-e22702b402d6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>358</th>\n",
       "      <td>NCT03537196</td>\n",
       "      <td>19839502</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>High prevalence of Hepatitis C virus genotype ...</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId      pmid        type  \\\n",
       "358  NCT03537196  19839502  BACKGROUND   \n",
       "\n",
       "                                                 title   doi  \n",
       "358  High prevalence of Hepatitis C virus genotype ...  None  "
      ]
     },
     "execution_count": 76,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# df_from_excel.loc[df_from_excel.loc[:, 'doi'].isna()]\n",
    "mask_doi_na = (df_final.loc[:, 'pmid'].notna() & df_final.loc[:, 'doi'].isna())\n",
    "df_final.loc[mask_doi_na, ['NCTId', 'pmid', 'type', 'title', 'doi']]\t"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "83d2616f-ce2e-4bff-847f-0236232e36b5",
   "metadata": {},
   "source": [
    "#### Envoi de la requête :"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "63ee8308-ef84-4e66-bcbf-84b9a69c2ca0",
   "metadata": {},
   "source": [
    "L'utilisation de l'API d'Unpaywall nécessite d'inclure son adresse email dans la requête:\n",
    "\n",
    "> **Authentication**  \n",
    "> Requests must include your email as a parameter at the end of the URL, like this: api.unpaywall.org/my/request?email=YOUR_EMAIL.\n",
    "\n",
    "Pour éviter de diffuser trop largement son adresse email, plutôt que de l'inclure dans le notebook, on l'exporte comme variable d'environnement, comme on l'a fait pour la clé API Pubmed.\n",
    "\n",
    "Ajouter `EMAIL_ADDRESS` aux variables d'environnement avec la commande suivante dans un Terminal:\n",
    "\n",
    "**Windows :** \n",
    "\n",
    "`setx EMAIL_ADDRESS \"unpaywall_01@example.com\"`\n",
    "\n",
    "**Linux/MacOS :**\n",
    "\n",
    "`export EMAIL_ADDRESS=unpaywall_01@example.com`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "bae4b08d-ff66-428e-a086-b657a011c1e5",
   "metadata": {},
   "outputs": [],
   "source": [
    "assert os.getenv('EMAIL_ADDRESS', None) is not None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "945c7a38-4f95-475c-aadd-5ae3d2444635",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "498 / 498..."
     ]
    }
   ],
   "source": [
    "# counter = 0  # To keep track of progress\n",
    "dois = df_final.loc[:, 'doi']\n",
    "num_dois = len(dois)\n",
    "session = requests.Session()\n",
    "\n",
    "# TODO: Use dictionnary {'NCTId': ..., 'doi': ..., 'is_oa': ...} instead of relying on the list order ?\n",
    "is_oa_list = []\n",
    "for i, doi in enumerate(dois):\n",
    "    # Display the progress on a single line\n",
    "    print(f'\\r{i+1} / {num_dois}...', end='', flush=True)\n",
    "\n",
    "    # Test if DOI is NaN\n",
    "    if pd.isna(doi):\n",
    "        # Add to the list (NaN, NaN)\n",
    "        is_oa_list.append((doi, doi))\n",
    "    else:\n",
    "        # Query Unpaywall's API\n",
    "        \n",
    "        # TODO: remove example address\n",
    "        query_url = f'https://api.unpaywall.org/v2/{doi}?email={os.getenv('EMAIL_ADDRESS')}'\n",
    "        response = session.get(query_url)\n",
    "        response.raise_for_status()\n",
    "    \n",
    "        # Add to the list ('doi', 'is_oa')\n",
    "        is_oa_list.append((doi, response.json()['is_oa']))\n",
    "# is_oa_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "id": "96f7e33a-718c-470d-ba33-1ad16caeb866",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>doi</th>\n",
       "      <th>is_oa</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10.1007/s40273-020-00987-3</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>10.1016/S2352-3018(20)30238-1</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>10.1093/ofid/ofad582</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10.1097/QAI.0000000000003273</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>10.1056/NEJMoa1904340</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>10.1016/S1474-4422(20)30235-0</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>10.1212/WNL.0000000000200257</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>10.1016/S1474-4422(13)70104-2</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>10.1136/jmedgenet-2013-102200</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>498 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                               doi  is_oa\n",
       "0       10.1007/s40273-020-00987-3   True\n",
       "1    10.1016/S2352-3018(20)30238-1  False\n",
       "2             10.1093/ofid/ofad582   True\n",
       "3     10.1097/QAI.0000000000003273  False\n",
       "4            10.1056/NEJMoa1904340   True\n",
       "..                             ...    ...\n",
       "493                            NaN    NaN\n",
       "494  10.1016/S1474-4422(20)30235-0   True\n",
       "495   10.1212/WNL.0000000000200257   True\n",
       "496  10.1016/S1474-4422(13)70104-2  False\n",
       "497  10.1136/jmedgenet-2013-102200   True\n",
       "\n",
       "[498 rows x 2 columns]"
      ]
     },
     "execution_count": 79,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_is_oa = pd.DataFrame(is_oa_list, columns=['doi', 'is_oa'])\n",
    "df_is_oa"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "15a6c313-d2cd-4ba5-a6be-3cb752de7f22",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>date</th>\n",
       "      <th>publication_types</th>\n",
       "      <th>is_oa</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>33355914</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Cost-Utility Analysis of a Dolutegravir-Based ...</td>\n",
       "      <td>Bousmah MA; Nishimwe ML; Tovar-Sanchez T; Lant...</td>\n",
       "      <td>10.1007/s40273-020-00987-3</td>\n",
       "      <td>2021/03/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>33010241</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Dolutegravir-based and low-dose efavirenz-base...</td>\n",
       "      <td>Calmy A; Tovar Sanchez T; Kouanfack C; Mpoudi-...</td>\n",
       "      <td>10.1016/S2352-3018(20)30238-1</td>\n",
       "      <td>2020/10/01 00:00</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>38156046</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Durability of the Efficacy and Safety of Dolut...</td>\n",
       "      <td>Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...</td>\n",
       "      <td>10.1093/ofid/ofad582</td>\n",
       "      <td>2023/11/20 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>37851566</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Improvements in Patient-Reported Outcomes Foll...</td>\n",
       "      <td>Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...</td>\n",
       "      <td>10.1097/QAI.0000000000003273</td>\n",
       "      <td>2023/11/01 00:00</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article]</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>31339676</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Dolutegravir-Based or Low-Dose Efavirenz-Based...</td>\n",
       "      <td>NAMSAL ANRS 12313 Study Group; Kouanfack C; Mp...</td>\n",
       "      <td>10.1056/NEJMoa1904340</td>\n",
       "      <td>2019/08/29 00:00</td>\n",
       "      <td>[Journal Article, Multicenter Study, Randomize...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493</th>\n",
       "      <td>NCT02172677</td>\n",
       "      <td>The Influence of Collective Schemas on Individ...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>La Région Basse-Normandie | Université de Caen...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-06-24</td>\n",
       "      <td>2014-10</td>\n",
       "      <td>2016-10-14</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>32822634</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Conversion of individuals at risk for spinocer...</td>\n",
       "      <td>Jacobi H; du Montcel ST; Romanzetti S; Harmuth...</td>\n",
       "      <td>10.1016/S1474-4422(20)30235-0</td>\n",
       "      <td>2020/09/01 00:00</td>\n",
       "      <td>[Clinical Trial, Journal Article, Multicenter ...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>35264424</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Levels of Neurofilament Light at the Preataxic...</td>\n",
       "      <td>Wilke C; Mengel D; Schöls L; Hengel H; Rakowic...</td>\n",
       "      <td>10.1212/WNL.0000000000200257</td>\n",
       "      <td>2022/05/17 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>23707147</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Biological and clinical characteristics of ind...</td>\n",
       "      <td>Jacobi H; Reetz K; du Montcel ST; Bauer P; Mar...</td>\n",
       "      <td>10.1016/S1474-4422(13)70104-2</td>\n",
       "      <td>2013/07/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>NCT01037777</td>\n",
       "      <td>RISCA : Prospective Study of Individuals at Ri...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-23</td>\n",
       "      <td>2009-05-07</td>\n",
       "      <td>2017-12-14</td>\n",
       "      <td>24780882</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Prediction of the age at onset in spinocerebel...</td>\n",
       "      <td>Tezenas du Montcel S; Durr A; Rakowicz M; Nane...</td>\n",
       "      <td>10.1136/jmedgenet-2013-102200</td>\n",
       "      <td>2014/07/01 00:00</td>\n",
       "      <td>[Journal Article]</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>498 rows × 18 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "1    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "2    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "3    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "4    NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "..           ...                                                ...   \n",
       "493  NCT02172677  The Influence of Collective Schemas on Individ...   \n",
       "494  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "495  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "496  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "497  NCT01037777  RISCA : Prospective Study of Individuals at Ri...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0                   ANRS, Emerging Infectious Diseases   \n",
       "1                   ANRS, Emerging Infectious Diseases   \n",
       "2                   ANRS, Emerging Infectious Diseases   \n",
       "3                   ANRS, Emerging Infectious Diseases   \n",
       "4                   ANRS, Emerging Infectious Diseases   \n",
       "..                                                 ...   \n",
       "493  Institut National de la Santé Et de la Recherc...   \n",
       "494  Institut National de la Santé Et de la Recherc...   \n",
       "495  Institut National de la Santé Et de la Recherc...   \n",
       "496  Institut National de la Santé Et de la Recherc...   \n",
       "497  Institut National de la Santé Et de la Recherc...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "1    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "2    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "3    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "4    Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "493  La Région Basse-Normandie | Université de Caen...     COMPLETED   \n",
       "494                                               <NA>     COMPLETED   \n",
       "495                                               <NA>     COMPLETED   \n",
       "496                                               <NA>     COMPLETED   \n",
       "497                                               <NA>     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate   StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "1    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "2    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "3    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "4    INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "..              ...         ...                ...         ...            ...   \n",
       "493  INTERVENTIONAL       False         2014-06-24     2014-10     2016-10-14   \n",
       "494   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "495   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "496   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "497   OBSERVATIONAL       False         2009-12-23  2009-05-07     2017-12-14   \n",
       "\n",
       "         pmid     type                                              title  \\\n",
       "0    33355914  DERIVED  Cost-Utility Analysis of a Dolutegravir-Based ...   \n",
       "1    33010241  DERIVED  Dolutegravir-based and low-dose efavirenz-base...   \n",
       "2    38156046   PUBMED  Durability of the Efficacy and Safety of Dolut...   \n",
       "3    37851566   PUBMED  Improvements in Patient-Reported Outcomes Foll...   \n",
       "4    31339676  DERIVED  Dolutegravir-Based or Low-Dose Efavirenz-Based...   \n",
       "..        ...      ...                                                ...   \n",
       "493      <NA>      NaN                                                NaN   \n",
       "494  32822634  DERIVED  Conversion of individuals at risk for spinocer...   \n",
       "495  35264424  DERIVED  Levels of Neurofilament Light at the Preataxic...   \n",
       "496  23707147  DERIVED  Biological and clinical characteristics of ind...   \n",
       "497  24780882  DERIVED  Prediction of the age at onset in spinocerebel...   \n",
       "\n",
       "                                               authors  \\\n",
       "0    Bousmah MA; Nishimwe ML; Tovar-Sanchez T; Lant...   \n",
       "1    Calmy A; Tovar Sanchez T; Kouanfack C; Mpoudi-...   \n",
       "2    Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...   \n",
       "3    Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...   \n",
       "4    NAMSAL ANRS 12313 Study Group; Kouanfack C; Mp...   \n",
       "..                                                 ...   \n",
       "493                                                NaN   \n",
       "494  Jacobi H; du Montcel ST; Romanzetti S; Harmuth...   \n",
       "495  Wilke C; Mengel D; Schöls L; Hengel H; Rakowic...   \n",
       "496  Jacobi H; Reetz K; du Montcel ST; Bauer P; Mar...   \n",
       "497  Tezenas du Montcel S; Durr A; Rakowicz M; Nane...   \n",
       "\n",
       "                               doi              date  \\\n",
       "0       10.1007/s40273-020-00987-3  2021/03/01 00:00   \n",
       "1    10.1016/S2352-3018(20)30238-1  2020/10/01 00:00   \n",
       "2             10.1093/ofid/ofad582  2023/11/20 00:00   \n",
       "3     10.1097/QAI.0000000000003273  2023/11/01 00:00   \n",
       "4            10.1056/NEJMoa1904340  2019/08/29 00:00   \n",
       "..                             ...               ...   \n",
       "493                            NaN               NaN   \n",
       "494  10.1016/S1474-4422(20)30235-0  2020/09/01 00:00   \n",
       "495   10.1212/WNL.0000000000200257  2022/05/17 00:00   \n",
       "496  10.1016/S1474-4422(13)70104-2  2013/07/01 00:00   \n",
       "497  10.1136/jmedgenet-2013-102200  2014/07/01 00:00   \n",
       "\n",
       "                                     publication_types  is_oa  \n",
       "0                                    [Journal Article]   True  \n",
       "1    [Journal Article, Multicenter Study, Randomize...  False  \n",
       "2                                    [Journal Article]   True  \n",
       "3       [Randomized Controlled Trial, Journal Article]  False  \n",
       "4    [Journal Article, Multicenter Study, Randomize...   True  \n",
       "..                                                 ...    ...  \n",
       "493                                                NaN   <NA>  \n",
       "494  [Clinical Trial, Journal Article, Multicenter ...   True  \n",
       "495                                  [Journal Article]   True  \n",
       "496                                  [Journal Article]  False  \n",
       "497                                  [Journal Article]   True  \n",
       "\n",
       "[498 rows x 18 columns]"
      ]
     },
     "execution_count": 80,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_with_oa_status = df_final.join(\n",
    "    df_is_oa.loc[:, 'is_oa'].astype('boolean'),\n",
    "    validate = 'one_to_one',\n",
    ")\n",
    "# df_with_oa_status.loc[:, ['NCTId', 'pmid', 'doi', 'is_oa']]\n",
    "df_with_oa_status"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fdb1cec1-d9da-496d-904d-d21432d8e550",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "d5132e99-076f-46b6-9007-fa34d0abef35",
   "metadata": {},
   "source": [
    "### Resultat final:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "d31b1848-6436-4ac9-a8bd-bd3d63558aa3",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 498 entries, 0 to 497\n",
      "Data columns (total 18 columns):\n",
      " #   Column              Non-Null Count  Dtype   \n",
      "---  ------              --------------  -----   \n",
      " 0   NCTId               498 non-null    object  \n",
      " 1   BriefTitle          498 non-null    string  \n",
      " 2   LeadSponsorName     498 non-null    string  \n",
      " 3   CollaboratorName    224 non-null    string  \n",
      " 4   OverallStatus       498 non-null    category\n",
      " 5   StudyType           498 non-null    category\n",
      " 6   HasResults          498 non-null    boolean \n",
      " 7   StudyFirstPostDate  498 non-null    string  \n",
      " 8   StartDate           498 non-null    string  \n",
      " 9   CompletionDate      498 non-null    string  \n",
      " 10  pmid                393 non-null    object  \n",
      " 11  type                393 non-null    category\n",
      " 12  title               393 non-null    object  \n",
      " 13  authors             393 non-null    object  \n",
      " 14  doi                 392 non-null    object  \n",
      " 15  date                393 non-null    object  \n",
      " 16  publication_types   393 non-null    object  \n",
      " 17  is_oa               392 non-null    boolean \n",
      "dtypes: boolean(2), category(3), object(7), string(6)\n",
      "memory usage: 54.5+ KB\n"
     ]
    }
   ],
   "source": [
    "df_with_oa_status.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "52dafbcd-284c-4aa4-81f5-e2f6506a8105",
   "metadata": {},
   "source": [
    "# Export en CSV: "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "id": "062a8821-b680-4e5a-823e-256adda183e0",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_with_oa_status.to_csv(\n",
    "    'Data/outputs/df_extract.csv',\n",
    "    sep=';',\n",
    "    index=False,\n",
    "    encoding='utf-8-sig',\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fb7433f5",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "49f4e637-25ae-4ddf-871a-1d93e4f8b3dc",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
